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Bioluminescence imaging (BLI) is widely used in pre-clinical research to monitor the location
and migration of different cell types, and the growth of cancerous tumours and response to
treatments within murine models. However, the quantitative accuracy of the technique is
limited. The position of the animal is known to affect the measured bioluminescence, with a
change in position causing a change in measurement. Work presented here will address this
problem, validating a free space model in a murine model to produce surface bioluminescence
measurements which are independent of the position of the animal.
The position of the source within the animal and the underlying tissue attenuation also
affect the quantitative accuracy of bioluminescence measurements. An extension to biolumi-
nescence imaging, bioluminescence tomography (BLT), aims to overcome these problems by
recovering the three-dimensional distribution of the source within the animal. However, there
are limitations to the quantitative accuracy of BLT. Current reconstruction algorithms ignore
the bandwidth of band pass filters used for multi-spectral data collection for BLT. This work
develops a model which accounts for filter bandwidth in the BLT reconstruction. Simulation
data shows that when ignoring bandwidth the intensity of a bioluminescent source recon-
structed assuming a bandwidth of 20 nm is ⇠ 20⇥ that reconstructed assuming a bandwidth
of 1 nm. When the filter bandwidth was accounted for in the reconstruction this variation is
reduced to ⇠ 0.9⇥. When applied experimentally to data taken using a multi-modal optical
imaging system using a mouse-shaped phantom, the variation in intensity is reduced from
iii
⇠ 5⇥ to ⇠ 1.5⇥ when considering data acquired using filters of bandwidth 10 and ⇠ 20
nm. The model is also validated in a post mortem murine model with the intensity of the
recovered sources quantitatively comparable to the target source intensity, and two orders
of magnitude lower than the sources recovered ignoring the bandwidth. These results all
demonstrate the increased quantitative accuracy achieved when using the filter bandwidth
model presented in this thesis.
An additional limitation to the quantitative accuracy of BLT is that accurate knowledge
of the optical properties of the animal are required but are difficult to acquire. Work to
improve the quantitative accuracy by obtaining subject-specific optical properties through
use of a spectral derivative reconstruction method for diffuse optical tomography (DOT)
is presented. The model thus far has not been applied to measurements acquired using a
non-contact imaging system. The efficacy of the spectral derivative method as applied to
non-contact data is demonstrated through simulation using a heterogeneous mouse model,
and experimentally using a post mortem murine model. In both cases the recovered optical
properties are used as prior knowledge for BLT source recovery, producing promising results
for the application of the spectral derivative method in vivo.
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“If a thing is worth doing, it is worth doing well.
If it is worth having, it is worth waiting for.
If it is worth attaining, it is worth fighting for.
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Chapter 1
Introduction to Pre-Clinical Imaging
Pre-clinical studies use animal models to study the progression of a disease or efficacy of a
potential clinical therapy in vivo before moving forward to full in-human clinical trials. They
are vital for developing understanding of disease behaviour and the efficacy of novel drugs and
treatments in vivo, following preliminary in vitro and ex vivo studies. Further developments
to a treatment can then be made before proceeding to clinical trials and finally clinical use.
It is important to understand the behaviour of a certain condition or treatment in vivo and
animal models provide a complex environment in which to develop this understanding.
Imaging is an effective way to anatomically or functionally monitor disease progression
and response to treatment noninvasively during pre-clinical studies. Traditionally studies into
cancerous tumour growth for example, involved using a group of animals, all injected with
cancer cells at the same time point. To assess tumour growth, animals were sequentially
sacrificed and the tumour in each animal measured with calipers [1, 2]. This introduced
inter-animal variability, as the tumour measurement at each time point was made using a
different animal, as well as ethical issues in using a large number of animals. Imaging, such as:
magnetic resonance imaging (MRI); X-ray computed tomography (CT) or bioluminescence
imaging (BLI), enables the same study to be performed using a reduced number of animals,
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as the growth of the tumour in each animal can be monitored longitudinally throughout
the experimental timescale. Therefore, imaging reduces the number of animals used in the
experiment and removes the inter-animal variability of tumour growth, with each animal
acting as a self-control, which can improve the quantitative accuracy of the pre-clinical study
[1, 2].
This chapter will provide an overview of pre-clinical imaging techniques relevant to this
work: BLI, bioluminescence tomography (BLT) and diffuse optical tomography (DOT); and
a brief review of bioluminescence imaging systems, before a comparison of BLI and BLT with
other commonly used pre-clinical imaging modalities is made.
1.1 Pre-Clinical Imaging Techniques Relevant to this Work
1.1.1 Bioluminescence Imaging (BLI)
Bioluminescence imaging involves labelling cells of interest, for example cancer cells or stem
cells, with a bioluminescent reporter gene which emits light when a substrate is introduced.
Luciferases are often used as the bioluminescent source, these enzymes emit light through a
metabolic reaction, as described by simplified Eq. 1.1 [3, 4].
Luciferase+ Luciferin+ ATP +O
2
 ! Light+ oxyluciferin (1.1)
The process by which firefly luciferase (fluc) emits light is detailed in ref. [5]. Images of
the light which reaches the surface of the animal (via diffuse propagation through tissue, as
shown in Fig. 1.1) are taken, enabling the intensity or radiance to be measured and can be
used to gain information about the number of cells which are bioluminescently labelled. BLI
has many applications, for example in investigations of: the growth of cancerous tumours
and their response to treatments [1, 4, 6–12]; migration and location of stem cells [13–15];
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immune cells [12, 16,17]; bacteria [18–21] and viruses [19, 22,23].
Figure 1.1: Diagram to demonstrate BLI in a murine model. (a) Schematic of diffuse prop-
agation of bioluminescent light through tissue from a tumour. (b) BLI set-up, typically an
animal will be placed on an imaging platform with a CCD camera positioned above to capture
images of the bioluminescent light which has reached the surface of the animal.
A study performed by Jenkins et al. in 2003 demonstrated the ability of BLI to monitor
tumour growth and effect of treatment in a murine model [1]. Prostate cancer cells were
injected subcutaneously into the left flank of the mice. The size of the subcutaneous tumours
was measured at intervals over the course of 35 days using calipers and the volume calculated
from these measurements (measurement timeline shown in Fig. 1.2). Bioluminescence images
were also taken using an IVIS imaging system (Perkin Elmer) enabling the bioluminescent
signal to be monitored over the time-course of the experiment and therefore the growth of
the tumour to be monitored via the BLI measurement variation.
Fig. 1.2 A shows BLI images of mice from 0 to 28 days after injection of cells, without
treatment (‘Vehicle’) and with two different treatments: 5-FU which inhibits tumour growth,
and Mitomycin C which causes tumour regression [1]. As is seen in Fig. 1.2 A and B the
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Figure 1.2: (A) Bioluminescence images of a subcutaneous tumour, labelled with luciferase,
treated in three different ways: ‘Vehicle’ animals received no treatment; middle row treated
with ‘5-FU’ which inhibits tumour growth; bottom row treated with ‘Mitomycin C’ which
causes tumour regression. (B) Mean bioluminescence intensity (photon counts) of tumour.
(C) Mean tumour volume (mm3) as measured using calipers. Reproduced from ref. [1].
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bioluminescent signal in the untreated tumour increased over the course of 28 days, while that
from the 5-FU tumour increased until treatment at day 11, after which it remained constant,
and the signal from the Mitomycin C-treated tumour increased until treatment at day 11,
before decreasing. The trends observed were as expected from knowledge of the treatment
given in each case. The tumour volume measured using calipers (Fig. 1.2 C) follows a similar
trend to the BLI measurements, but BLI was able to detect smaller tumours, or groups of
cells, than were measurable by the calipers [1]. The study demonstrated how BLI can be used
to monitor tumour growth and treatment efficacy in a murine model longitudinally using the
same animal throughout the course of the experiment, thus decreasing the number of animals
required for the study.
It is important to choose the bioluminescent reporter carefully. Tissue is strongly absorb-
ing at wavelengths shorter than approximately 600 nm (Fig. 1.3 a) and so the bioluminescent
signal will be highly attenuated at these wavelengths. It is therefore desirable for biolumi-
nescent reporters to emit light at near-infrared (NIR) wavelengths where the attenuation is
lower. Multiple luciferase reporters are available, all with different spectral emission charac-
teristics [24,25], the emission spectra of a selection of luciferases are shown in Fig. 1.3 b. The
peak emission wavelength of fluc is 612 nm [25], tissue attenuation is low for wavelengths
above this peak emission wavelength (Fig. 1.3 a) and the signal is therefore subject to min-
imum attenuation and is able to propagate through the animal to the surface. However,
longer wavelength reporters are desirable.
BLI is extremely useful in a range of pre-clinical studies. However, the quantitative
accuracy of the technique is limited. The planar images obtained during BLI (such as those
shown in Fig. 1.2) give very little information about the position or size of the bioluminescent
source within the imaging subject, from these images it is impossible to determine any three-
dimensional information about the source. It is possible that a weak, diffuse source near the
surface of an animal could produce identical surface fluence to that from a stronger, more
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compact source deeper within the animal (demonstrated in Fig. 1.4) [26]. Bioluminescence
Tomography (BLT, Section 1.1.2) aims to address this. Further limitations to BLI include:
dependence of the measured bioluminescence on the position of the animal [27, 28] and the
underlying tissue attenuation [29, 30] (these limitations will be addressed and discussed in
more detail in Chapter 3, and Chapters 5 and 6 respectively), and additionally depends on
the level and type of anaesthesia [21,31], temperature [25,32] and substrate concentration [33]
(Eq. 1.1).
Figure 1.3: (a) Total attenuation of tissue, with contributions by oxy- and deoxy-
haemoglobin (HbO and deoxyHb) and water, assuming equal concentrations of HbO and
deoxyHb (1 mM). The water attenuation has been multiplied by a factor of 1000 due to the
low contribution compared to HbO and deoxyHb. (b) Emission spectra of four different lu-
ciferases which are currently available for bioluminescence studies, reproduced from ref. [24].
1.1.2 Bioluminescence Tomography (BLT)
BLT is an extension to BLI which provides three-dimensional volumetric information about
the bioluminescent source, i.e. providing more information about the size and shape of a
tumour for example, than BLI. BLT uses multi-spectral BLI data to reconstruct the three
dimensional position of the source within the animal, using reconstruction algorithms which
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use models of light propagation through tissue to estimate the true three-dimensional source
distribution (more detail on these algorithms in Chapter 2). Using multi-spectral BLI data
rather than data encompassing the entire emission spectrum of the reporter has been shown
to improve the quantitative accuracy of BLT by reducing the non-unique, ill-posed nature
of the reconstruction [26, 34]. The non-unique nature of BLT is shown in Fig. 1.4, both
sources (one deeper and more localised with a higher intensity, one superficial and diffuse
with a low intensity) give rise to the same surface measurements (Fig. 1.4 c). Acquiring data
at multiple wavelengths will enable these sources to be distinguished due to the differing
attenuation experienced by different wavelengths of light (Fig. 1.3 a).
Figure 1.4: (a) and (b) show two different bioluminescent sources, with different intensities,
as shown in the colourbars, which both give rise to identical surface measurements at the po-
sitions shown by the arrows. Surface measurements of both sources shown in (c). Reproduced
from ref. [26].
Model-based tomographic reconstruction requires knowledge of the shape of the imaging
subject (a three-dimensional model is required by the reconstruction algorithm), the internal
tissue attenuation and a model of light propagation through the medium. In this work, NIR-
FAST, a numerical modelling software package which implements the diffusion approximation
to the radiative transport equation via a finite element method (FEM) framework [35], is
used for all modelling of light transport through tissue. The application of NIRFAST to this
work will be described in Chapter 2.
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However, truly quantitative BLT is a challenge. It is vital to have accurate knowledge
of the optical properties of the imaging subject in order to perform quantitatively accurate
BLT [36,37]. When using BLT as a pre-clinical imaging technique the optical properties are
highly heterogeneous due to the underlying anatomy of the animal being imaged, so using
heterogeneous models of optical property distribution as opposed to homogeneous models is
important [29,30,32,38]. However, in practice heterogeneous models are not always adopted.
For example, a commonly used commercial optical imaging system, the IVIS Spectrum Pre
Clinical In Vivo Imaging System (IVIS), assumes homogeneous models of tissue attenuation
for use in BLT source recovery [39, 40]. Heterogeneous models can be derived from atlas
data [41, 42] or from complementary imaging modalities such as DOT [37, 43–47] and there
are multi-modal optical imaging systems which are able to perform both DOT and BLT
measurements [43, 46–49]. Chapters 5 and 6 present data applying a spectral derivative
(SD) DOT algorithm to data taken using a multi-modal optical imaging system, to obtain
underlying tissue attenuation for use in BLT source recovery.
Additionally, current reconstruction algorithms do not account for the bandwidth of band
pass filters used for multi-spectral data collection [26, 34, 35, 50–52]. Thus far the effect
this has on the quantitative accuracy of the recovered bioluminescent source has not been
assessed. Work to investigate this is presented in Chapter 4, and a model which accounts
for the filter bandwidth in the BLT reconstruction is introduced and validated. Chapter
6 presents data demonstrating the efficacy of the SD DOT algorithm in a murine model,
utilising the recovered optical property distribution in combined DOT-BLT, to validate both
the SD algorithm and the filter bandwidth model in a murine setting.
1.1.3 Diffuse Optical Tomography (DOT)
DOT is an optical imaging technique which is used to produce tomographic maps of attenu-






tissue chromophore concentrations. An array of light sources on the surface of the imaging
subject are illuminated sequentially, and the light which passes through the imaging subject
is detected at a number of locations across the surface. The sources can either be broad-band
illumination, with the detected signal filtered with band pass filters to measure the trans-
mitted NIR light at different wavelengths [48, 49], or discrete NIR wavelengths, using light
emitting diodes (LEDs) [53–55] or lasers or laser diodes [45,56,57]. The use of multi-spectral
data enables the attenuation to be determined at multiple wavelengths and enables the chro-
mophore concentrations to be determined if necessary. When performing DOT on human or
animal tissue the main chromophores present are oxyhaemoglobin (HbO), deoxyhaemoglobin
(deoxyHb) and water, and these are the chromophores which are considered in this work
(attenuation spectra shown in Fig. 1.3 a). Each tissue has different total attenuation due to
the different combinations of chromophores present, e.g. due to varying tissue oxygenation
causing variation of the ratio between HbO and deoxyHb.
In humans DOT has been shown to provide brain functionalisation maps comparable
to those achievable with functional magnetic resonance imaging (fMRI) [54, 55, 58]. At the
bedside DOT can be used to assess haemodynamics during seizures of neonates [56,59], and
functional connectivity in infants [53, 54, 60] and adults [61] through monitoring of tissue
oxygenation and blood volume changes. DOT can also be used to assess traumatic brain
injury [62] through identification of changes in blood concentration. The technique is also
used to differentiate cancerous from normal tissue by the different haemodynamic response of
the two tissue types, for example in breast cancer studies [63–67], and to identify arthritis in
joints in the human hand [68–71] through changes in attenuation of the joint due to chronic
inflammation.
As mentioned in Section 1.1.2 DOT can be used as a complementary imaging modality to
BLT, providing prior knowledge of the tissue optical properties, increasing the quantitative
accuracy of the BLT reconstruction [37,43–47]. This is how DOT is used in this work.
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1.1.4 Bioluminescence Imaging Systems
Over the past two decades bioluminescence imaging and tomography systems have developed
substantially. Early imaging systems with BLT capabilities consisted of a CCD camera
focused on a 360o rotating imaging platform which enabled images to be taken of the surface
fluence from multiple different angles [72–74]. Broadband emission data was collected, filters
were not used to obtain multi-spectral data. A disadvantage of these systems was the long
data acquisition time required due to separate images being taken at each angle, and so the
imaging throughput of these systems was low. Additionally, the emission of bioluminescent
reporters such as fluc have a window over which the maximum emission intensity of the
reporter occurs, for fluc this is ⇠10-20 minutes [75], but varies depending on the animal
model and bioluminescent reporter used [75, 76]. So due to the long acquisition time, use of
these early imaging systems in vivo presented a challenge.
Meanwhile, it was shown that using multi-spectral BLI data for tomographic source re-
construction enhanced the quantitative accuracy of the recovered source [26, 34]. This led
to developments to imaging systems to facilitate multi-spectral imaging, e.g. by including
filter wheels [40, 77]. Developments were also made to the 360o rotation stage to simplify
and streamline the multi-view imaging process by fixing the imaging platform and including
mirrors which were positioned around the imaging subject to provide multiple views of the
animal via the mirrors [49,77–79].
As stated earlier, both BLT and DOT reconstructions require knowledge of the three-
dimensional shape of the imaging subject. Further developments to imaging systems has
been made to enable this to be determined using a complementary modality such as CT or
MRI [30, 37, 38, 77, 80–82]. This can be either through incorporation of the system within
the optical imaging system or production of an animal holder to keep the animal in the
same position while it is moved between imaging systems. Structured light techniques have
also been used for acquisition of imaging subject topography [49,83,84], these are simpler to
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incorporate into existing optical systems and are more cost-effective and user friendly than
techniques such as CT or MRI.
The importance of accurately determining the optical properties of the imaging subject
for use in the BLT reconstruction was described in Section 1.1.2. Some systems adopt the
method of acquiring CT or MRI data and applying literature optical property values to
segmented tissue types [36, 77], others use integrated DOT systems to gain subject-specific
optical properties [43,47,49,85].
The optical imaging system used for the work presented in this thesis (BLDOT system,
Fig. 1.5) is a multi-modal optical imaging system with BLT, DOT and three-dimensional
surface capture (using structured light [83]) capabilities [48,49]. The system is based on the
simple BLT systems, with a fixed imaging platform and two right-angled mirrors which are
freely positioned on either side of the imaging subject to provide multi-view data in a single
CCD image. A filterwheel with six possible filter positions enables multi-spectral imaging
and DOT illumination is provided via patterned light projection (patterns customisable by
the user) using a projector, coupled via an optical fibre to a tungsten-halogen lamp [48, 49],
similarly to the method adopted in a combined DOT-fluorescence tomography system [86,87].
The remainder of this section will provide an overview of a selection of commercially
available bioluminescence imaging systems which are used in pre-clinical studies, and a com-
parison of these systems with the BLDOT system.
The capabilities of the imaging systems are summarised in Table 1.1. The IVIS Spec-
trum In Vivo Imaging System (IVIS) produced by Perkin Elmer is the most commonly
used commercial imaging system in pre-clinical research. The system is used in cancer re-
search [1,4,6–12], stem cell research [14,15] and work with immune cells [12,17], bacteria and
viruses [19–22]. The IVIS Spectrum is predominantly used for planar BLI imaging, where
BLI images are overlaid onto a bright image of the animal. Due to the customisable field


















enabling a high imaging throughput which is advantageous in pre-clinical studies. It is also
possible to perform BLT [40, 89, 98]. A laser galvanometer is used to produce a point cloud
of coordinates of the surface of the animal to create a three-dimensional model for use in
BLT reconstruction [84]. For animal imaging the optical properties used by the “DLIT 3D
source reconstruction” (DLIT: Diffuse Luminescence Imaging Tomography) are defined as
‘tissue’ (exact properties unknown) and are assumed to be homogeneous [39, 89] which will
introduce errors when performing animal BLT [52], where using heterogeneous optical prop-
erties for tomographic source recovery has been shown to improve the quantitative accuracy
of BLT [29,30,32,38]. Although the system is capable of multi-spectral imaging, during BLI
data collection an open filter is used, collecting data across the entire emission spectrum of
the bioluminescent source [1, 4, 21,99].
The In-Vivo Xtreme II by Bruker is less commonly used than the IVIS, with only a small
number of examples of use of the system in cancer research [100–102]. Additionally, it is
only possible to perform planar BLI which limits the applicability and quantitative accuracy
of the system. However, the additional capabilities of fluorescence, radioisotopic, cerenkov
and X-ray imaging enable complementary information to be obtained during an experiment,
but this complicates the work. The X-ray imaging system enables some anatomical context
to be gained, with BLI data overlaid on to the X-ray image where possible [91]. Like the
IVIS Spectrum the customisable FOV enables up to 5 animals to be imaged simultaneously
[91,92,103] which is advantageous for throughput.
BioSpace produce the PhotonIMAGERTM. The standard system is able to perform multi-
spectral imaging, however the wavelength and bandwidth of the filters present is unknown,
but in published studies in cancer research [31, 33, 104, 105] and stem cell studies [106, 107],
broadband data collection is performed. As with the IVIS Spectrum and In-Vivo Xtreme II
the FOV is customisable, enabling up to 10 animals to be imaged simultaneously [93]. The
standard system is customisable and multiple ‘modules’ are available to add to the system
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to extend the range of capabilities [93]. The ability to include the ‘X-ray Module’ enables
anatomical context to the BLI data to be provided, and a ‘3D Module’ enables multi-view
data collection and surface rendering of BLI data to be performed [93]. However it is unclear
whether this module enables full tomography or just three-dimensional surface rendering of
data.
The final commercial system included here is the Pearl® Trilogy by LI-COR [94,95]. This
system has only recently been developed from a purely fluorescence imaging system so is still
in its infancy for use in bioluminescence imaging, and no publications using the system for
BLI have been sourced. The system is less customisable than the systems presented above
and is only capable of imaging a single animal at a time, with no multi-spectral data collection
capabilities - broadband BLI data is collected across the range 450-640 nm [94,95].
The BLDOT system (Fig. 1.5) takes inspiration from all of the above commercial systems
and their capabilities. Previous work on the BLDOT system, detailing the development of the
system and the capabilities in BLI, BLT, DOT and combined DOT-BLT applied to phantom
data, can be found in references [27, 48, 49, 83, 97]. The free space modelling that produces
surface mapped BLI images, accounts for inaccuracies in BLI measurements introduced by
changes in the position of the animal (i.e. corrects BLI data) [27,28], which aren’t accounted
for by the commercial systems above. The modelling not only produces surface mapped
(corrected) BLI but also provides accurate surface measurements to use in BLT. The first
use of this model on murine data is presented in Chapter 3.
By using freely positioned mirrors to provide multi-view data, more information about
the bioluminescent signal can be provided [48, 49], which is vital when performing BLT.
Additionally, the mirrors enable the surface capture system to gain topographic information
from a larger surface area of the imaging subject [83]. The surface capture system was custom-
developed for the BLDOT imaging system, and has been shown to be accurate within 0.4
mm and have the ability to resolve features of the order of hundreds of µm [83, 97]. The
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Figure 1.5: Schematic (left) and photograph (right) of the BLDOT imaging system. The two
upper projectors facilitate surface capture, the lower projector diffuse imaging and the filter
wheel enables multi-spectral imaging. The two right-angled mirrors on the imaging platform
expand the field of view of the system. Reproduced from ref. [49].
surface capture system is used to produce three dimensional models of the imaging subject
for use in free space modelling, BLT and DOT.
The optical properties used for BLT source recovery are typically defined by the user. It
is possible to use homogeneous properties, heterogeneous properties from atlas models (this
requires registration of an atlas model to the subject-specific surface topography data) and
subject-specific heterogeneous properties from DOT imaging. This customisation of optical
properties cannot be done using the commercial systems above. Use of DOT-determined
optical properties as prior knowledge for the BLT reconstruction, DOT-BLT, is presented in
ref.’s [48, 49] for phantom data, and in Chapter 6 applied to murine data using a SD DOT
reconstruction method.
The filterwheel, which enables multi-spectral data collection, has only 6 filter positions.
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However, these can be changed enabling imaging wavelengths to be customised depending
on the particular application. Available filters range from 500 to 850 nm with bandwidths
ranging from 10 to 34 nm, but additional filters can be purchased to suit the application. The
work presented in Chapter 4 demonstrates that wider bandwidth filters can be used for multi-
spectral data collection for BLT, provided the bandwidth of the filters are accounted for in
the reconstruction using the filter bandwidth modelling method [96] which is also introduced
in Chapter 4. This filter bandwidth modelling is not applied by the IVIS Spectrum, during
BLT source recovery.
The additional capabilities of the BLDOT system compared to the commercial systems,
i.e. free space modelling, filter bandwidth modelling and DOT (including SD DOT), are
advantageous in enhancing the quantitative accuracy of BLI and BLT achievable with the
system.
The following sections provide an overview of pre-clinical imaging modalities, including
comparison to BLI and BLT.
1.2 Common Pre-Clinical Imaging Modalities
Additionally to BLI and BLT a wide range of different imaging modalities are used in pre-
clinical studies, ranging from MRI and CT to positron emission tomography (PET) and
optical techniques. This section will give an overview of imaging techniques which are used
in pre-clinical research.
1.2.1 Fluorescence Imaging and Tomography (FLI and FLT)
Fluorescence imaging (FLI) is a functional technique with many similarities to BLI. A cell
or antibody of interest within an animal is labelled with a fluorescent molecule which is
excited by an external light source, usually a laser, and the subsequent fluorescence emission
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is captured by a CCD [108–110]. As with BLI only the light which reaches the surface of the
animal can be detected, meaning that reconstruction algorithms are required to extend FLI
into FLT. FLI is used in cancer research to image tumours [111,112], adhesion molecules [113],
in evaluation of therapies [114] and has been used to image plaque present in the brain
associated with Alzheimer’s disease [115] and vascular plaque present in atherosclerosis [116].
It is also possible to perform dual-marker imaging to study binding kinetics [117,118].
FLI is a well-establised imaging technique and a large number of fluorophores have been
developed for use in a wide range of applications. Fluorophores can be synthesised to se-
lectively target particular cell surface receptors or antibodies and can be developed for the
requirements of a particular experiment. Due to particular cell surface receptors or antibod-
ies being labelled, the number and location of the specific molecules are tracked in FLI. In
contrast, the whole cell is labelled in BLI, enabling only the location and proliferation of
entire cells to be monitored. Thus, currently FLI is more versatile than BLI but both tech-
niques have their own advantages and disadvantages, and can be applied to slightly different
applications.
Quantitative FLI is limited by the diffuse propagation of light through tissue, as with
BLI. However, with FLI both excitation and emission light propagate diffusely through tis-
sue, adding additional complications in the imaging and FLT reconstruction process when
compared to BLI, where only emission light is subject to tissue attenuation (as no excitation
light source is required). FLT, like BLT, requires a model of the propagation of light through
tissue in order to reconstruct the internal light source [109]. In FLT the emission can be










are measurements at fluorescence and excitation wavelengths respectively [109]. This
makes the assumption that the excitation and emission light have the same tissue interac-
tions, which is not the case due to spectral attenuation of tissue (see Fig. 1.3 a) but when
the tissue optical properties are unknown has been shown to be an effective simplification to
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make in the FLT reconstruction [109,111,119].
Figure 1.6: In vivo (A) Fluorescence and (B) bioluminescence images of cells dual labelled
with a fluorophore and a bioluminescent reporter (DsRed/PC-3M-luc) subcutaneously in-
jected into a nude mouse. The enhanced SNR for BLI images can be seen. Reproduced from
ref. [112].
In addition to the diffuse optical signal there are other similarities between BLI and FLI:
a complementary imaging modality is required in order to provide anatomical information
[108, 111, 119, 120]; the wavelength of the emission and, additionally in FLI, the excitation
light must be long, ideally into the red and near-infrared, to maximise excitation of the
fluorophore and maximise the emission which reaches the surface of the imaging subject, due
to tissue attenuation being low at these wavelengths (Fig. 1.3 a) [111, 119]. Although there
are many similarities between FLI and BLI, an advantage of BLI over FLI is the absence of
excitation light which can contaminate the fluorescence measurements. The excitation light
present during FLI data collection can be reduced by using optical filters, fluorophores with
large Stokes’ shifts and calculating the Born ratio of data, but will still affect the measured
fluorescent signal.
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A further advantage to BLI is the high signal-to-noise ratio (SNR): all signal detected
during BLI is due to bioluminescence, there is no autoluminescence of tissue, analogous to
the autofluorescence present during FLI [119]. Fig. 1.6 demonstrates the enhanced SNR of
BLI images compared to FLI images. The animal in the images shown was injected subcu-
taneously with human prostate cancer cells which had been labelled with firefly luciferase
(PC-3M-luc) and DsRed, a fluorescent protein, both of which had comparable peak emission
wavelengths [112]. As shown in the figure, although the maximum fluorescent signal mea-
sured was ⇠⇥102 larger than the bioluminescent signal, the signal to background ratio was
substantially larger for the BLI images [112]. However, with FLI it is possible to selectively
excite regions of interest, decreasing the contribution of autofluorescence from tissue at a dis-
tance from the fluorophore localisation, and fluorescence emission from fluorophores located
in tissue far from the region of interest. This is not possible with bioluminescence, where
all bioluminescently labelled cells emit light following administration of the substrate to the
animal.
1.2.2 Magnetic Resonance Imaging (MRI)
MRI is a non-invasive technique based on nuclear magnetic resonance, able to provide
anatomical information about an imaging subject through application of a number of mag-
netic fields and radiofrequency (RF) pulses. The subject is placed in the bore of an electro-
magnet, which produces a strong magnetic field (>0.5T for clinical scanners [121]). An odd
number of protons and/or neutrons within nuclei will give rise to a net spin and magnetic
moment which aligns with the magnetic field. Protons (1H atoms), which are present in
high abundance in living tissue, for example in water, proteins and lipids, have an inherent
magnetic moment and therefore are ideal nuclei to image in MRI. Application of an RF pulse
changes the alignment of the proton magnetic moment. When the RF signal is removed the
protons relax back to align with the magnetic field, emitting an RF signal as they do so which
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is detected by a receiver coil. The rate at which the protons relax is the ‘relaxation time’ and
this depends on the environment of the protons, including: the surrounding atoms; the size
of the molecule the protons are associated with and the atoms which the protons are bound
to within the molecule. So the relaxation time and therefore the RF pulse that is received as
the protons relax is dependent on tissue type and gives rise to the contrast observed within
the high resolution images of the internal anatomy of a patient or animal [121].
The image contrast can be altered through the use of different pulse sequence designs
in order to highlight specific features, based on the different relaxation properties of various
tissue types. This versatility enables MRI to image a wide range of different anatomical
features and is customisable by the user, dependent on the desired anatomical informa-
tion. For example, tissues with high water or fat content can be highlighted using different
pulse sequences [121]. The versatility of MRI is demonstrated by its use in a wide range of
pre-clinical studies, including: monitoring tumour growth and response to treatment [122];
angiogenesis [123]; cell tracking [124,125]; and neurological activation and diseases [126,127].
In pre-clinical research into cancerous tumour growth BLI is able to detect a smaller
number of cells than MRI, for example it is possible to detect a cluster of cancer cells with BLI
before a tumour is visible using MRI [128]. Due to the process through which bioluminescence
emission occurs, only metabolically active cells emit bioluminescent light, so BLI is able to
provide information about the portion of a tumour occupied by metabolically active cells, i.e.
cells which are actively proliferating, through monitoring of surface intensity data, whereas
MRI will provide structural information about the size of the whole tumour including necrosed
cells. However, the high resolution structural information which can be gained from MRI is
advantageous and, when used in conjunction with BLI, provides anatomical context for the
bioluminescent signal. Moreover, the techniques used in MRI can be translated into human
imaging, which is not possible during BLI due to the signal penetration depth limitations of
the bioluminescent signal posed by tissue attenuation.
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Figure 1.7: (A) MRI and (B) BLI images of a rat brain tumour from 0-24 days after treatment
with a chemotherapeutic agent. (C) Tumour volume (MRI, mm3) and photon counts (BLI)
as a function of number of days after treatment. (D) Cell kill values quantified from MRI
volume and BLI photon count plots. There is a strong agreement between the two modalities.
Reproduced from [128].
Due to the functional information about the tumour which can be obtained using BLI, it
would be beneficial to develop BLT further to enable quantitative three-dimensional informa-
tion to be obtained in vivo. The spatial resolution achievable by BLT is limited by the diffuse
propagation of light through tissue, so it is possible to use MRI and BLT/DOT as comple-
mentary techniques, using the structural information achievable from MRI imaging as prior
knowledge for the BLT or DOT reconstruction [80,129] or drawing comparisons between the
size of a tumour on MRI images and the bioluminescence emission intensity [128, 130]. The
equipment required for BLI is cheaper and more compact than MRI, and is often simpler to
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use without the requirement for specialist training. Imaging is much faster (of the order of
minutes for BLI but can range from tens of minutes to over an hour for MRI depending on
the size of the imaged volume) and multiple animals may be imaged simultaneously in some
commercial imaging systems, such as the IVIS [131], enabling a high imaging throughput
which is advantageous in pre-clinical studies.
A study in 2000 by Rehemtulla et al. compared BLI and MRI during monitoring of the
growth of a rat brain tumour and response to a chemotherapeutic agent [128] (MRI and
BLI images are shown in Fig. 1.7 A and B respectively). A correlation of 91% between
the volume (mm3) of the tumour measured from MRI data (Fig. 1.7 C black line) and the
bioluminescence emission intensity (photon counts, Fig. 1.7 C green line) over the course
of the experiment was observed. Both modalities show increasing tumour volume until the
treatment takes effect around day 8, decreasing as cells are killed, and increasing again as
remaining cells begin to proliferate. There was also a strong agreement between cell kill
values (Fig. 1.7 D) [128]. This agreement between the two modalities has been found by
other groups [132] and demonstrates how the two techniques can be used in a complementary
fashion.
1.2.3 X-Ray Computed Tomography (CT)
CT, like MRI, provides anatomical information about an imaging subject. The imaging sub-
ject is moved through the CT gantry, which is a circular bore with an X-ray tube and detector
array mounted on opposite sides. The X-ray tube and detector rotate around the gantry, and
therefore the imaging subject, the detector measuring transmitted X-rays. Multiple projec-
tions are recorded during one complete 360o rotation of the X-ray tube and detector. As the
imaging subject is moved through the gantry, transmission data is recorded from different
longitudinal locations throughout the subject. Images of the internal attenuation can then
be reconstructed from the recorded transmission data, which will build up a tomographic
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image of the inside of the imaging subject [133,134]. The intensity of the image is dependent
on the attenuation of X-rays by tissue, for example bone is highly attenuating and appears
white on images, air has a low attenuation and appears black in images [133, 134]. Due to
the high attenuation of bone compared to soft tissue, CT lends itself to imaging bones and is
widely used in arthritis studies [133, 134]. Contrast agents extend the capabilities of CT to
soft tissue imaging, for example intravenous agents enable imaging of the circulatory system,
oral fluid agents produce contrast within the gastrointestinal tract and gaseous agents can
be used to provide information about the colon [133,135].
Pre-clinically, microCT is used, due to the size difference between small animals and
humans and the higher resolution required to image these small animals [135]. The technique
is used in a variety of applications, including: cancer research [135, 136]; vascular imaging
[137–141]; lung disease [142, 143]; and investigating bone diseases [138, 144, 145]. In cancer
research, structural infomation about tumours is achievable both with and without contrast.
For example contrast is not required in the lungs where the contrast in CT intensity between
air and soft tissue is such that the tumour can be directly visualised [135]. However, due to
the similarity in intensity between different soft tissue types, contrast agents are required to
visualise soft tissue tumours.
Due to the ability of CT to provide anatomical information, it is often used in conjunction
with a functional imaging technique, such as PET [146, 147], BLT [46, 47] and FLT, [108,
111, 115], which are unable to produce structural images such as those achievable with CT,
making CT a valuable complementary technique which can provide anatomical context to
the data achievable with the functional techniques. This multi-modality imaging involves
either post-imaging registration of images from the two modalities or the use of a dual-
modality imaging system [108,111]. There are also multi-modality imaging systems available
which combine nuclear, CT and optical imaging [81, 148]. CT data can also be used as
prior structural knowledge for BLT reconstructions [30, 38, 80, 81, 148], similarly to MRI.
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Like with MRI and nuclear techniques (discussed in the following section), pre-clinical CT
imaging and multi-modal CT-nuclear imaging can be translated into human imaging as the
signal is only mildly attenuated by tissue. This is advantageous as, when a pre-clinical study
is ready to be translated to humans, the imaging methodology can be kept constant. As
mentioned in previous sections, imaging in humans is not possible using optical techniques.
Disadvantages of CT in comparison to BLI and BLT are the use of ionising radiation, which
is not required to image bioluminescent signal, and the complex and expensive equipment
required, which requires specialist training for use. CT has been used to produce a mouse
atlas: Digimouse [42], which has been used in fluorescence [149] and bioluminescence [96]
studies and is used in simulation work presented in Chapter’s 4 and 5.
1.2.4 Positron Emission Tomography (PET) and Single Photon Emis-
sion Computed Tomography (SPECT)
PET and SPECT are functional techniques which involve labelling cells of interest with a
radionuclide tracer, and are able to produce three dimensional tomographic images of the
tracer distribution in vivo. In PET, each tracer molecule emits a positron as it undergoes
b+ decay. The positrons annihilate with electrons in the surrounding tissue producing two
gamma rays of energy 511 keV for each annihilation event. SPECT tracers directly emit one
gamma ray per molecule during electron capture decay, these photons are of a lower energy
than those emitted in PET [150, 151]. The emitted photons are detected by scintillation
detectors which are placed around the patient, this projection data can then be reconstructed
into a tomographic image of tracer distribution [150–152].
Due to the method of photon production, the reconstruction process differs for PET and
SPECT. In PET, the two photons which result from electron-positron annihilation events
are emitted at approximately 180o from each other. Therefore by using detectors on either
side of the imaging subject the position of the radiotracer can be estimated by drawing a line
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between the positions of photons detected within a small time window on each detector [150].
In SPECT only a single photon is emitted so the directional information achievable in PET
is not possible. In order to gain directional information, collimators can be placed in front
of the detector to enable detection of photons from a small range of angles, however this
decreases the sensitivity of SPECT in comparison to PET [150,151,153].
These nuclear imaging techniques are used in stem cell tracking studies [154–156], cancer
studies [152,157,158], to monitor perfusion [153], image plaques associated with Alzheimer’s
disease [159, 160] and in pharmacokinetic studies [161]. An advantage of nuclear imaging
over BLI and BLT is the ability to directly translate pre-clinical animal studies into human
imaging, which is not possible using BLI due to the signal penetration depth limitations of
the bioluminescent signal as explained earlier. Also, the high energy photons emitted during
nuclear imaging are not subject to tissue attenuation, particularly scatter, to the same degree
as bioluminescent photons and therefore the tomographic reconstruction problem doesn’t
require modelling of diffuse propagation of light through tissue. However the photons are
still affected by tissue attenuation and therefore model-based reconstruction algorithms are
required [162–164], and there remains some uncertainty about the exact location of the tracer
within the imaging subject, as with BLI. There is also a concern that radionuclide tracers
affect the viability, function and differentiation of cells [124], and during cancer studies it is
possible that the radiation may provide some anticancer therapy or produce further cancerous
cells [150].
Like BLI and BLT, nuclear imaging techniques provide functional information and have
uncertainty associated with the recovered tomographic source location, so in order to pinpoint
anatomically where the tracer is located, complementary structural imaging techniques must
be used. Commercial dual modality CT/PET and MRI/PET systems are available [146,165],
however the incorporation of an extra imaging system introduces significant spatial and
monetary costs and additional specialist training is required for use. Dual modality optical-
25
PET/SPECT systems have been reported [82, 166] which can be used to compare the data
produced using both modalities. Probes have been developed which are dual radionuclide and
optical probes [148,166,167] so that the signals detected using both modalities are from the
same position within the animal. As the resolution of nuclear techniques is higher than that
of optical techniques it would be possible to use the reconstructed nuclear source as prior
information for the BLT reconstruction, enabling a more accurate bioluminescent source
reconstruction.
1.2.5 Ultrasound Imaging (US)
Ultrasound imaging is a structural imaging technique based on the reflection of acoustic waves
from a change in density such as the boundary between two tissue types. Traditionally used
in the imaging of foetuses in the womb, this technique is also used in pre-clinical research. In
cancer research [168–172] the technique can be used to monitor tumour growth, and is able
to produce tumour measurements comparable to histologically measured volumes [170,171].
US has also been used in studies which investigate vasculature, blood flow or drug delivery
[168,173,174]. Some studies make use of microbubble contrast agents which enhance contrast
by increasing the intensity of the backscattered ultrasound signal [168,171–175].
A major advantage of US is that it is a real-time imaging technique. It is relatively
inexpensive, although some training is required both to use the instrument and to interpret
the images. Some functional information can be obtained, for example doppler-US is able to
provide information about blood flow [168, 171, 173]. US could be used in conjunction with
optical imaging to determine the origin of a bioluminescent signal, rather than using CT or
MRI which are significantly more expensive and much slower. For this purpose it would be
possile to incorporate the US probe into the optical system.
A drawback to the technique is the low spatial resolution when compared to CT and MRI
but the low cost, ability to do real-time imaging quickly and high throughput makes US an
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attractive structural imaging technique for use in pre-clinical studies.
1.2.6 Photoacoustic Tomography (PAT)
Photoacoustic tomography is a rapidly developing technique which is able to image biological
features of a range of sizes from organelles to organs [176, 177]. Molecules in the sample of
interest absorb an optical excitation, a nanosecond laser pulse, the wavelength of which
is chosen depending on the optical absorption of the molecules of interest. Through the
photoacoustic effect, absorption of the laser light causes a localised thermal expansion which
in turn induces a mechanical wave which propagates through the sample [176, 178]. This
mechanical wave is detected in the same way as in US imaging, with a piezoelectric transducer,
and the signal processed using reconstruction algorithms to reconstruct an image of the
absorbed energy density [176, 179]. The large size range of features which can be resolved
using PAT is accessed by modifying the focus of the excitation light and detection geometry
[176].
Due to the spectral absorption of light by chromophores, multispectral imaging can be
performed, making it possible to calculate chromophore concentrations and, in an in vivo
setting, tissue oxygen saturation throughout the field of view [176,178,180]. As the contrast
in this modality is based on the absorption of excitation light [176, 178], and in tissue, the
strongest absorption of light at optical and near-infrared wavelengths is haemoglobin (Fig.
1.3 a), PAT lends itself to imaging vasculature in vivo. As such there have been studies using
PAT to image tumour vasculature and response to therapy [176,179,181,182]. By tuning the
wavelength of the laser excitation, a range of chromophores other than haemoglobin can be
imaged: DNA/RNA, melanin, water and lipid for example [176, 183]. It is also possible to
make use of contrast agents such as nanoparticles, organic dyes and reporter genes, which can
be functionalised to target a cell type of interest [176]. Examples of a range of applications
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Figure 1.8: Examples of the application of PAT in biological imaging. A Nuclei of ex vivo
murine intestinal villi epithelial cells, contrast achieved by exciting DNA/RNA. B in vivo
murine melanoma (cells injected subcutaneously) and surrounding vasculature. C As B but
with additional gold nanocage contrast. D Overlay of US (grey) and photoacoustic (green)
images of an in vivo murine tumour with carbon nanotube contrast. F In vivo gliosarcoma
and surrounding vasculature in a rat brain. G Brain of a transgenic zebrafish expressing the
fluorophore mCherry. H Images of blood flow (including velocity) in the in vivo murine ear.
Reproduced from ref. [176].
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and size scales of PAT are shown in Fig. 1.8. The technique has also been shown to be
effective in imaging functional connectivity in the brain [184] and has been extended to
acquire temporal information [185].
The technique has advantages over optical imaging in that ultrasound waves are less
scattered in tissue than light at typical bioluminescent wavelengths, so PAT images are of
a higher resolution than optical images (demonstrated by the ability of the technique to
image subcellular structures). However, the pulsed laser required for excitation significantly
increases the cost of PAT systems above that of BLI systems, but the versatility of PAT is
clear from the breadth of imaging size scales and applications that are achievable.
1.3 Conclusions
This chapter outlines the wide range of pre-clinical imaging techniques which are available,
each with their own advantages and disadvantages. CT and MRI are able to provide high-
resolution structural information about an imaging subject, but functional information is
either not possible (CT) or extremely complicated (MRI). These techniques could be com-
plementary to optical and nuclear techniques which rely on complicated reconstruction algo-
rithms to reconstruct the internal distribution of the source (in bioluminescence, fluorescence
and nuclear techniques) or tissue chromophores (in DOT). The reconstruction problem can
be simplified by providing structural information from CT or MRI for example. However, this
increases both the cost and time required to collect all necessary data, and the structural and
functional images from the multiple modalities must be accurately registered together. To
decrease the imaging time it would be possible to use US to obtain the structural information
for the optical reconstruction but this technique is unable to produce structural images of a
resolution comparable to MRI and CT, and would require incorporation of an US probe to
the existing imaging system. PAT is an extremely versatile imaging technique, which requires
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a subset of differing imaging set-ups depending on the application. Although the technique
is still emerging, the range of size scales which can be imaged with the technique make PAT
an attractive imaging technique for use in a range of pre-clinical studies.
Bioluminescence imaging and tomography are the focus of this work. The technique re-
quires relatively simple, user friendly equipment without the need for any ionising radiation
(nuclear imaging, CT) or excitation light source (FLI). This work focuses on use and modifi-
cation of hardware and software applied to the BLDOT system, but can be applied to other
systems with an aim to enhance the quantitative accuracy of BLT in all non-contact optical
imaging systems.
1.4 Thesis Outline
The work presented in this thesis aims to tackle a number of limitations to the quantitative
accuracy of BLI and BLT with a view to advancing BLT towards routine use in pre-clinical
studies. Firstly, the dependence of BLI measurements on the position of the imaging subject
is addressed. Then possible limitations to the quantitative accuracy of BLT introduced by
not including filter bandwidth modelling in the reconstruction algorithm are investigated.
Finally the necessity of accurate knowledge of underlying attenuation of the imaging subject
is addressed by using DOT as prior knowledge for BLT.
Chapter 2 introduces the theory and models used during BLI, BLT and DOT analysis in
later chapters. Included in the chapter is a description of the propagation of light through
diffuse media (i.e. tissue), with a particular focus on the forward model, which models the
propagation of light from a light source within an imaging subject to the surface. Next, the
free space model, which models the propagation of light through the free space between the
surface of the imaging subject and the CCD, and back to the surface, is outlined. Finally,
recovery of the internal source distribution (BLT) or the internal attenuation (DOT) from
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free space-mapped surface measurements, using the inverse model, is described.
Chapter 3 applies the Free Space Model to post mortem murine BLI data for the first
time, accounting for the dependence of measured data on the position of the animal. Thus
far the model has only been applied to phantom data, but the results presented here show
the model to be promising for future application in vivo.
Chapter 4 describes the addition of a novel filter bandwidth model to the BLT recon-
struction algorithm. Currently the bandwidth of filters used in multi-spectral data collection
for BLT is not accounted for. The effect of ignoring these bandwidths is investigated and
the importance of including filter bandwidth modelling is highlighted through simulation and
phantom studies. These studies are done using multi-spectral data at only three measure-
ment wavelengths rather than the conventional five (or six) wavelengths which are used in
the BLDOT system. Further data presented in this chapter assesses the effect of using fewer
wavelengths for data collection on the quantitative accuracy of the recovered bioluminescent
source.
Chapters 5 and 6 describe the application of a spectral derivative DOT reconstruction
method to non-contact data for the first time. The DOT-determined, subject-specific, optical
properties are then used as prior knowledge for BLT reconstructions, in combined DOT-BLT.
This work aims to tackle the limitation to the quantitative accuracy of BLT posed by the
difficulty in acquiring accurate knowledge of underlying tissue attenuation. The SD DOT
method is first validated via simulation using a heterogeneous mouse model in Chapter 5, and
then applied to a post mortem murine model using data acquired using the BLDOT system
in Chapter 6. Modifications to the BLDOT system in preparation for this data collection are
described and characterisation of the system is also presented.
Chapter 7 provides a summary of the work presented in this thesis, with ideas for future





Optical tomographic imaging relies on accurate mathematical models of light propagation
through tissue. These models enable surface measurements to be predicted based on a known
light source distribution, or estimates of internal source distribution (BLT) or internal optical
property distribution (DOT) to be calculated, based on surface measurements which are
acquired using imaging systems such as the BLDOT system.
There are multiple steps involved in BLT and DOT data processing. Using the BLDOT
system as an example, the light (either from an internal bioluminescent source or transillu-
mination diffuse light source) propagates through the imaging subject to the surface. This
process is described by the Forward Model (Section 2.2). The light then travels from the
surface of the imaging subject to the CCD, where measurements are made. In order to
perform tomographic reconstruction, the CCD data is mapped back on to the surface of
the imaging subject to gain measurements of the distribution of light at the surface. The
passage of light through the free space between the surface of the imaging subject and the
CCD is described by the Free Space Model (Section 2.3). The surface data is then used in
tomographic reconstruction for either bioluminescent source distribution in BLT, or optical
property distribution in DOT, which requires knowledge of the propagation of light through
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the imaging subject back to the source. This process is described by the Inverse Model
(Section 2.4).
This chapter will describe the mathematical models implemented in this work, starting
with an introduction to the propagation of light through tissue, diffuse optics.
2.1 Introduction to Diffuse Optics in Tissue
The passage of light through tissue is governed by absorption and scattering. Absorption
is determined by chromophores present in tissue, the main ones at visible and near-infrared
wavelengths (relevant to BLT and DOT) being oxy- and deoxy-haemoglobin (HbO and de-
oxyHb respectively) and water [3]. The absorption spectra of these chromophores is shown
in Fig. 1.3 a. During an absorption event, an incident photon is absorbed by a molecule,
causing an electron to be excited to a higher energy level. This process requires the energy of
the photon (which is inversely proportional to wavelength) to equal the difference in energy
between the two energy levels in the molecule. As such, absorption is energy dependent, and
is therefore a spectral quantity.
The reduction in intensity of light as it passes through tissue due to absorption by chro-
mophores can be described by the Beer-Lambert Law [186]:
I (d) = I
0
e "Cd (2.1)
where I (d) and I
0
are the intensity at distance d through the medium and initial intensity
respectively, " is the molar extinction coefficient (units: µM 1cm 1) and C is chromophore
concentration (units: µM for HbO and Hb, and % for water concentration). The absorption
coefficient, µ
a
, provides information about the number of expected absorption events per unit
length, and varies depending on the concentration of each of the n chromophores present in














Scattering is caused by structural components of tissue, for example: cells, subcellular
species such as cell nuclei and other organelles, and the refractive index mismatch at the
boundaries between structural components and different tissue types [3,187,188]. At red and
near-infrared wavelengths, the total attenuation of tissue is at its lowest (Fig. 1.3 a) and
therefore the transmitted light intensity is high, so long-wavelength bioluminescent reporters
are desirable to maximise the signal that can be measured. The absorption of light at
these wavelengths by tissue chromophores is low and therefore scatter dominates, making
the passage of light through tissue diffuse [3, 187,188].
The scattering coefficient, µ
s








A second scatter parameter, the reduced scattering coefficient, µ0
s
describes the distance









is related to µ
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where g is the anisotropy factor which is the average of the cosine of the scattering angles in
a particular medium. An anisotropy factor of close to 1 indicates that forward scattering is
predominant [187]. For tissue, g ranges from 0.8-0.98 depending on the tissue [187], and so
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light is likely to be forward scattered. These parameters are all wavelength dependent.




( ) = sa  sp (2.6)
where sa and sp are the scatter amplitude and scatter power respectively, and   is the
wavelength in µm.
The diffuse propagation of light through tissue is described by the diffusion approximation
to the radiative transport equation. This will be outlined in the following section.
2.2 Forward Model
The Forward Model describes the propagation of light from the light source (bioluminescent
source in BLT or diffuse light source in DOT) to the surface of the imaging subject, calculat-
ing boundary data at pre-defined measurement locations (detectors) across the surface. The
forward model is based on the diffusion approximation to the radiative transport equation,
which is widely used to describe the diffuse propagation of light through tissue. For a contin-
uous wave system (i.e. a system with a continuous light source) the diffusion approximation
is given by the equation [34,35]:
x (r) =  r ·  (r)r  (r) + µ
a
(r)  (r) (2.7)








diffusion coefficient and   (r) is the fluence rate at position r.
A surface boundary condition is applied to the model, which enables fluence to be calcu-
lated at the boundary but prevents light from re-entering the imaging subject:
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  (⇠) + 2An̂ ·  (⇠)r  (⇠) = 0 (2.8)
where ⇠ is a point on the boundary, n̂ is the surface normal directed out of the imaging
subject, and A is derived from Fresnel’s law:
A =
2/(1 R0) 1+|cos(✓c)|3

















is the refractive index
of air, n
AIR
= 1). Total internal reflection occurs for photons passing from the medium to









Equations 2.7 and 2.8 are implemented in this work by NIRFAST [35], a numerical mod-
elling software which uses a finite element method (FEM) framework. The FEM method
breaks the problem into finite elements, i.e. if the problem involved a murine model, a vol-
ume mesh of the animal would be produced containing elements (small volumes) and nodes
(at the intersection of elements). For data taken using the BLDOT system the FEM mesh
is created from three-dimensional surface capture data.
2.3 Free Space Model
Free Space modelling has been developed to account for the dependence of BLI measurements
on the position of the imaging subject when using a non-contact imaging system for data
collection. A change in position of the animal causes the perspective of the animal visible to
the camera to change, causing the source to appear to be at a different position within the
animal, producing a different surface flux and therefore different BLI measurements. This is
demonstrated using a cylindrical phantom in Fig. 2.1. The position of a light source within
the cylindrical phantom is shown in Fig. 2.1 a, and bioluminescence images of the phantom
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at 0o and 60o shown in Fig. 2.1 b and c demonstrate the change in appearance of surface
fluence visible by the CCD. Although the fluence at the surface is identical in both cases,
the light which is measured at the CCD is different due to the change in the relative position
of the source due to rotation of the phantom. The colourbars show a corresponding change
in intensity measured at the CCD. The change in position of the cylinder is analogous to
the change in position of an animal between imaging sessions or due to repositioning of an
animal during an imaging session.
The variation in measurement intensity introduced by a change in position of the imaging
subject may cause inaccurate conclusions to be drawn from a pre-clinical study. For example
the growth of a tumour may appear less significant than it truly is, or a novel treatment
less effective. Therefore, this dependence must be accounted for. Free space models have
been developed to do this. These models model the propagation of light through the free
space between the surface of the imaging subject and the CCD, and back again, mapping
the CCD measurements back on to the surface of the imaging subject. The resulting surface
measurements are independent of the position of the imaging subject. These models can, and
should, be used for any optical imaging modality which uses non-contact imaging, including
bioluminescence, diffuse transmission imaging for DOT and fluorescence imaging.
Ripoll et al. first developed a model of light propagation through free space which intro-
duced the concept of approximating the focal plane of the system as a discretised array of
virtual detectors [190]. Chen et al. built on this model by approximating the system such that
the light propagation can be approximated as a simple thin lens problem [191] and included
the ability to model multiple apertures present in the system, such as filter wheels [192]. The
incorporation of the thin lens approximation was accompanied by the inclusion of visibility
criteria, which enabled the visibility of points on the surface of the imaging subject by the
CCD to be determined. Guggenheim et al. [27] extended the model further still to enable the
focal plane to be placed arbitrarily relative to the imaging subject. The inversion method
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Figure 2.1: (a) Cross section through a plastic cylindrical phantom with an internal light
source in the position shown. (b) and (c) are images of the phantom taken using the BLDOT
system showing the change in appearance of the surface fluence visible at the CCD, and the
change in measured intensity indicated by the colourbar scales. Colourbar units: counts s-1.
Reproduced from [27].
which maps CCD data back on to the surface of the imaging subject was also modified from
a backprojection method [191,192] to a non-negative least squares method which was found
to improve the quantitative accuracy of the model [27].
The free space model developed by Guggenheim et al. was developed for use with the
BLDOT system but can be applied universally provided the dimensions of the system are
known. The model has been previously shown to be effective in accounting for the position
of a cylindrical phantom [27,28], but thus far work has not been done to validate the model
using murine data. This validation is performed in Chapter 3 where the model is referred to
as the ‘free space model.’
2.4 Inverse Model
The inverse model uses boundary measurements to reconstruct either the source (in BLT) or
the underlying optical properties of the imaging subject (in DOT). This section will give an
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overview of the theory behind the reconstruction algorithms used for BLT and DOT in this
work.
2.4.1 Inverse Model: BLT




) of the imaging subject are known, boundary
measurements of the bioluminescent source (following free space modelling), b, are used to
calculate the three dimensional internal bioluminescent source distribution, x. Due to the
linearity of the solution to Eq. 2.7 with respect to the bioluminescent source x(r), the BLT
reconstruction problem is a linear problem. The problem aims to minimise the difference
between the measured bioluminescence data, b, and simulated data, F (x), which is calculated
from Eq. 2.7 assuming knowledge of the underlying attenuation of the imaging subject (F is
a model of light propagation that accounts for the underlying optical properties and geometry
of the imaging subject). This minimisation can be solved as a Least-squares minimisation:
x = min
x
k b  F (x) k (2.10)
The relationship between the internal source distribution, x, and the boundary measurements,






is the number of boundary measurements, N
n
is the number of nodes in the mesh). The
boundary measurements can therefore be calculated using Eq. 2.11:
b = Jx (2.11)
and the solution for x is given by the expression:
x = J 1b (2.12)
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. The problem is also non-
unique due to the possibility of multiple different bioluminescent sources producing identical
surface measurements as shown in Fig. 1.4. The non-uniqueness can be reduced by using














































is defined as the central filter wavelength of the band pass filters used for data
collection). Using spectral measurement data reduces non-uniqueness by exploiting the fact
that tissue attenuation (and source emission) is spectral and therefore the recovered source
distribution must satisfy the measurements at each wavelength. Utilising heterogeneous
optical property distributions reduces the possible pathways of light through the imaging
subject, thus further reducing non-uniqueness. The permissible source region can also be
used an additional constraint [51, 193].
This work uses a Compressive Sensing Conjugate Gradient (CSCG) based algorithm to
solve Eq. 2.12 [50] which reduces the ill-posed and non-unique nature of BLT reconstructions
by assuming a sparse source distribution and using techniques inspired by compressive sens-
ing, enabling more biologically plausible source distributions to be calculated. In the case
of pre-clinical cancer research where the bioluminescent source is located within a tumour,
the assumption of a sparse source distribution is appropriate. Work has shown the algo-
rithm to outperform a number of more commonly used algorithms, including a non-negative
least squares algorithm, in both simulation and experiment using a mouse-shaped phantom
(XPM2) [50,97].
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2.4.2 Inverse Model: DOT
The inverse model for DOT aims to recover the internal optical property distribution of
the imaging subject given knowledge of the external illumination source, x, and boundary





) the DOT reconstruction problem is an iterative process.
A three-dimensional model of the imaging subject is created and the positions of the DOT
light sources are placed on the lower surface of the mesh. In order to calculate the optical
properties the following iterative process is implemented:
• Start with an estimate of µ and use this to calculate an estimated Jacobian, J (µ) and
modelled boundary data.
• Compare the modelled data to the actual measurement data to calculate an update to
µ,  µ.
• Iterate the above steps, modifying µ, until the difference between the simulated and
actual measurement data is minimised (according to pre-defined stopping criteria, a
difference of <2% is used in this work).





and chromophore concentrations respectively. The methods for these will
be outlined in the following sections and can be found in more detail in ref. [35].
2.4.2.1 Standard Reconstruction


































are measured and calculated fluence respectively, µ
0
is an initial optical
property estimate which can be obtained via a data calibration procedure (see Chapter 6 of
ref. [194] and Chapter 8 of ref. [48] for details) or from prior knowledge, e.g. incorporating
structural information from CT or MRI as described in Chapter 1, with literature values for
tissue optical properties, or using atlas models, such as the Digimouse atlas [42]. ⇣ is the







, the ratio of variances of the measurement data
and optical properties [35]. The data calibration procedure also accounts for the offset in  M
and  C due to differences in the initial external source strength for the two data sets [194].
In order to calculate the solution to Eq. 2.15, the solution to Eq. 2.16 must be calculated





JT    =  µ (2.16)
   is the data-model mismatch (recalculated at each iteration), ⇣̃ = 2⇣ and the Jacobian,






The solution to Eq. 2.16 for  µ is calculated until the data-model mismatch is reduced to a
pre-defined tolerance, typically 2%. This is done at each required wavelength. Chromophore
concentrations and scattering parameters (scatter amplitude, sa, and scatter power, sp) can
then be calculated using Eq.’s 2.2 and 2.6, [35,189]. Alternatively, the chromophore concen-




This is the approach taken in the work presented in Chapters 5 and 6, where HbO, deoxyHb
and water concentrations are considered. Similarly to Eq. 2.17 the spectral Jacobian is









i.e. the rate of change of amplitude of measured data with chromophore concentration (phase
information is also included, but when considering the BLDOT system which is a continuous

























measurements and can be combined into a single linear problem for k measurement
wavelengths (Eq. 2.21, assuming three chromophores but can be extended to include more)
to solve the spectral case for chromophore concentrations c
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× number of parameters} the simplified structure of the Jacobian is shown in Fig. 2.2
(assuming three measurement wavelengths and three chromophores and ignoring scattering
parameters). Update Eq. 2.16 is solved for  µ, as with the standard case, but  µ now
relates to the chromophore concentrations and scatter parameters. A number of physiological
constraints are applied to the reconstruction: maximum water content limited to 100%,
scatter parameters and concentrations of HbO and deoxyHb constrained to non-negative
values [35].







is the number of measurements and N
n
is number of nodes.
2.5 Summary
This chapter has given an overview of the methods used to model the propagation of light
through tissue and factors which affect the path taken by the light. This work uses the
diffusion approximation to the radiative transport equation to model the light propagation
through the imaging subject (either phantom or murine models) implemented through the
forward and inverse models. In a non-contact imaging system such as the BLDOT system it
is important to additionally model the light propagation through the free space between the
surface of the imaging subject and the detector (CCD) using the free space model.
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Thus far, the free space model implemented in this work has only been validated in
phantom studies. The work presented in Chapter 3 applies the model to murine data for the
first time. This is important work which aims to determine the applicability of the model to
in vivo pre-clinical studies. As explained above, the inverse model for BLT currently ignores
the bandwidth of the band pass filters used for multi-spectral data collection. Chapter
4 includes work which investigates the effect this has on the quantitative accuracy of the
recovered source. A new filter bandwidth model for BLT is presented and applied to simulated
and phantom data with a view of improving the quantitative accuracy achievable by BLT.
The model is then validated in a murine environment in Chapter 6. Chapter 5 outlines a
spectral derivative method for DOT. The applicability of the model in non-contact imaging
is investigated for the first time, through simulation, evaluating the ability of the model to
remove the need for free space modelling and DOT data calibration prior to full tomographic
reconstruction. The model is then applied to data acquired using the BLDOT system in
Chapter 6, determining the efficacy of the model when applied to murine data.
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Chapter 3
Validation of a Free Space Model
Applied to Murine Bioluminescence Data
The application of free space modelling to phantom BLI data has demonstrated substantial
improvements to the quantitative accuracy of measured fluence [27, 48]. Thus far the model
has not been validated in small animal imaging, and this is vital in order to determine whether
the model will be effective when applied in pre-clinical studies. This chapter builds on the
previous phantom work, applying the model to murine BLI data acquired using the BLDOT
system for the first time, validating the model for use in small animal imaging.
3.1 Introduction
Bioluminescence imaging has numerous applications in pre-clinical studies (see Section 1.1.1),
including in assessing the efficacy of novel cancer treatments by monitoring tumour growth
[1, 6, 195], and studies into the localisation of stem cells within a murine model [13, 14].
However, the quantitative accuracy is limited. For instance, an animal with an internal
bioluminescent source may be imaged on two different occasions on the same day, and produce
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two different BLI measurements as the perspective of the animal visible at the CCD may
be different. This measurement variation may be due to a slight change in position of the
animal or a change in the underlying optical properties.
The underlying optical properties of the animal are determined by the concentrations of
different tissue chromophores (Fig. 1.3 a). If, for example, the oxygen saturation of the
tissue were to decrease (hypoxia), the ratio of HbO to deoxyHb will change, and the total
attenuation of the tissue will change, resulting in a different surface fluence arising from an
internal bioluminescent source. These factors make it difficult to accurately quantify the
bioluminescent source intensity and may cause inaccurate conclusions to be drawn during
pre-clinical studies about how effective a treatment is or how quickly a tumour is growing
for example.
The change in position of the animal can be accounted for by modelling the propagation
of light from the surface of the animal to the CCD using a free space model [27]. This models
the propagation of light from the surface of the imaging subject to the CCD calculating a
transfer matrix which describes the contribution of each point on the surface of the imaging
subject to each pixel in the CCD. Inverting the relationship enables CCD data to be mapped
back on to the surface of the imaging subject, determining true surface fluence values which
are independent of the position of the imaging subject (see ref. [27] for more detail).
The efficacy of this free space model in accounting for the change in position of a cylindri-
cal phantom in the BLDOT system has been previously demonstrated [27,28,48]. However,
the efficacy of the model when applied to animal data has not yet been demonstrated. In this
chapter, the free space model is applied to murine BLI data taken using the BLDOT system,
demonstrating that the ability of the model in accounting for a change in position is effective
in a murine model. This data was presented at the World Molecular Imaging Congress 2015
and European Conferences on Biomedical Optics 2015.
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3.2 Methods
The BLDOT system was used to image three mice post mortem1 with an artificial light
source (tritium-based, Trigalight Orange III; mb-microtec, Switzerland) inserted in positions
shown in Table 3.1. This particular light source was chosen due to the similarity in emission
to that of firefly luciferase (fluc), as shown in Fig. 3.1, the peak emission intensity of the
artificial light source occurs at 607 nm, while that of firefly luciferase (fluc) is at 612 nm.
However, there are some disadvantages to using the trigalight source as a model of fluc:
it is possible that the emission from the artificial source is of a higher intensity than that
from an equivalent volume of fluc-labelled cells, and will therefore produce BLI images with
a higher SNR. Additionally, the trigalight source is a well-defined volume, however in vivo
fluc-labelled cancer cells will not produce a well-defined volume. In vivo the cells will be
actively proliferating and infiltrating the surrounding tissue and it is possible for cells to
dissociate from the tumour. The trigalight source is unable to model this tumour growth.
Despite these differences between the artificial source and BLI in vivo, the trigalight source
is considered a good model to use in this work, testing the validity of the Free Space model
in a post mortem murine model due to the similarity of the emission spectra (Fig. 3.1). The
trigalight source acts as an ideal tumour, well defined and with a high emission intensity,
which is a reasonable intermediate experiment to perform between phantom experiments and
in vivo work. Note that it is not possible to use fluc-labelled cells in a post mortem model as
bioluminescent emission is a metabolic process (as explained in Section 1.1.1) and therefore
requires an in vivo model.
In order to insert the source (Fig. 3.2), a hypodermic needle (Henke-Sass, Wolf GmbH,
Tuttlingen, Germany; 18 gauge with an outer diameter of 1.2 mm) was inserted to the
required depth within the animal. The source was introduced through the bore of the needle,
1
The animals used in this work were donated by the Biomedical Services Unit, Birmingham as they were
not suitable for use in the pre-clinical studies they were intended for. This was due to the genetically altered
genotype being incorrect and unsuitable for use elsewhere.
49
Figure 3.1: Emission spectrum of the artificial light source, ‘Trigalight’, (tritium-based, Tri-
galight Orange III; mb-microtec, Switzerland) used in these experiments, obtained from man-
ufacturer data (presented in Appendix A.1 of ref. [48]). The spectrum is similar to that of
firefly luciferase (‘Fluc’, dotted lines; data supplied by Dehghani et al. [26]).
followed by wire which was used to force the source out of the needle and into the animal,
enabling the needle to be removed, leaving the source in position.
To insert the source subcutaneously, the needle was inserted through the skin by ‘pinching’
the skin using tweezers. Insertion of the source at any greater depth is approximate. It is
possible that the source could move to a more superficial location as the needle is withdrawn.
Additionally, source insertion was performed away from the imaging system and the animal
subsequently moved and placed onto the imaging platform. The internal organs of the animal
may have moved in this process, causing the position of the source to change, or the skin
and shape of the animal may have changed resulting in the source moving to a different
depth. Care was taken to minimise these factors however they will be present to some extent
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whenever this method of source insertion is used.
It would be possible to determine the true source location within the animal using a
second imaging modality, such as ultrasound, but in this experiment the true source location
is not considered to be important. This work aims to determine the efficacy of the Free Space
Model in accounting for the dependence of measured bioluminescence on a change in position
of the animal. Therefore, as long as the position of the source within the animal is consistent
between the two positions the animal is imaged in (positions detailed below) the efficacy of
the Free Space Model can be determined. The assumption has been made that the source
position is constant between the two positions. Once the needle used for source insertion is
removed from the animal it is possible that the source could move slightly within the animal.
This movement is believed to be negligible due to the care that was taken when moving the
animal to the imaging platform after source insertion and when changing the position of the
animal to the second position. Additionally, by the time imaging of the second of the animal
was performed, rigor mortis was beginning to set in, reducing the possible movement of the
source within the animal.
Table 3.1: Source depth and position, and rotation angle of the animal, for the three animals
used in this study.
Mouse Approximate Source Depth Source Position Approximate Rotation
1 Subcutaneous Right dorsally 6o
2 5 mm Right laterally in abdomen 23o
3 Subcutaneous Right laterally in abdomen 44o
BLI images of each animal were taken at 600 nm (band pass filter with bandwidth 22
nm, Semrock Inc.) with 4⇥ binning and exposure times limited to 60 s, along with a three-
dimensional surface capture, with the animal in two different positions: (1) the source position
pointing towards the CCD (mouse 1 placed prone, mice 2 and 3 on the left side) and (2)
animal rotated by an angle, j, as indicated in Table 3.1.
The method of calculation of j is shown in Fig. 3.3: After free space modelling the
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BLI data is viewed on the mesh surface via the x-z axis. This enables the location of the
maximum bioluminescence intensity to be determined (indicated by crosses in Fig. 3.3) and,
as the mesh coordinates of the maximum BLI intensity and the base of the mesh are known,
Figure 3.2: Insertion of a tritium light source into a mouse. (a) Schematic of the source
insertion, with the light source and hypodermic needle shown. (b) Schematic of the two
positions at which data was collected in the BLDOT system. (c) Source insertion into a
mouse cadaver, the needle is in position. (d) Equipment used during source insertion, the
source is inserted into the bore of the needle and the wire is used to force the source out
when the needle is in position in the animal.
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the angle from vertical of the location of the maximum bioluminescence intensity is calculated




). The angle of rotation between the two positions, j, can then





Figure 3.3: Determination of the angle of rotation between position 1 and position 2. The
diagrams here show the animal from the tail end. The cross in each of the diagrams indicates
the location in the x-z plane of the maximum bioluminescence intensity. The angle from
vertical of each of the maximum intensity locations, f, is calculated enabling the angle of





The angles of rotation used in this animal study are  45  and therefore the region of the
animal surface containing the maximum intensity is visible by the CCD in all cases. Due to
this, the method of calculating the angle of rotation described above is considered suitable for
this application. If the angle of rotation was much greater, the maximum intensity location
would not be visible by the camera and so a more suitable method should be implemented,
such as registration of the three-dimensional meshes of the animal created from the surface
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capture data from both positions.
The aim of this work is to determine the effect of changing the position of the animal on
the measured bioluminescence. The free space model was applied to the BLI data obtained
with a view of demonstrating that any effect of position on quantitative bioluminescence data
can be accounted for. This work represents the first application of the free space model to
murine data and is an important step towards widespread implementation of the model in
pre-clinical studies.
3.3 Results and Discussion
Raw bioluminescence images of mice 1-3 in two positions, overlaid onto a bright image are
shown in Fig. 3.4 (top row). The difference in position of each animal after rotation is
demonstrated in these images, and the change in appearance of the surface fluence can be
seen. There is a variation in intensity measured for each animal in the two positions, as
shown in Fig. 3.5 a (graphs of total intensity normalised to the maximum for each animal,
and considered only above a threshold of 50% of the maximum intensity), supporting the
findings of the previous phantom work [27,28]. The percentage variation in intensity between
the two positions is shown in Table 3.2, with all animals showing a variation of >30%,
demonstrating that even a small rotation of ⇠ 6o can introduce large errors into the measured
bioluminescence intensity.
Table 3.2: Variation in intensity between position 1 and position 2 for the three animals for
raw bioluminescence data, 4I, and corrected bioluminescence data, 4I0. The decrease in
variation between the two positions is more than 25% in all cases.
Animal Approximate Rotation 4I / % 4I0 / %
Mouse 1 6o 33 5.7
Mouse 2 23o 53 22

















































































































































Figure 3.5: Total intensity (above 50% of the maximum intensity) of (a) raw and (b) corrected
BLI data for mice 1-3, normalised to the maximum for each animal. The large difference in
intensity between the two positions is demonstrated in (a), while the considerably smaller
intensity variation after free space modelling is shown in (b).
Images of the data following free space analysis, ‘Corrected BLI’, overlaid onto a bright
image of each animal are shown in Fig. 3.4 (bottom row), this data qualitatively resembles
the raw BLI data. The total intensity of this data (considered above a threshold of 50% of
the maximum value) is plotted in Fig. 3.5 b showing a reduction in the intensity variation
of up to 31% (Table 3.2). Therefore, the effect of changing the position of the animal on the
measured bioluminescence has been reduced.
Mouse 2 has the largest variation in intensity between the two positions in both raw and
corrected bioluminescence images. It is possible that this is due to the increased depth of the
source within the animal (⇡ 5 mm) as compared to mice 1 and 3 (subcutaneous). The animals
used in this work are post mortem, and as such the tissue oxygenation decreases as the time
after animal sacrifice increases (data demonstrating this effect, which caused a reduction in
measured intensity of up to 10%, and a 5% change in the first five minutes, is presented in
Chapter 5, Fig. 5.3). This is a highly heterogeneous variation as the underlying anatomy of
the animal is heterogeneous and the blood ceases to circulate when the heart stops beating,
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so it is possible that blood collects in different regions of the anatomy. The exact time
between animal sacrifice and imaging is unknown for mice 1 and 2, but imaging in this work
commenced between 15 and 30 minutes following animal sacrifice. There was approximately
30 minutes between the commencement of imaging in the two different positions for mouse 2.
This is due to changing the position of the animal, taking a three-dimensional surface capture
(usually this takes approximately 4 minutes, however due to imaging system problems the
surface capture of position 2 for this animal took 10 minutes) and imaging took approximately
16 minutes. Over this period of time the tissue oxygenation, and therefore the ratio between
HbO and deoxyHb, would have decreased causing a change in the tissue attenuation of mouse
2 between the two positions. Therefore, it is likely that the surface fluence had changed. Free
space modelling may have accounted for the change in position of the animal more effectively
than is apparent, but because the surface fluence had truly varied between the two positions
it was impossible to recover the same BLI measurement in both cases. This is also true
to some extent for mouse 1, which had a period of 25 minutes between imaging in the two
positions (there was a shorter imaging time of approximately 8 minutes 35 s due to the more
superficial position of the source). However, due to the superficial position of the source, the
attenuation variation affected the surface fluence to a lesser extent.
The imaging for mouse 3 started approximately 50 minutes after sacrifice of the animal
with only 15 minutes between the commencement of imaging in the two positions. The
variation in corrected bioluminescence intensity between the two positions still present after
Free Space modelling could again be due to the change in tissue attenuation, but it is thought
that the change in tissue attenuation will have stabilised due to the long delay between animal
sacrifice and imaging. So it is possible that the Free Space model has struggled to effectively
account for the large change in position for this animal (⇡ 44o). The variation in intensity
between the two positions has, however, been reduced by the Free Space model showing some
improvement through use of this method. More controlled experiments (detailed below) will
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better enable the true efficacy of the model to be determined.
The reduction in intensity variation between the two positions is most pronounced for
the smallest rotation (mouse 1, ⇠6o) which is considered to be most relevant to pre-clinical
imaging. A change in position such as this could arise during live animal imaging from
repositioning an animal to ensure the nose cone which sustains anaesthesia is positioned
appropriately, or due to placing the animal in the imaging system for different imaging
sessions. However, the reduction in intensity variation for the larger rotations (mouse 2,
⇠23o; mouse 3, ⇠44o) proves the model is capable of accounting for larger positional changes
should they arise.
The remaining discrepancy in intensity between the two positions is not believed to be
due to the irregular shape of the animals as the Free Space Model is applied individually to
images taken in the two positions. Three dimensional surface capture images of the animals
are taken at each position to enable a subject-specific mesh to be created for each animal
in each position, and the Free Space Model applied to each mesh individually. Therefore,
deformation of the animal between the two positions should not affect the calculation of the
corrected intensity, as the current shape of the animal is known via surface capture data.
The variation in intensity still present is thought to be due in part to the nature of
this experiment, using mouse cadavers, which results in the underlying tissue attenuation
varying throughout the course of data collection. To determine whether the change in tissue
oxygenation is the true cause of the remaining variation between the two positions following
Free Space Modelling it is important to repeat this experiment in a more controlled manner.
To remove the inter-animal uncertainty present in this work, multiple animals should be
imaged with the same source depth, determined using a secondary imaging modality such as
ultrasound. Additionally, it would be valuable to control the degree of rotation more strictly.
Rotations should be kept consistent between animals, with multiple rotations performed for
each animal to determine the efficacy of the Free Space Model in accounting for multiple
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rotations, rather than the single rotation in the data in this chapter. The animals should
also be imaged at a consistent time after death to remove any effect of variation of tissue
oxygenation between animals.
In the future it is important to determine the true efficacy of the free space model in
accounting for positional changes of animals, by performing live animal imaging. Additionally
this will be more appropriate for demonstrating the efficacy of the model for use in pre-clinical
imaging.
3.4 Conclusions
The quantitative accuracy of BLI is dependent on the position and underlying optical prop-
erties of the imaging subject. A free space model has previously been shown to effectively
account for the positional changes when applied to phantom data and this work demonstrates
the efficacy of the model when applied to murine data for the first time. It was important to
validate the model in a murine environment to determine whether the model will be effective
when applied in pre-clinical studies. The data presented here showed the model to be able
to reduce the error in bioluminescence measurements introduced by positional changes in
the animal. However, as the animals were post mortem it is thought that the efficacy of the
model was limited by changing attenuation over the timescale of data collection. To accu-
rately determine the limitations to the efficacy of the model this work should be repeated in a
more controlled manner, with consistent source depth, rotation angles and time after death,
as detailed in Section 3.3. The work should also be repeated in vivo, but these first results
on the application of the free space model to murine data are encouraging. The data pre-
sented here shows the free space model to be effective in reducing positional variation when
applied to BLI data, however the method can be applied to any modalities which produce
non-contact surface fluence measurements, such as DOT and FLI. Moreover, it is possible to
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apply the model to data from any non-contact imaging system provided the dimensions of
the system are known.
The efficacy of the free space model, in improving the quantitative accuracy of BLI
surface data for use in further analysis (BLT and DOT reconstructions for example), has
been demonstrated in this chapter. Additionally, other methods of accounting for the errors
in the measurements which accompany a change in position of the imaging subject are under
investigation, in order to reduce the reconstruction time for both BLT and DOT. For example
spectral derivative methods (see Chapter 5 and 6).
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Chapter 4
Effect of Filter Bandwidth on the
Quantitative Accuracy of
Bioluminescence Tomography
In Chapter 3 the efficacy of the free space model in reducing the dependence of surface
measurements on the position of the animal was demonstrated. These surface measurements
provide a starting point for performing further analysis, such as BLT and DOT. However,
there are additional factors which limit the quantitative accuracy of BLT.
This chapter investigates the effect of ignoring the bandwidth of band pass filters (which
are used for multi-spectral data collection) on the quantitative accuracy of BLT. A method of
accounting for the filter bandwidth in the BLT reconstruction algorithm is presented and the
efficacy of the model in producing quantitatively accurate BLT reconstructions is determined
(this data was presented at SPIE Photonics West 2015). The data presented to validate the
model uses multi-spectral data acquired at only three wavelengths. Usually, when acquiring
multi-spectral BLI data for BLT with the BLDOT system, five or six wavelengths are used
[48, 49]. The second section of this chapter investigates whether using three wavelengths for
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data collection has any detrimental effect on the quantitative accuracy of BLT.
This chapter is based on work published in ref.’s [96] and [196] and sections of the text
have been reproduced from these references.
4.1 Introduction
As discussed previously, BLI has a number of limitations. The work presented in Chapter 3
showed that the dependence on the position of the animal can be accounted for. A further
limitation to BLI is that the images are planar, so it is impossible to determine the true
location of the bioluminescent source within the animal. For instance, a deep but small and
intense source may produce very similar surface fluence to a weaker but larger and more
superficial source (as demonstrated in Fig. 1.4) [26]. BLT makes steps towards overcom-
ing this limitation by reconstructing a three-dimensional estimate of the distribution of the
bioluminescent source within the animal from multi-spectral BLI data.
When performing BLT, multi-spectral data collection is facilitated by using band pass
filters. However, the bandwidth of the filters used for data acquisition is currently not
considered in the reconstruction algorithm, with the data assumed to be collected at the
central filter wavelength [26, 34, 35, 50–52]. This is an incorrect assumption to make. For a
given filter, data are collected over the range of wavelengths which are transmitted through
that filter. For example, for a filter with a central wavelength of 600 nm and a bandwidth
of 20 nm, the data collected consists of data from all wavelengths in the range 590-610 nm.
Ignoring this and assuming all data comes from the central filter wavelength will introduce
a model-data mismatch during model-based image recovery. This is because the range of
wavelengths which are transmitted through the filter, and therefore the spectral properties
of both tissue attenuation and bioluminescent source emission within the bandwidth of the
filter are not considered, resulting in a loss of accuracy in the reconstruction.
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The work presented in this chapter examines the effect of ignoring filter bandwidth in
BLT source recovery through both simulation, using a complex mouse model (Digimouse
atlas), and experiment, imaging a mouse phantom (XPM2, Perkin Elmer) in the BLDOT
imaging system. A filter bandwidth model, which is incorporated into the BLT reconstruction
algorithm, is presented and the effect of the model on the quantitative accuracy of the
simulation and phantom data is determined. This work is done using three wavelengths in
the multi-spectral data collection, which is fewer than the five or six which are currently used
in the BLDOT system [48, 49] and others [34, 36, 52], so the second section of this chapter
investigates whether using selected wavelengths has an effect on the quantitative accuracy of
BLT. A secondary result from this work, if quantitative accuracy can be preserved when using
wide bandwidth filters and fewer wavelengths, is a reduction in data acquisition time for BLT.
This will enable imaging to be done during the window of time over which the maximum
emission intensity of the bioluminescent reporter occurs (⇠10-20 minutes for Firefly luciferase,
fluc [75]), whilst minimising the time for which an animal is under anaesthetic and increasing
the imaging throughput.
First the filter bandwidth modelling will be outlined, followed by results on the effect
of filter bandwidth on the quantitative accuracy of BLT, with and without including filter
bandwidth modelling in the reconstruction. Finally results on the effect of using fewer filters
for multi-spectral data collection will be presented.
4.2 Incorporating Filter Bandwidth Modelling into the
BLT Reconstruction Algorithm
This section details modifications to the existing BLT reconstruction algorithm to incorporate
filter bandwidth modelling. This modified algorithm will be validated in Section 4.4 through
both simulation, using the Digimouse model and experiment, using the XPM2 mouse shaped
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phantom.
When performing bioluminescence tomographic reconstructions, surface-weighted mea-
surements are used along with reconstruction algorithms to recover the internal biolumines-
cent source [26]. Given a known source distribution, x, and a model of light propagation,
J , the boundary measurements, b, are given by a linear relationship (Jx = b, Eq. 2.11).
As explained in Chapter 2, the Jacobian, J , and measurement matrix, b, are created from a
combination of Jacobians/measurements (Eq.’s 2.13 and 2.14) for each of the measurement
wavelengths,  ⇤
i
(the central filter wavelength of the band pass filters used for data collection).




, are assumed to be from a single wavelength,  ⇤
i
, the cor-
responding Jacobians are calculated according to this assumption; these Jacobians will be
referred to as the narrow bandwidth (NBW) Jacobians. However, as explained earlier, when
using band pass filters for data collection, measurements are comprised of signal from all
wavelengths which are transmitted through the filter, governed by its bandwidth, w. There-
fore, assuming a band pass filter with a top-hat transmission profile with 100% transmission,
































measurement contribution from each wavelength  
j
transmitted through the filter. (Note
that any filter transmission profile [such as a Gaussian model], not just top hat transmission,
can be used by convolving the profile with the measurement data.) Approximating this










































































is the Jacobian for measurement wavelength  ⇤
i




is the Jacobian matrix calculated for each wavelength transmitted through the
filter. Using the definitions above, Eq. 2.11 becomes:
J̃x = b̃ (4.5)
where J̃ is the modified Jacobian accounting for the bandwidth of the filters used for data
collection, and will be referred to as the wide bandwidth (WBW) Jacobian.
In order to evaluate the effects of including filter bandwidth in source recovery, both the
NBW and WBW Jacobians are used for image reconstruction.
4.3 Methods
4.3.1 Simulation using a Heterogeneous Mouse Model
A three-dimensional heterogeneous mouse model (the Digimouse atlas [42]) with a biolu-
minescent pancreas (Firefly Luciferase, fluc) was used for simulation studies (Fig. 4.1).
Tissue properties of the eight regions of the model are shown in Table 4.1 and the opti-
cal properties for each wavelength were calculated using appropriate extinction coefficients
65
Figure 4.1: Digimouse model used in the simulations. The left image indicates the regions of
the mesh, with the colourbar representing region number, as detailed in Table 4.1. Region 8 is
the pancreas, which was made bioluminescent (fluc). 451 detectors were positioned uniformly
across the surface of the mesh in the boxed areas. The bioluminescent pancreas alone is shown
in the right image, colourbar units: modelled bioluminescence intensity. Adapted from [96].
(http://omlc.org/spectra/). A total of 451 detectors were modelled over the surface of the
mesh above the pancreas, and simulated boundary data were calculated using NIRFAST, as
explained in Section 2.2 [35].
Effect of Filter Bandwidth To determine the effect of filter bandwidth on the data
quality, data were calculated at three measurement wavelengths, l* = 600, 620 and 640 nm,
and eight different bandwidths (1, 2, 4, 6, 8, 10, 16 and 20 nm). The source emission spectrum
over the range of wavelengths considered in this part of the study is shown in Fig. 4.2 b,
along with the spectral coverage of the 1, 10 and 20 nm bandwidth filters (1 nm bandwidth
spectral coverage covers the measurement wavelength only) assuming filters with top hat
transmission profile and 100% transmission. BLT reconstructions on this noise-free data
were performed using the CSCG reconstruction algorithm [50] using both NBW and WBW
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Table 4.1: Tissue properties of the mouse mesh. [HbT] - total haemoglobin concentration,
[StO
2
] - oxygen saturation, [H
2
O] - water concentration, sa - scatter amplitude, sp - scatter
power. Reproduced from ref. [149].
Region Tissue [HbT] / mM [StO
2
] / % [H
2
O] / % sa sp
1 Adipose 0.0033 70 50 0.98 0.53
2 Bone 0.0049 80 15 1.4 1.47
3 Muscle 0.07 80 50 0.14 2.82
4 Stomach 0.01 70 80 0.97 0.97
5 Lungs 0.15 85 85 1.7 0.53
6 Kidneys 0.0056 75 80 1.23 1.51
7 Liver 0.3 75 70 0.45 1.05
8 Pancreas 0.3 75 70 0.45 1.05
Jacobians. In each case the WBW Jacobians are calculated for the bandwidth corresponding
to the bandwidth used in data calculation. Noise-free data enabled evaluation of the filter
bandwidth modelling in this best case scenario.
To determine whether there is any correlation between the filter bandwidth and the
recovered source intensity, position (error in centre-of-mass compared to the true source
location) and size (equivalent radius - the radius of a sphere of the same volume as the
recovered source), the Pearson’s correlation coefficient was calculated. In order to ascertain
whether there was any significant difference between the sources recovered using the NBW
and WBW models, a Wilcoxon signed rank test was performed on intensity, centre-of-mass
and equivalent radius data from reconstructions using both models, assuming that the data
are paired and non-parametric. The null hypothesis for this test was ‘WBW reconstructions
are the same as NBW reconstructions’.
Effect of Filter Selection To determine whether data can be acquired at fewer selected
measurement wavelengths without compromising data quality, boundary data were calculated
at five measurement wavelengths, l*= 560, 580, 600, 620 and 640 nm, which span the emission
spectrum of fluc (Fig. 4.2 a), assuming a bandwidth of 10 nm. These measurements are
67
representative of the filters used in the BLDOT system.
Figure 4.2: (a) Normalised total attenuation of tissue and emission spectrum of firefly lu-
ciferase (fluc). Measurement wavelengths are indicated on the x axis. The high attenuation
of tissue and lower emission of fluc at 560 and 580 nm can be seen. (b) Normalised total
attenuation of tissue and emission spectrum of fluc in the spectral region considered in the
filter bandwidth study. Measurement wavelengths and the spectral coverage of 1, 10 and 20
nm filters indicated. Adapted from [96].
Tomographic source recovery was performed on the noise-free multi-spectral data, using
the CSCG reconstruction algorithm [50] with the WBW Jacobian model (calculated according
to the 10 nm bandwidth assumed during calculation of the data). Three different wavelength
combinations were used for source recovery:
1. 5wv - All five wavelengths
2. 3wv_1 - 560, 580, 600 nm
3. 3wv_2 - 600, 620, 640 nm
These combinations of wavelengths used were chosen after considering the spectral attenua-
tion of tissue and the source emission (Fig. 4.2 a) as follows: of the measurement wavelengths
simulated, the tissue attenuation is highest at 560 and 580 nm, while the source emission is
lowest at these wavelengths, so the measured bioluminescence intensity at these wavelengths
is expected to be low. Therefore, when performing BLT using data from all five wavelengths
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(5wv) the majority of the signal used for reconstruction is from the three higher wavelengths
(600, 620 and 640 nm). Additionally the three higher wavelengths span the peak emission
of fluc, which occurs at 612 nm [25] (Fig. 4.2). In order to determine whether the two
lower wavelengths have any effect on the recovered source, it was decided that reconstruc-
tions would be performed using data at all five wavelengths (5wv), as is conventional when
performing BLT data collection in the BLDOT system, the three lower wavelengths (3wv_1)
and the three higher wavelengths (3wv_2) which are expected to produce recovered sources
similar to the 5wv reconstruction due to the high signal at these wavelengths.
It is important to note that 3wv_1 and 3wv_2 combinations of wavelengths also span a
narrower region of the emission spectrum than the coventionally used 5wv. This simulation is
concerned with the effect of using fewer wavelengths, and in this specific case (which should
apply to all in vivo murine experiments which use fluc as the bioluminescent reporter in BLT)
the logical selection of fewer wavelengths for data collection, as described above, results in
wavelengths for data collection which span a narrower range of the spectrum. In the future
it is important to determine the effect of using wavelengths for data collection which span
a narrower range. For example the experiment presented here could be repeated using 5wv
and then using five wavelengths which span a narrower range of the spectrum (e.g. 600, 610,
620, 630, 640 nm) to determine the effect of using a narrower spectral range of data on BLT
source recovery, so that only one variable is changed, rather than the two which are changed
here (range and number of wavelengths).
4.3.2 Phantom Data Collection
A plastic mouse phantom (XPM2, Perkin Elmer, Fig. 4.3), with two internal light sources,
was imaged using the BLDOT system.
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Effect of Filter Bandwidth For the filter bandwidth study, data were collected at  ⇤ =
600, 620 and 640 nm with 10 nm bandwidth filters (Thorlabs Inc.) and at  ⇤ = 600, 623 and
643 nm, where each filter had a different bandwidth: 22, 32 and 34 nm respectively (Semrock
Inc.), the bandwidth of these filters is referred to as ⇠20 nm. Tomographic reconstruction of
this data was performed using the CSCG algorithm and both NBW and WBW Jacobians.
Three-dimensional surface capture data was taken of the phantom to enable mesh cre-
ation for use in free space modelling which was used to calibrate data, and tomographic
reconstruction. The emission characteristics of the light sources within the XPM2 phantom
have been previously characterised (Fig. 4.3) and the spectral optical properties experimen-
tally determined [48,197] and are accounted for in all BLT reconstructions.
Figure 4.3: (a) XPM2 mouse shaped phantom. Position of the two sources (at the end of the
internal rods) are indicated in the lower image, obtained from microCT data. Reproduced
from ref. [96]. (b) Emission spectrum of the internal light sources of the XPM2 phantom.
Reproduced from ref. [48]. (c) Emission spectrum and total attenuation of the phantom at
discrete wavelengths.
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Effect of Filter Selection In order to determine whether data can be collected at fewer
wavelengths without compromising data quality, data were collected at  ⇤ = 560, 580, 590,
600, 620 and 640 nm with 10 nm bandwidth filters (Thorlabs Inc.). Tomographic reconstruc-
tion of this data was performed using the CSCG algorithm and the NBW Jacobian, using
data at all six wavelengths (6wv) and three wavelengths only,  ⇤ = 600, 620 and 640 nm
(3wv).
On consultation of the spectral attenuation and source emission of the phantom it is
unclear which three measurement wavelengths are optimal to use for reconstruction (Fig. 4.3
c). With the simulation model, the peak source emission occurred when the attenuation was
low (Fig. 4.2 a), so it was sensible to choose measurement wavelengths in this region of the
spectrum. Considering the XPM2 attenuation and emission spectrum in the region 560 to
650 nm, the source emission is high when the attenuation is high and vice versa. So 600,
620 and 640 nm were chosen as the three wavelengths to use in BLT reconstruction since the
attenuation is low at these wavelengths and also to be consistent with the simulation study.
4.4 Results: Effect of Filter Bandwidth on the Quantita-
tive Accuracy of BLT
This section aims to determine whether increasing the bandwidth, and additionally including
filter bandwidth modelling in the tomographic reconstruction algorithm, has an effect on the
quantitative accuracy of the recovered source.
4.4.1 Simulation
Raw measurement data at a range of bandwidths (1, 10 and 20 nm) are shown in Fig. 4.4
a. The simulated surface intensity is greater for data simulated at larger bandwidths for a
given exposure time, as expected due to the increase in total light transmitted through the
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filter, arising from the larger number of transmitted wavelengths. The percentage variation





to 1 nm bandwidth (I
1nm
): P = 100⇥ (I10nm I1nm)
I1nm
(for 10 nm), shows the extent to which the
signal varies (Table 4.2 *). The maximum variation is for 620 nm data in all cases, as the
source emission is close to the peak intensity of fluc (612 nm, [25]) and the tissue attenuation
is low (Fig. 4.2 a). Therefore, the intensity of all wavelengths transmitted through the filter
is high, introducing a larger error when only the central filter wavelength is considered. The
increase in measured intensity when using 10 and 20 nm filters suggests that a reduction
in exposure time of the order of 17⇥ and 58⇥ for 10 and 20 nm filters respectively can be
applied to obtain the same signal as when using a filter with 1 nm bandwidth.
Table 4.2: Percentage difference of total intensity (thresholded at 50% of maximum value)
of boundary data between bandwidths of 10 and 20 nm and 1 nm to two significant figures.
Shown for raw data (*) and data normalised by bandwidth (†).
Wavelength / nm 10 nm* 20 nm* 10 nm† 20 nm†
600 980 1800 7.8 -3.5
620 1700 5800 82 200
640 960 1900 5.6 -2.1
In the case of BLT, the target source and recovered sources for simulated data at band-
widths of 10 and 20 nm are shown in Fig. 4.5. Considering only the NBW model, which
is currently used in BLT reconstructions, the reconstructed source distributions for the two
bandwidths are qualitatively similar. The error in centre-of-mass (Fig. 4.6 a, black bars) of
the reconstructed sources using the NBW model remained constant to within 0.2 mm over
the range of bandwidths simulated. This small variation, and a low correlation (Table 4.3,
‘r
NBW
’), demonstrates a negligible dependence of centre-of-mass error on bandwidth. Some
variation in the equivalent radius is observed (maximum variation, 0.77 mm, Fig. 4.6 b, black
line). However this variation does not appear to have a strong dependence on bandwidth,




Figure 4.4: (a) Measurement data calculated at 600 nm at three bandwidths, thresholded at
12.5% for visualisation. The same distribution is seen but the intensity varies with bandwidth.
(b) As (a) with data normalised by bandwidth. Colourbar units: arbitrary intensity units.
Adapted from ref. [96].
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These results suggest that bandwidth has qualitatively little effect on the recovered source
size and position, for the range of bandwidths considered. The equivalent radius further
demonstrates the observed similarity between the recovered sources at 10 and 20 nm band-
widths (Fig. 4.5), which have an 0.34 mm variation in equivalent radii.
Table 4.3: Pearson’s correlation coefficient, r, to determine correlation between bandwidth
and centre-of-mass, equivalent radius and total intensity of recovered sources using both







Centre-of-mass 0.39 0.30 0.47
Equivalent radius -0.49 -0.87 0.47
Total intensity 0.99 -0.27 0.02
When considering the total recovered source intensity of NBW reconstructions at all
bandwidths, a strong linear dependence on bandwidth is observed (Fig. 4.6 c, black line),
and a strong positive correlation calculated (Table 4.3, ‘r
NBW
’). As bandwidth increases,
the discrepancy between the total intensity of the target and reconstructed sources increases
dramatically, resulting in the intensity of the source recovered using 20 nm bandwidth data
being approximately 20⇥ higher than that using 1 nm data. This is due to an increase in the
model-data mismatch which occurs in the model-based image reconstruction algorithm when
using the NBW model: at higher bandwidths it becomes less appropriate to approximate the
data as being collected at the single, central wavelength of the filter. A strong dependence of
the quantitative accuracy of the recovered source on filter bandwidth has been demonstrated
and must be accounted for in the reconstruction.
A possible method to remove the intensity dependence is normalisation of the BLI mea-
surement data by the bandwidth of the filters used for data collection, i.e. data taken using a
filter with a bandwidth of 10 nm is divided by 10 etc.. This results in intensity distributions
with similar maximum intensities at each bandwidth (Fig. 4.4 b). However, there is still some








































































































































































































tissue attenuation and source emission within the bandwidth of the filter. This variation is
different for filters of different bandwidths due to differing spectral coverage of different filters
(demonstrated in Fig. 4.2 b). If the measured intensity for different bandwidths is identical,
P = 0% and the variation in measured bioluminescence intensity with bandwidth has been
accounted for. However, following normalisation of this data by bandwidth, there still exists
a variation in maximum intensity, P, of up to 82% for 10 nm data and 200% for 20 nm data
(Table 4.2 †). Due to this large variation still present, normalisation is not considered to
be an appropriate method of accounting for the bandwidth of the filters used. The WBW
Jacobian method was devised as a method of accounting for filter bandwidth, and has been
used to reconstruct the simulated data in this work.
4.4.1.1 Effect of Including Filter Bandwidth Modelling in the BLT Reconstruc-
tion
The sources recovered using both NBW and WBW Jacobians for bandwidths of 10 and 20
nm are shown in Fig. 4.5. The position and distribution of the sources recovered using
both Jacobian types are qualitatively very similar, supported by the error in centre-of-mass,
which varies by a maximum of 0.14 mm between the two Jacobian types (Fig. 4.6 a). There
is a negligible correlation between centre-of-mass error and bandwidth (Table 4.3, ‘r
WBW
’),
comparable to that for NBW reconstructions. The difference between the centre-of-mass
errors for the two Jacobian types was not statistically significant (Table 4.3, ‘p’), supporting
qualitative observations and similar correlations with bandwidth.
The equivalent radius (Fig. 4.6 b) behaves similarly for both NBW and WBW reconstruc-
tions. There appears to be a moderate decrease with bandwidth for WBW reconstructions
(Table 4.3, ‘r
WBW
’) whereas the variation observed for NBW reconstructions is more random.
However, the variation between equivalent radii for all bandwidths is submillimeter in both
cases (0.77 and 0.51 mm for NBW and WBW reconstructions respectively) and there is no
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significant difference between the two data sets (Table 4.3, ‘p’).
Figure 4.6: (a) Error in centre-of-mass (COM) of recovered sources as a function of band-
width, for NBW (black bars) and WBW (white bars) reconstructions. There is negligible
variation with both bandwidth and Jacobian type. (b) Equivalent radius of recovered sources
for NBW (black line) and WBW (red line) reconstructions with the target value (1.23 mm)
indicated. (c) Total intensity of recovered sources for NBW (black line) and WBW (red
line) reconstructions, with the target value (124) shown. A linear dependence of intensity on
bandwidth is observed for NBW reconstructions. This dependence is removed when using the
WBW model, demonstrating the increased quantitative accuracy of WBW reconstructions.
Adapted from ref. [96].
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The similarity in appearance of the recovered sources using both Jacobian types (Fig. 4.5),
combined with the lack of significant difference between NBW and WBW reconstructions in
terms of size and position of the recovered source, suggests that there is no qualitative
difference between sources recovered using the two Jacobian types.
The real advantage of using the WBW Jacobian model for image reconstruction is demon-
strated when the total intensity of the recovered source is considered (Fig. 4.6 c). There is a
significant difference between the recovered source intensity using the two Jacobian models
(Table 4.3, ‘p’). As described above, the total intensity of NBW reconstructions increases
linearly as bandwidth is increased due to the model-data mismatch in the reconstruction
algorithm becoming greater at larger bandwidths. This variation in intensity is removed by
using the WBW model (Table 4.3, ‘r
WBW
’), demonstrating that the WBW model has im-
proved the quantitative accuracy of BLT compared to that achievable using the traditional
NBW model. The intensity of the source recovered from 20 nm bandwidth data is now
0.88⇥ that of the 1 nm data (compared to approximately 20⇥ for the NBW model), with
the intensity of all reconstructions within 58% of the target value (as opposed to 2918% for
the NBW model).
The time taken to perform the reconstruction using the WBW model increases with the
bandwidth of the filter, as compared to the constant reconstruction time when using the
NBW model. This increase in processing time is due to the nature of the WBW model,
which calculates Jacobians at each wavelength transmitted through the band pass filter,
governed by the bandwidth, and combines them, whereas the NBW model calculates one
Jacobian only at the central filter wavelength regardless of the bandwidth of the filter. The
computation time for NBW and WBW reconstructions at all bandwidths relative to the time
taken to reconstruct data of a bandwidth of 1 nm is shown in Table 4.4. For reference, for
a workstation running on 64-bit Windows (Windows 7 Enterprise) with 16 GB RAM, using
an Intel® Core™ i7-3770 CPU at 3.40 GHz, using MATLAB R2013a, the NBW and WBW
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reconstructions for 1 nm took around 2960 s. Although the processing time is increased,
the increase in quantitative accuracy of the recovered sources demonstrated that using the
WBW model has clear potential in enhancing the quantitative accuracy of BLT, advancing
the technique towards implementation routinely in in vivo pre-clinical studies. The variation
in reconstruction time for using the NBW model is unexpected, all reconstructions are cal-
culating a single Jacobian matrix and therefore should all take equal time. The variation is
thought to be due to variation in use of the computer that was used to run the reconstruc-
tions. It is possible that during some of the reconstructions, other processes were running
in the background, limiting the processing power available and therefore increasing the time
taken for source recovery.
Table 4.4: Reconstruction time for simulation data at all bandwidths relative to the time
taken to reconstruct data of a bandwidth of 1 nm for both NBW and WBW Jacobian models.
The increase in time to reconstruct wider bandwidth data using the WBW method is shown.









This simulation study has shown that the bandwidth of filters used for multi-spectral
data collection for BLT must be accounted for in the reconstruction algorithm. The WBW
model has been shown to effectively account for the bandwidth of the filters, increasing the
quantitative accuracy of the recovered source compared to that achievable using the NBW
model. The WBW model was also applied to phantom data taken with the BLDOT system




Sources recovered from experimental data of the XPM2 mouse-shaped phantom with two
internal sources illuminated (Fig. 4.3), taken using 10 nm and wider (⇠20 nm) bandwidth
filters and using both NBW and WBW Jacobian models, are shown in Fig. 4.7. Little
difference is observed in terms of position and appearance of the recovered source, when
comparing both bandwidths and Jacobian models. This suggests qualitatively that the range
of bandwidths used for data collection has no effect on the source reconstructions, as with
simulation, and as the total imaging time is decreased from 10 minutes 45 seconds to 5 minutes
20 seconds (including 4 minutes for surface capture), it is experimentally advantageous to
use wider bandwidth filters. This will enable the imaging throughput to be maximised whilst
minimising distress to animals during in vivo imaging.
The error in centre-of-mass of the reconstructions (Table 4.5) is similar for both Jacobian
models at both bandwidths. Note the larger error for source B, which is due to the greater
depth of the source within the phantom as compared to source A (Fig. 4.3 a) and therefore
the increased absorption and scatter of the signal from source B as it travels to the surface
of the phantom, where it is detected. Additionally, as both source A and B are illuminated
simultaneously and source A is more superficial than source B, the signal from source B at
the surface is overwhelmed by that from source A. Therefore the measured signal from source
B is lower than that from source A and more susceptible to measurement noise, so is more
difficult to reconstruct to a high degree of quantitative accuracy.
The equivalent radius is also very similar for both NBW and WBW Jacobian models
(Table 4.5). This, along with qualitative observations of the reconstructions, supports the
findings of the simulations that in terms of the size and position of the recovered source,
there are very few differences between reconstructions using data at different bandwidths
when using either the NBW or WBW Jacobian model to reconstruct. However, as with the





































































































































































































































Table 4.5: Quantitative analysis of XPM2 source reconstructions of sources A and B. The
larger bandwidth filters used for imaging are referred to as having a 20 nm bandwidth in this
table, ‘c-o-m error’ is centre-of-mass error and ‘ER’ is equivalent radius.
Bandwidth / nm Jacobian type
c-o-m error / mm ER / mm Total Intensity
A B A B A B
10 NBW 1.62 3.58 0.65 1.60 4.89 ⇥108 2.88 ⇥108
20 NBW 1.71 3.63 0.65 1.53 2.33 ⇥109 1.44 ⇥109
10 WBW 1.59 3.84 0.42 1.47 4.25 ⇥107 2.50 ⇥107
20 WBW 2.03 4.28 1.13 1.89 6.20 ⇥107 3.79 ⇥107
of the recovered source is considered (Table 4.5).
Considering NBW reconstructions, the total recovered source intensity from data taken
using ⇠20 nm bandwidth filters is approximately 5⇥ greater than that for 10 nm bandwidth
data, for both sources A and B. As the same sources are being reconstructed in both cases,
the recovered source intensity should be identical regardless of the bandwidth of the filters
used for data collection. When the WBW model is used to reconstruct, the difference in
intensity is decreased (Table 4.5). The total intensity of the recovered source from data
taken using ⇠20 nm bandwidth filters is just ⇠1.5⇥ that using 10 nm bandwidth data.
Therefore the WBW model has accounted for the bandwidth of the filters to some extent,
reducing the dependence of the intensity of the recovered sources on the bandwidth of the
filters used for data collection. However, as with the simulation study, the increased number
of Jacobians which are calculated in the WBW reconstruction (one for each wavelength which
is transmitted through the filter, which are then added together to produce the full WBW
Jacobian) results in an increase in the reconstruction time as compared to when using the
NBW model, with data taken using wider bandwidth filters taking the longest to reconstruct.
The filter transmission profiles for the filters used for data collection in this section were
assumed to be top hat profiles, as per manufacturer data. However, the profiles should be
confirmed using a spectrometer rather than relying on the manufacturers data for use in
WBW reconstruction, as any variation will affect the quantitative accuracy of the recovered
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bioluminescent source distribution. Additionally, the transmission percentage was assumed
to be equal between the different bandwidth filters, although this was not the case in practice.
The transmission percentage for the 10 and ⇠20 nm filters, from manufacturer data, are 50-
60% and 90-100% respectively. It is possible that not accounting for these differences is the
cause of the remaining variation in total recovered source intensity between the WBW recon-
structions using data from the different bandwidth filters (intensity using ⇠20 nm bandwidth
data is ⇠1.5⇥ that using 10 nm bandwidth data). Although the true transmission profiles
of the filters are not accounted for in this chapter, results from this first experiment are
promising for the application of the WBW model in vivo.
Experimental results presented here support the simulation work: using the WBW Jaco-
bian model to reconstruct increases the quantitative accuracy of the recovered sources in BLT.
There is qualitatively little effect on the source reconstructions, in terms of centre-of-mass
error and equivalent radius, but quantitatively, the difference between the total reconstructed
intensity at different bandwidths is greatly reduced, albeit with an increase in reconstruction
time. In future work the true transmission profile of the filters should be measured and
accounted for in the WBW reconstruction.
4.5 Results: Effect of Filter Selection for Multi-Spectral
Data Collection on the Quantitative Accuracy of BLT
This section aims to determine whether using fewer selected wavelengths for multi-spectral
data collection for BLT (three, as used in Section 4.4, as opposed to five or six which are




Figure 4.8 shows the recovered source after reconstruction with the CSCG algorithm using
data at the three combinations of wavelengths: 5wv, 3wv_1 and 3wv_2. There is qualita-
tively negligible difference between the sources recovered using 5wv and 3wv_2, supporting
the hypothesis that the lower wavelengths (560 and 580 nm) contribute negligibly to the
reconstruction. The total measurement intensity of each of the measurement wavelengths
is shown in Fig. 4.9 a, demonstrating the low intensity of the 560 and 580 nm data com-
pared to the three higher wavelengths, supporting the hypothesis further. On comparison of
the 5wv and 3wv_1 recovered sources, differences in appearance are observed. The 3wv_1
source appears more sparse and disjointed than the 5wv source, this is attributed to the lower
intensity of the 3wv_1 data.
Figure 4.8: Target and recovered sources from data simulated at three different wavelength
combinations: 5wv, 3wv_1 and 3wv_2 at a bandwidth of 10 nm. There is negligible qual-
itative difference between the sources recovered using 5wv and 3wv_2 and on consultation
of the colourbar, the intensity of these reconstructions is quantitatively similar. Colourbar
units: arbitrary intensity units.
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Figure 4.9: (a) Total intensity above a threshold of 50% of the maximum value of mea-
surement data at a bandwidth of 10 nm; (b) Total recovered intensity, with target intensity
indicated; (c) Error in centre-of-mass of recovered source, for reconstructions performed with
5wv, 3wv_1 and 3wv_2. In both (b) and (c) the 5wv and 3wv_2 recovered sources have
comparable values.
Figure 4.9 b shows the total intensity of the recovered sources for each of the wavelength
combinations. Note that only intensity above an empirically chosen threshold of 2% of the
maximum was considered here. The recovered source intensity for 5wv and 3wv_2 data is
very similar, with errors relative to the target value of 25% and 37% respectively. The 3wv_1
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source has a much lower intensity, with an error of 57% relative to the target. The error in
centre-of-mass of the recovered source (Euclidian distance between the centre-of-mass of the
target and reconstructed sources) behaves in a similar way (Fig. 4.9 c), showing a much larger
error for 3wv_1 compared to the other wavelength combinations which have positional errors
of approximately 0.5 mm. The ability to recover sources with sub-millimetre accuracy using
both 5wv and 3wv_2 shows that it is possible to recover an internal source to a high degree of
quantitative accuracy using different wavelength combinations and, along with the similarity
in intensity, demonstrates the similarity between 5wv and 3wv_2 reconstructions.
These simulation results show that it is possible to recover the internal bioluminescence
distribution using fewer wavelengths without compromising quantitative accuracy, provided
the wavelengths are sensibly chosen with consultation of the tissue attenuation and emission
spectrum of the bioluminescent source. Although these results are promising, it is important
to confirm these conclusions experimentally.
4.5.2 Phantom Data
Multi-spectral BLI data were taken using the XPM2 mouse-shaped phantom with two internal
light sources illuminated, at six wavelengths using the BLDOT system. BLT reconstructions
performed using the CSCG algorithm using data at all six wavelengths (6wv) and three
wavelengths only (3wv: 600, 620, 640 nm) are shown in Fig. 4.10. Note that the NBW model
was used for these reconstructions, this is due to the work being done prior to the development
of the WBW model. It is thought that the conclusions drawn from this section using the
NBW model are applicable to WBW source recovery, and due to the results presented in
Section 4.4 which show the WBW model to improve the quantitative accuracy of BLT, the
WBW model will be used in future experiments.
On visual inspection of the recovered sources, the 6wv sources appear more diffuse than
the 3wv sources but they appear to be in a similar location. It is possible that the data
86
Figure 4.10: Target sources A and B (at the end of the rods pictured) and reconstructed
sources for the XPM2 phantom, from data taken at 6 and 3 wavelengths (6 wv and 3 wv
respectively). Qualitatively the sources recovered from data taken at three wavelengths
appear smaller than those recovered from data at six wavelengths. The position of the
sources from the two wavelength combinations appears similar. Colourbar units: arbitrary
intensity units.
taken at 560, 580 and 590 nm, which is used in the 6wv reconstructions and not the 3wv
reconstructions was noisy which introduced some error into the reconstructions, causing the
source to be reconstructed more diffusely. This is speculation based on the high attenuation
of the phantom at these wavelengths.
In order to perform quantitative comparisons between the 6wv and 3wv reconstructions
the error in centre-of-mass, equivalent radius and intensity of source A relative to that of
source B (above a threshold of 50 % of the maximum) were calculated for sources A and B.
This data is shown in Table 4.6. The error in centre-of-mass of source A is less than that for
source B for both wavelength combinations. This is due to the increased depth of the source
within the phantom (Fig. 4.3 a) as explained in Section 4.4.2.
The error in centre-of-mass of source A recovered from 6wv is smaller than that for 3wv
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Table 4.6: Quantitative analysis of XPM2 source reconstructions of sources A and B using
data from 6 or 3 wavelengths to reconstruct. ‘c-o-m error’ is centre-of-mass error, ‘ER’ is
equivalent radius and I
AB
is the intensity of source A relative to B (from manufacturer data
this is 96%).
#Wavelengths
c-o-m error / mm ER / mm I
AB
/ %
A B A B
6 1.12 4.15 2.11 2.48 121
3 1.62 3.58 0.65 1.60 170
but the variation between the two is small (0.5 mm). The converse is found for source B,
but the difference is submillimetre (0.57 mm). This is thought to be due to the balance
between source emission and attenuation as explained before, it is possible that the data
contribution from the three lower wavelengths is low as the attenuation is higher at these
wavelengths. Therefore, these lower wavelengths will contribute low intensity, noisy data to
the reconstruction which will decrease the quantitative accuracy compared to higher intensity
data.
The equivalent radii of both sources A and B reconstructed with three wavelengths are
smaller than the 6wv reconstructions (Table 4.6). Although the true size of the sources is
unknown, the sources are LEDs located at the end of two tunnels within the phantom (Fig.
4.10) and so are expected to be small. This further supports that the data acquired from the
three lower wavelengths is poor quality and is decreasing the quantitative accuracy of the
reconstructions, suggesting that it is possible to use only three wavelengths to reconstruct
without any loss of quantitative accuracy.
The intensity of source A relative to source B, from manufacturer data, should be 96%.
However, in both cases source A has been recovered at a higher intensity than source B
(Table 4.6). This is likely to be due to the higher position of source A in the phantom than
source B, and so the signal from source B is affected as described earlier.
The reconstructions using 6wv and 3wv perform differently in each analysis metric chosen
to evaluate the recovered source so it is difficult to conclude which reconstruction has per-
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formed better. Data collection using all six wavelengths (10 nm bandwidth band pass filters)
took a total of 29 minutes 20 seconds (including 4 minutes for surface capture), whereas the
total data collection time for three wavelengths only was 11 minutes and 30 seconds. Due to
these factors, the results presented here suggest that it is possible to use fewer wavelengths to
reconstruct. In the future, if the wavelength choice is difficult, as it is here, it would be advis-
able to do initial controlled experiments (e.g. using a source with known size and intensity)
at a number of different wavelength combinations to determine the appropriate wavelengths
for data collection in the specific case. Additionally, as with the simulation study, both num-
ber of wavelengths and spectral range have been varied in this experiment. It is important
to repeat this work to determine the effect of spectral range on the quantitative accuracy of
BLT. For example comparing BLT source recovery using all six wavelengths (6wv) and six
wavelengths which span a narrower spectral range (e.g. 600, 610, 620, 630, 635, 640 nm).
4.6 Conclusions
This chapter shows that the quantitative accuracy of BLT is affected by the bandwidth
of the filters used in multi-spectral data collection. The WBW model was developed as
a method of accounting for the bandwidth of the filters and has been shown to improve
the quantitative accuracy of the recovered source intensity compared to the NBW model,
which is traditionally used. The position and size of the recovered source was consistent
between the two reconstruction types. In future work it is important to measure and account
for the transmission profile of the filters when using the WBW model for bioluminescent
source recovery, it is thought that this will improve the efficacy of the WBW model. Data
has also been presented which shows that it is possible to take multi-spectral BLI data for
use in BLT at fewer measurement wavelengths (three, as opposed to five or six) without a
loss in quantitative accuracy. This is provided the wavelengths selected for data collection
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are selected by consulting the spectral attenuation of tissue and the source emission, with
optimum imaging wavelengths when the attenuation of tissue is low and the source emission
is high.
Although the data presented here shows that it is possible to take data at fewer measure-
ment wavelengths, both number of wavelengths and spectral range of measurement wave-
lengths were varied in this work. A further experiment should be performed to investigate
the effect of spectral range of measurements on the quantitative accuracy of the recovered
source in BLT, whilst keeping the number of measurement wavelengths constant. As men-
tioned in Section 4.3.1, data in the simulation study should be collected using 5 wavelengths
in the range 600-640 nm and used in BLT source recovery. The recovered source can then be
compared to that using the set of 5wv used in this c
hapter, which spanned 560-640 nm. It is thought that there will be minimal change in
the recovered source due to the majority of the data collected at the wider spectral range
coming from measurements taken at 600-640 nm. However, it is possible that using more
measurement wavelengths in the range 600-640 nm will improve the quantitative accuracy
of the recovered source. The quantitative accuracy can be tested, as it was in this Chapter,
by comparing the recovered sources to the target source intensity and position. The effect of
spectral range can also be tested using fewer measurement wavelengths, by using the 3wv_2
data presented in this chapter (which spanned 600-640 nm) and repeating the simulation
using three measurement wavelengths in the range 560-640 nm. Further work should also
include repetition of the experiment presented here such that statistical analysis can be
performed on the resulting data, strengthening the work presented in this chapter. The data
presented here is from a single experiment only and while there appears to be no loss in
quantitative accuracy, it is important to determine this definitively.
If future experiments corroborate the data presented here, the ability to take data with
wider bandwidth filters and at fewer wavelengths will decrease the data acquisition time.
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Originally multi-spectral data collection in the BLDOT system was done at five or six wave-
lengths using band pass filters with a bandwidth of 10 nm. This resulted in an acquisition
time of approximately 15 minutes when including surface capture (⇠4 minutes). By using
three measurement wavelengths at a bandwidth of 10 nm the imaging time is reduced to
⇠10 minutes. Increasing the bandwidth of the filters to ⇠20 nm decreases the acquisition
time further, to ⇠5 minutes. So, with further confirmatory experiments, the work in this
chapter suggests that the acquisition time for data collection in the BLDOT system can be
reduced by a factor of 3 without any apparent loss in quantitative accuracy of BLT. During
pre-clinical imaging this will enable imaging to be performed during the time window at
which the maximum intensity of the bioluminescent reporter occurs (approximately 10-20
minutes for fluc [75]) whilst decreasing the total time the animal must be anaesthetised and
maximising imaging throughput.
The BLT reconstructions performed in this chapter used models with ground truth optical
properties in the simulation studies, and well characterised optical properties were available
for the XPM2 phantom. However, in pre-clinical work the true underlying tissue attenuation
of the animal will be unknown, and therefore quantitative BLT is a challenge. The following
chapters aim to tackle this problem and work towards truly quantitative BLT. Additionally,




Development and Validation of a
Spectral Derivative DOT Method
The data presented in the previous chapters tackles some of the limitations to the quantitative
accuracy of BLI, in overcoming the dependence of measured intensity on animal position
(Chapter 3), and BLT, in accounting for the dependence of the recovered source intensity
on filter bandwidth (Chapter 4). Thus far, the BLT reconstructions have been performed on
simulation and phantom data which have well characterised optical properties. In pre-clinical
imaging the tissue attenuation of the animal will be unknown. This chapter will begin by
demonstrating the importance of using accurate optical properties in the BLT reconstruction.
A spectral derivative (SD) DOT reconstruction method is then proposed as a way of obtaining
accurate optical properties for animals imaged using the non-contact BLDOT system, and
validated by applying the method to data simulated using the Digimouse atlas. Finally BLT
is simulated using the Digimouse atlas, with a view to demonstrating that BLT using optical
properties obtained from SD DOT has superior quantitative accuracy to other estimates of
the optical properties. Some of the work presented here was presented at the OSA Biomedical
Optics Congress 2016 and can be found in ref. [198].
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5.1 The Importance of using Accurate Optical Properties
in BLT Source Recovery
As an initial demonstration of the importance of the optical properties used in BLT recon-
structions, BLT was performed on data taken from a post mortem mouse with an artificial
light source (tritium-based, Trigalight Orange III; mb-microtec, Switzerland) inserted at a
depth of approximately 2 mm using the method detailed in Section 3.2 (Fig. 3.2). Data
were taken at 600, 623 and 643 nm using the BLDOT system and the CSCG algorithm was
used to reconstruct the internal bioluminescent source distribution [50]. Four different sets
of optical properties, all homogeneous, with varying total haemoglobin concentration, [HbT],
were assumed in the reconstruction (Table 5.1).
Table 5.1: Tissue composition parameters (total haemoglobin concentration, [HbT] / mM,
and tissue oxygen saturation, StO
2
/ %) used in BLT reconstructions for an animal with an
artificial light source inserted at a depth of approximately 2 mm, and the depth of the source
recovered using these tissue properties. Properties ‘a’ are ‘muscle’ optical properties from
the Digimouse atlas, properties b-d are calculated by reducing [HbT] for ‘a’ by 25%, 50%
and 75% respectively.
[HbT] / mM StO
2
/ % Depth / mm
a 0.070 80 1.69
b 0.053 80 2.30
c 0.035 80 3.62
d 0.018 80 6.24
The appearance of the recovered source has a dependence on the assumed optical proper-
ties (Fig. 5.1), as does the position (Table 5.1, ‘Depth’). The depth of the recovered source
was calculated by determining the Euclidian distance of the centre-of-mass of the recovered
source from the surface of the animal. A four-fold increase in the depth of the recovered source
with a four-fold decrease in HbT concentration (which corresponds to a decrease in tissue
attenuation) was found (Table 5.1). Reconstructions a and b achieve a source depth close to
the target depth of 2 mm, suggesting these estimates of tissue attenuation are closest to the
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true values, supported by the appearance of the recovered source which is more compact for
a and b (Fig. 5.1). However, these are only estimates, the true attenuation of the animal
is unknown. The variation in the recovered sources, in terms of appearance and position,
demonstrates the importance of having accurate knowledge of underlying tissue attenuation
in order to perform quantitative BLT. However, these reconstructions assume homogeneous
tissue attenuation, which is incorrect, the heterogeneity of the underlying anatomy of animals
must also be accounted for in order to perform quantitative BLT [29,30].
Figure 5.1: BLT data for a mouse with an artificial light source inserted at an approximate
depth of 2 mm assuming different total haemoglobin concentrations, decreasing from (a)-(d)
(see Table 5.1). Colourbar units: arbitrary intensity units. Reproduced from ref. [198].
The Digimouse atlas, used in previous chapters, incorporates the heterogeneity of the un-
derlying anatomy of the mouse. The model of mouse anatomy was acquired from coregistered
microCT and cryosection images of a male nude mouse [42], and is shown in Fig. 4.1. The
model is split into different regions, encompassing the organs of the animal, in this case there
are 8 regions which all have different optical properties. The optical properties of this model
have been calculated using appropriate extinction coefficients (http://omlc.org/spectra/)
[149, 199]. The variation between the optical properties in each region is up to 91× when
considering HbT concentration and 6× when considering water content (see Table 4.1). It
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is therefore important to consider this heterogeneity in anatomy and chromophore content
when performing quantitative BLT. One method of doing this would be to use the heteroge-
neous optical properties of a mouse atlas to reconstruct murine BLT data [41]. This will pro-
duce more accurate reconstructions than assuming homogeneous tissue, but the chromophore
concentrations in this model are fixed and in reality these will vary from animal-to-animal
limiting the achievable quantitative accuracy.
Figure 5.2: Schematic of the imaging set up for collection of trans-illumination images to
monitor the change in attenuation with time after death of an animal, which is being used to
represent the change in oxygenation of tissue. The animal is placed on the imaging platform
in the BLDOT system with the optical fibre positioned below the abdomen and data collected
at 643 nm.
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To demonstrate the heterogeneity of underlying tissue attenuation, and variation with
oxygen saturation and between animals, images of light transmitted through two mice (post
mortem) from a single point trans-illumination source were taken using the BLDOT system,
over 35 minutes at 643 nm (a schematic of the imaging set up is shown in Fig. 5.2). Resulting
transillumination images of the two animals are shown in Fig. 5.3. The sources were placed in
different locations for the two animals, one placed under the lower abdomen (Fig. 5.3 a) and
one under the upper abdomen (Fig. 5.3 b). Imaging commenced between 5 and 10 minutes
after sacrifice, following shaving of the animal. In the data analysis here the assumption has
been made that the time after death is inversely proportional to the tissue oxygen saturation
of the animals.
The intensity in four different 2 mm2 regions of interest (ROIs) across each animal was
plotted (Fig. 5.3 b and d). The ROIs were chosen by taking the highest intensity region
on each side of the spine (ROI1 and ROI2) and then choosing an arbitrary location within
the transmitted signal on each side of the animal for ROIs 3 and 4. The intensity varies
with both time, and therefore oxygen saturation, and position, with all eight ROIs for the
two animals varying differently. The maximum variation in intensity over time is 7% and
35% for the animals with the light source under the upper and lower abdomen respectively.
Although the variation for most of the ROIs is <10% (with a particularly small variation
of <7% for the animal with light source under the upper abdomen, Fig. 5.3 d) this data
demonstrates that there is a variation present which is different for different regions of the
animal. At 643 nm the attenuation of deoxyHb is greater than that of HbO (Fig. 1.3 a) so as
tissue oxygenation decreases the total attenuation will increase and the transmitted intensity
will decrease. This is true for constant blood volume. However, prior to death the blood
is circulating around the animal and so when the heart stops beating the blood will likely
collect in different organs within the body. So a decrease in intensity could also correspond
to an increase in blood volume within the ROI, and an increase in intensity suggests that the
97
volume of blood in that region is decreasing. The intensity of all ROIs for the animal with
the light source underneath the lower abdomen (Fig. 5.3 a) and ROIs 2 and 4 for the animal
with the light source under the upper abdomen (Fig. 5.3 c) are decreasing. However, ROIs
1 and 3 in the upper abdomen have increasing intensity (maximum variation of 6% and 4%
respectively). These regions correspond with the position of the liver [42] and may suggest
Figure 5.3: (a) and (c) transillumination images from a single point source of two different
mice, measured at 643 nm. Four regions of interest (area 2 mm2) are indicated. Colourbar
units: counts s-1 on CCD. (b) and (d) variation of the total measured intensity in the four
ROIs over the time course of the experiment, demonstrating the heterogeneity of the under-
lying tissue attenuation. Adapted from [198].
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that the blood volume within the liver is decreasing with time after death. These results show
how it is difficult to produce an accurate estimate of tissue attenuation as the chromophore
distribution is highly heterogeneous with each region of the animal varying differently.
As shown in Fig. 5.1 it is important to have accurate optical properties for use in BLT
reconstructions, so the aim of this work is to use DOT to obtain subject-specific optical
properties for use in BLT reconstructions. The following sections introduce a SD DOT
reconstruction algorithm for application to the non-contact BLDOT imaging system (and
all non-contact DOT imaging systems) and validation of this algorithm through simulation
using the Digimouse atlas.
5.2 Spectral Derivative DOT
Previous work has shown a SD approach to DOT reconstruction to improve the quantitative
accuracy of the recovered chromophore distribution and remove uncertainty (‘noise’) based on
fibre-surface coupling efficiency and boundary variations when using a contact DOT system
for data collection [200, 201]. A SD approach in application to data taken using the non-
contact BLDOT system is described in this chapter. Simulations are performed on the
Digimouse atlas to assess the efficacy of the SD method in removing the angular dependence
of the signal measured at the CCD, a dependence accounted for currently using the free space
model, with an aim of negating the need to perform free space modelling on DOT data which
will decrease the data processing and reconstruction time.
Additionally, the traditional spectral DOT reconstruction (Section 2.4.2), referred to here
as ‘normal spectral’ or NS, requires data calibration as detailed in Chapter 6 of ref. [194].
This is a complicated process to calibrate data, account for system offsets and obtain an
initial estimate of the optical properties of the imaging subject to use in the reconstruction.
The SD method is proposed as a method which does not require the initial data calibration
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step to produce accurate attenuation maps of the imaging subject. If the data calibration
step is not performed, a method of producing an initial optical property estimate for use
in the full reconstruction is required. A SD region based (SDR) reconstruction method is
proposed to provide this data, which performs chromophore recovery using experimental data
assuming a homogeneous volume.
5.2.1 Theory
The SD approach uses spectral difference data rather than absolute calibrated measurements
at each wavelength. For simplicity, only deoxyHb, HbO and water concentrations are recon-
structed for, scatter parameters are not considered in the reconstructions presented here but
should be included in future work. This will limit the quantitative accuracy of the recovered
chromophore distribution, but to validate the method using the Digimouse atlas it is assumed
that the scatter parameters are that of ‘adipose’ tissue which is known to occupy the bulk of
the model (Fig. 4.1) and is therefore considered to be a good approximation. The imaging
process and collected data are identical to when using the NS method, however differences
are present in the Jacobian calculation and measured data preparation processes.




JT    =  µ) must be modified, J is now the spectral difference Jacobian and
  is the spectral difference data. Assuming three measurement wavelengths, the spectral
difference data can be calculated from measured data ( 
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Similarly the SD Jacobian can be calculated from the traditional NS Jacobian by calculat-
ing the difference between equivalent entries for two adjacent wavelengths, i.e. for equivalent
node and detector combinations. The structure of the NS and SD Jacobians are shown in
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Fig. 5.4 a and b respectively.
Figure 5.4: Structure of the (a) normal spectral, NS, (b) spectral derivative, SD, and (c)
spectral derivative region reconstruction, SDR, Jacobians for data at three wavelengths,  
i
,




is the number of measurements and N
n
is number
of nodes. The SDR Jacobian has one chromophore concentration per wavelength combination
as the volume is considered to be homogeneous.
As was shown in previous work on the SD method, the noise in the data can be accounted
for using this method [200, 201]. The noise in data in previous work based on a contact
imaging system was due to the fibre-surface coupling and boundary variations of the imaging
subject. These effects were assumed to be constant for adjacent wavelengths when considering
wavelengths 2 nm apart, with the efficacy of the SD method showing the assumption to be
accurate [200]. Further simulation studies also showed the SD method to be effective when
using data with 20 nm spacing between measurement wavelengths [201]. This work aims
to show that the SD method can be applied to non-contact data from the BLDOT system.
Similar assumptions will be made, that the noise in the data measured at the CCD is constant
at adjacent measurement wavelengths. The noise considered here is the angular dependence
of the measured data and the effect of apertures and lenses that the light passes through
before being incident on the CCD, both of which are geometric (wavelength-independent)
errors accounted for by the free space model [27], and any noise in the detection system which
is also wavelength-independent [48]. It is assumed that the noise contributions will remain
constant between measurements conducted under the same experimental conditions.
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In contrast to the large number of wavelengths, with small spectral spacing, used for
data collection in previous experimental work with the SD method [200], DOT data collected
using the BLDOT system will be collected at only three wavelengths: 643, 720 and 850
nm. However, the SD method has been shown to be effective for a 20 nm spacing through
simulation [201], suggesting that the efficacy of the model can translate to larger spectral
spacings.
5.2.1.1 Mathematical Basis of the Spectral Derivative Method
The Jacobian at each wavelength is defined as the change in log amplitude (ignoring phase
information which is not present in this continuous wave system,   = ln (I 0), where I 0 is the
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Theoretically, now the data used for DOT reconstruction is noise-free under the assumptions
stated above. The difference Jacobians are then concatenated together to produce the SD
Jacobian, J
SD
(Fig. 5.4 b). Which is used to solve Eq. 2.16.
As mentioned above, the data calibration method required for the NS reconstruction
produces an initial estimate of the optical properties of the imaging subject for the full DOT
reconstruction, as well as accounting for system offsets in the data. Due to the hypothesis
that when using the SD method the data calibration step will not be required, a method
of acquiring an initial estimate of optical properties is required. The method proposed is a
region based reconstruction method, detailed below.
5.2.1.2 Region-Based Reconstruction for Initial Global Estimates of Chromophore
Concentration
The region reconstruction method treats the whole imaged volume as homogeneous and
follows the DOT reconstruction process detailed in Section 2.4.2. This process does still
require an initial estimate of the optical properties so is not an ideal process to replace the
data calibration procedure. However, the data calibration procedure is unable to deal with




[194]. For the purposes of
producing an initial estimate of chromophore concentrations when given initial values which
are of the order of those present in tissue (chosen by consulting Digimouse values Table 4.1),
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the region based method is considered to be adequate in determining the capability of the
SD method in this initial study. The initial estimate of the optical properties used in this
work is 0.1 mM, 0.1 mM and 50% for HbO, deoxyHb and water respectively.
Both NS and SD region-based reconstruction methods (NSR and SDR respectively) are
applied to the data presented here. The SDR Jacobian, J
SDR
, is calculated by calculating
the difference between the NSR Jacobian entries at sequential wavelengths, in the same way
as the full Jacobian. The structure of the SDR Jacobian is shown in Fig. 5.4 c. As can
be seen, the dimensions of the Jacobian are N
m
⇥ 1 (for each wavelength combination and
chromophore). All the sensitivity values calculated for each node in the whole mesh, which is
considered as a single region, are summed to determine a single sensitivity value. This value
is then applied to the whole mesh for each wavelength and each chromophore [202]. This
gives a global, homogeneous starting point for the full SD reconstruction calculated from true
measurement data.
To validate the efficacy of the SD method in enabling data calibration (required during
NS reconstruction) and free space modelling to be removed from the data analysis process of
DOT, the reconstruction technique was applied to data simulated using a three-dimensional
heterogeneous mouse model (the Digimouse atlas [42]).
5.2.2 Methods
5.2.2.1 Forward Data Calculation
Data were simulated using the Digimouse atlas with 15 sources positioned on the underside
of the model underneath the abdomen in a 3 × 5 grid with 4 mm spacing, and 63 detectors
placed evenly across the surface of the mesh, the areas occupied by the sources and detectors
are shown in Fig. 5.5 b. The source positions chosen were true source positions from the
BLDOT system (these will be detailed in Chapter 6). Three versions of Digimouse were used:
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1. Simple_2, which had homogeneous ‘adipose’ bulk optical properties with a spherical
anomaly of radius 4 mm in the abdomen with 2× HbT concentration of the bulk
properties (Table 5.2);
2. Simple_200 - as simple_2 but with 200× HbT concentration in the anomaly (Fig. 5.5
a, Table 5.2);
3. True heterogeneous Digimouse atlas (Fig. 4.1, Table 5.3).
Boundary data were simulated at 643, 720 and 850 nm using the NIRFAST forward model
(Section 2.2). These wavelengths are the same as the wavelengths which will be used for
data collection in the BLDOT system, however the bandwidth of the filters has not been
considered here.
Table 5.2: Tissue composition of the simple Digimouse models. The bulk properties of both
the simple_2 and simple_200 models are the same but the spherical anomalies (anom) have
different compositions, as indicated here.
Model Tissue [HbT] / mM [StO
2
] / % [H
2
O] / % sa sp
Simple bulk 0.0033 70 50 0.98 0.53
Simple_2 anom 0.0066 70 50 0.98 0.53
Simple_200 anom 6.6 70 50 0.98 0.53
Table 5.3: Tissue properties of the heterogeneous mouse mesh. [HbT] - total haemoglobin
concentration, [StO
2
] - oxygen saturation, [H
2
O] - water concentration, sa - scatter amplitude,
sp - scatter power. Adapted from ref. [149].
Region Tissue [HbT] / mM [StO
2
] / % [H
2
O] / % sa sp
1 Adipose 0.0033 70 50 0.98 0.53
2 Bone 0.0049 80 15 1.4 1.47
3 Muscle 0.07 80 50 0.14 2.82
4 Stomach 0.01 70 80 0.97 0.97
5 Lungs 0.0056 75 80 1.23 1.51
6 Kidneys 0.3 75 70 0.45 1.05
7 Liver 0.15 85 85 1.7 0.53
8 Pancreas 0.3 75 70 0.45 1.05
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Figure 5.5: (a) simple_200 mesh, spherical anomaly has 200× the [HbT] of the bulk.
Colourbar units: mM. The simple_2 model has the same structure, with the anomaly [HbT]
= 0.0066 mM. (b) Areas occupied by DOT sources (dotted line), and surface detectors (solid
line) in all simulations. DOT sources are positioned on the lower surface, surface detectors
across the top surface of the model.
5.2.2.2 Noise Addition to Data
Tomographic DOT reconstructions were performed using both NS and SD algorithms on
the noise-free (clean) data, data with 0.5% normally distributed noise added (using the
‘add_noise’ function in NIRFAST, [35]) and data with 0.5% noise and angular noise added.
Angular noise was added in order to assess the efficacy of the SD method in accounting for
the angular dependence of measured data at the CCD (which is currently accounted for using
the free space model). Figure 5.6 shows the method of calculation of angular noise at each
detector location. Assuming Lambertian emission of light from the surface of the animal [203],
the maximum intensity emission is normal to the detector location on the surface, and the
measurement at the CCD is cos# × maximum intensity, where # is the angle between the
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detector surface normal and the line connecting the surface detector to the CCD, assuming
a point measurement at the CCD. The distance between the imaging platform and the CCD
was assumed to be 320 mm, as is the case with the BLDOT system. Due to its geometric
nature, this ‘noise’ is independent of wavelength so should be effectively accounted for using
the SD method.
Figure 5.6: Angular noise addition to simulated measurement data. The noise is added in the
x-z plane. Each measurement is multiplied by cos' for each detector location. ' is calculated
assuming that the distance between the imaging platform and the CCD is 320 mm (as in the
BLDOT system). # is the true angle between the CCD and the detector location but ' is
used for simplicity.
To simplify the calculation of #, the surface normal is approximated as the line intersecting
the origin (located in these simulations at the central x and minimum z coordinates of
the mesh) and the detector, and the line connecting the surface detector to the CCD is
approximated as vertical, this results in the angle '. Angular noise is added to each surface
measurement, R, according to the equation:
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R̃ = R⇥ cos' (5.8)
where R̃ is the measurement with angular noise added. This is done at all measurement
wavelengths. The angular noise is calculated considering the x-z plane only, the longitudinal
y direction of the animal is ignored. This is in part to simplify the calculation, but also due
to the small curvature of the animal in the y-z plane compared to the x-z plane, and so noise
in this plane will contribute negligibly to the total angular noise.
If the SD method is able to account for the angular dependence of experimental data
from the BLDOT system (and therefore all other non-contact optical imaging systems which
require free space modelling) this suggests that the free space model is not a necessary data
processing step when performing SD DOT, saving time and computational processing power.
5.2.2.3 Reconstruction of Chromophore Distribution
Data with the three noise levels (clean, 0.5% noise and 0.5% + angular noise) was used to
reconstruct the internal chromophore distribution of the two simple models and the hetero-
geneous Digimouse model. Both the NS and SD algorithms were used to reconstruct in order
to compare the capabilities of the two algorithms. No data processing was performed prior
to the reconstruction to determine whether the SD method is capable of producing quan-
titatively accurate chromophore distributions without the data calibration step (as detailed
in ref. [194]). The initial guess of optical properties in simple_2 and simple_200 cases is
homogeneous ‘adipose’ (Table 5.3), the chromophore distribution in the heterogeneous case
was reconstructed using both homogeneous ‘adipose’ and NSR or SDR reconstruction as the
initial estimate. To simplify reconstructions, scatter is not included, only HbO, deoxyHb and
water are reconstructed for. The scatter is assumed to be that of ‘adipose’.
Qualitative assessment of the reconstructions was performed based on images of the recov-
ered total haemoglobin concentration. The distribution of HbT only is shown in this section
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as haemoglobin is the strongest absorber at NIR wavelengths (see Fig. 1.3 a which required
the attenuation of water to be scaled by 1000× in order to enable comparison between water
and haemoglobin attenuation), StO
2
is important physiologically but for the purposes of test-
ing the SD method it is not considered here. Quantitative evaluation of the heterogeneous
Digimouse recovered chromophore distribution was done by simulating combined DOT-BLT
and analysing the quality of the BLT reconstructions (Section 5.3).
5.2.3 Results and Discussion
5.2.3.1 Simple Meshes
The recovered distribution of total haemoglobin content for the two simple models (simple_2
and simple_200) is shown in Fig.’s 5.7 and 5.8. When considering the clean data and data
with 0.5% noise added, the recovered distribution of the chromophore is comparable using
both NS and SD methods. This is confirmed by the comparable range of HbT concentration
recovered by the two methods (Table 5.4). Note that the noise added to the data is more
significant in the simple_2 model due to the low contrast in attenuation between the anomaly
and the bulk, which explains the poorer performance of both NS and SD methods when
applied to the simple_2 model.
When considering the data with angular noise added, a substantial difference in recovered
HbT distribution is observed between the two methods used for reconstruction. This variation
is particularly clear in the simple_2 case (Fig. 5.7). When scaled to the data range (Fig. 5.7,
top right) the recovered distribution of HbT is seen to be concentrated at the central axis of
the mesh. This is also true for the simple_200 case (Fig. 5.8). In contrast, the SD method is
unaffected by the angular noise, performing comparably to the case with 0.5% random noise
only added to the data in both simple_2 and simple_200 cases. This suggests that the SD

































































































































































































































































































































































































































The inaccuracy in the range of concentration values recovered for data with angular noise
added using the NS method is shown in Table 5.4. The maximum recovered concentration
was > 650⇥ the true value of 0.0066 mM for the simple_2 model, while the SD method has
been able to recover a value comparable to the true concentration. The error in the recovered
concentration using the NS method for the simple_200 model is less pronounced and the SD
method has recovered a concentration which is lower than the target value. Consultation of
these values alone would suggest that the NS method has outperformed the SD method in
this case. However, the inaccuracy of the NS recovered distribution is shown in Fig. 5.8 and
the robustness of the SD method to the change in noise in the data is shown (additionally
demonstrated by the consistency of the recovered concentrations, Table 5.4).
The contrast between the anomaly and bulk optical properties in the simple_200 model
is more comparable to expected values, as shown in Table 5.3 the variation in [HbT] is
up to 91×. The enhanced contrast of the anomaly in this model causes the measured data
transmitted through this region to be attenuated by a greater extent than in the simple_2
model, enabling more effective reconstruction of the anomaly to be achieved.
The performance of the SD method when applied to this simple model is promising
in comparison to the NS method, particularly when considering the recovered chromophore
distribution, but the method must be validated in a more complex model if it is to be applied
to in vivo data.
5.2.3.2 Heterogeneous Mesh
The recovered total haemoglobin distribution for the heterogeneous Digimouse atlas is shown
in Fig. 5.9, the initial guess of the chromophore distribution was homogeneous adipose (Table
5.3). Similarly to the simple models in the previous section, both the NS and SD methods
recover comparable distributions of HbT when considering clean data. In this heterogeneous
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Table 5.4: Minimum and maximum HbT concentration (mM) for distributions recovered
using NS and SD models from data at all noise levels and the simple_2, simple_200 and
heterogeneous Digimouse model (‘Hetero’) assuming an initial chromophore distribution of
homogeneous ‘adipose’. ‘Hetero + region initial’ refers to the heterogeneous model assuming
a homogeneous initial chromophore distribution as determined by the corresponding NSR or
SDR method. The target concentration for HbT in each case is indicated in bold.
Clean 0.5% noise 0.5% noise + angle
Min Max Min Max Min Max
Simple_2
NS 0.0027 0.0089 0.0018 0.0049 0.00005 4.3730
SD 0.0030 0.0070 0.0012 0.0054 0.0012 0.0054
Target 0.0033 0.0066 0.0033 0.0066 0.0033 0.0066
Simple_200
NS 3.43×10-5 0.2187 3.10×10-5 0.2184 0.0001 0.8139
SD 0.84×10-5 0.3506 2.64×10-5 0.3763 2.67×10-5 0.3763
Target 0.0033 0.6600 0.0033 0.6600 0.0033 0.6600
Hetero
NS 1.32×10-5 0.3968 7.05×10-5 0.2374 6.77×10-5 0.8987
SD 0.47×10-5 0.3557 1.27×10-5 0.3847 0.97×10-5 0.3847
Target 0.0033 0.3000 0.0033 0.3000 0.0033 0.3000
Hetero NS 10.1×10-5 0.2309 10.5×10-5 0.2306 10.0×10-5 14.7327
+ SD 0.46×10-5 0.4015 1.60×10-5 0.3964 1.47×10-5 0.3964
region initial Target 0.0033 0.3000 0.0033 0.3000 0.0033 0.3000
model the SD method qualitatively appears to outperform the NS method when any noise
is considered in the data. As can be seen in Fig. 5.9 the NS method recovers a lower HbT
concentration than the SD method in the kidneys, (true concentration 0.3 mM) in the case
of 0.5% random noise in the data. Considering angular noise, the NS method is unable
to overcome this type of noise, recovering a HbT distribution along the central axis of the
animal similarly to the simple model. The SD method is able to account for the angular
noise, recovering a HbT distribution comparable to the case without angular noise added.
These early results, which show improvement in recovered chromophore distribution when
using the SD method over the NS method, are very encouraging.
The chromophore distributions in Fig. 5.9 have been plotted on a common colourbar scale
to enable comparison of the reconstructions. The maximum and minimum recovered HbT
concentrations are shown in Table 5.4 (‘Hetero’). As shown by these values, in all cases for
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both models, the minimum recovered concentration is low, however considering the maximum
concentration, the SD method has been able to recover a concentration comparable to the
target at all noise levels, further demonstrating the robustness of this model. The NS method
has again been unable to account for the angular noise in the data producing a maximum
intensity of 3× the true value, while performing well with clean data and reasonably well in
the case of 0.5% noise where there was a slight decrease in the maximum concentration.
It is essential to have a good initial estimate of the chromophore distribution within
the imaging subject when performing DOT reconstructions. In this simulation case, the
background optical properties are known to be ‘adipose’ optical properties, as can be seen
in the atlas model where adipose tissue occupies the whole background of the model not
occupied by organs (Fig. 4.1), so this is believed to be a good initial estimate. Experimentally
an accurate initial estimate of the optical properties is more difficult to approximate. To
determine the efficacy of the SDR method in calculating an initial chromophore distribution,
the NSR and SDR methods are applied to data from the heterogeneous model.
Table 5.5: Region reconstruction results for the heterogeneous mouse mesh. The SDR method
is able to recover chromophore concentrations closer to the target value than the NSR method
in the majority of cases, however the NSR method seems to have performed well for the
0.5% noise + angular noise case. The total haemoglobin concentration and water content of
‘adipose’ tissue from the Digimouse atlas [149] have been included for reference. The SDR
method recovers properties comparable to adipose for all noise levels.
Data Method HbO / mM deoxyHb / mM HbT / mM Water / %
Target 0.0144 0.0047 0.0191 52.65
Clean
NSR 0.0003 0.000014 0.0003 42.01
SDR 0.0045 0.0005 0.0050 52.18
0.5% noise
NSR 0.0003 0.000014 0.0003 41.97
SDR 0.0045 0.0005 0.0050 52.16
0.5% noise NSR 0.0046 0.0032 0.0078 47.66

















































































































































































































































Table 5.5 shows the region reconstruction results (both NSR and SDR) for the hetero-
geneous Digimouse atlas along with approximate target concentrations. The target concen-
trations were determined by calculating the node weighted average of optical properties in
the region of the mesh covered by the surface detectors. The initial concentrations given to
the NSR and SDR algorithms were 0.1 mM, 0.1 mM and 50% for deoxyHb, HbO and water
respectively. As can be seen in the table, the SDR method outperforms the NSR method
for the clean and 0.5% noise data, however, the concentration estimates are still lower than
the target values. Conversely, the concentration of HbT recovered by the NSR method for
0.5% noise + angular noise is closer to the target value than the concentration recovered
by the SDR method. Considering water content, both models produce values which are
comparable to the target values, however the SDR method has recovered a water content
very close to the target value. Although the accuracy of the recovered concentrations of all
chromophores varies for all noise levels in the data for the NSR method, the SDR method
produces consistent concentration estimates at all noise levels, suggesting that even in this
simplified DOT reconstruction the SDR method is successfully accounting for noise in the
data. The SDR method has proved to be more robust than the NSR method for determining
initial chromophore concentration estimates for the full DOT reconstruction.
These homogeneous values were used as initial estimates of chromophore concentrations
to perform full tomographic DOT reconstructions, shown in Fig. 5.10. The internal structure
of the HbT distribution can be seen in these reconstructions, similarly to those calculated
with an initial estimate of ‘adipose’ (Fig. 5.9). The NS reconstructions in this case appear
to underdetermine HbT concentration in the kidneys, this is due to the lower accuracy of the
initial estimate of the optical properties determined by the NSR reconstruction. As with all
other examples the NS method was unable to account for the angular noise in the data.
Considering the range of recovered HbT concentrations (Table 5.4), the minimum recov-













































































































































































































































The maximum concentrations are comparable to the target values for cases with no noise and
0.5% noise added, the NS method produces concentrations which are low but slightly closer
to the target value than the SD method, which produces higher values. Where angular noise
has been added to the data, the NS method recovers a maximum concentration of 50⇥ the
target value. This, compared to the maximum recovered HbT concentration (using the NS
method) when using homogeneous adipose as an initial estimate of the chromophore distribu-
tion (3⇥ greater than the target value), demonstrates the importance of gaining an accurate
initial optical property estimate for full DOT. This data also highlights the inaccuracy of
the NSR method. The ability of the SD method to recover comparable HbT distributions
from all sets of data, with comparable concentration ranges, is extremely promising when
applying this SD processing workflow (SDR reconstruction followed by full SD tomographic
reconstruction).
The robustness of the SD method to noise in the data compared to the NS method, when
applied to this complex model suggests that the SD method has potential in overcoming noise
experimentally in a murine model. This is explored in Chapter 6. In order to quantitatively
assess the accuracy of the recovered chromophore distributions, combined DOT-BLT was
performed on the Digimouse atlas. The methods and results from this investigation are
detailed in the following section.
5.3 DOT Optical Property Distribution as Prior Knowl-
edge for use in BLT
To quantitatively evaluate the efficacy of the SD method in performing DOT reconstructions,
the chromophore distributions for the heterogeneous mouse atlas recovered in Section 5.2.3.2,
were used as the optical property estimate for performing BLT source recovery. The BLT
source distribution was also recovered using a range of optical properties to determine the
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efficacy of the SD method in combined DOT-BLT.
5.3.1 Method
The method used in this simulation is as described in Chapter 4. The pancreas of the
Digimouse atlas was modelled to be bioluminescently labelled with firefly luciferase and
surface measurement data calculated at 600, 623 and 643 nm using NIRFAST [35]. The
CSCG reconstruction method [50] was used to reconstruct the internal source distribution.
Filter bandwidth was ignored in this study, data were simulated assuming a bandwidth of 1
nm, so the NBW Jacobian only (as defined in Section 4.2) was used in BLT reconstructions.
A range of optical properties were used as prior knowledge for the BLT reconstructions, as
detailed in Table 5.6.
Table 5.6: Details of the different optical properties used in BLT source recovery of the Digi-
mouse atlas. All DOT determined optical property distributions were recovered in Section
5.2.3.2. The name of the optical property will be used to refer to the optical property in the
remainder of the text.
Optical Property Name Details
1 True heterogeneous True Digimouse optical properties
2 Homogeneous adipose Adipose (Table 5.3)
3 DOT - NS - Clean Properties recovered from clean data using the NS method
4 DOT - SD - Clean Properties recovered from clean data using the SD method
5 DOT - NS - noise 0.5% + angle
Properties recovered using the NS method, from data with
0.5% random noise and angular noise added
6 DOT - SD - noise 0.5% + angle
Properties recovered using the SD method, from data with
0.5% random noise and angular noise added
7
Properties recovered using the SD method with an initial
DOT - SD - noise 0.5% + angle estimate of homogeneous optical properties determined
(from region initial) using the SDR method, from data with 0.5% random noise
and angular noise added
Qualitative inspection of the recovered sources was performed along with quantitative
analysis in calculating the error in the centre-of-mass (recovered source considered over 50 %
of the maximum intensity) and intensity per unit volume (recovered source considered over
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an empirically chosen threshold of 1 % of maximum intensity) of the recovered source.
5.3.2 Results and Discussion
The BLT reconstructions for the range of optical properties along with the target source are
shown in Fig. 5.11. All optical properties have achieved a recovered source in qualitatively
the correct position within the animal but there is variation in appearance of all sources.
Particularly apparent is the appearance of the source recovered using homogeneous adipose
attenuation, two regions of recovered source can be seen, one deeper than the other. This
suggests that the approximated attenuation is too low, the lateral view of this bioluminescent
source distribution has a similar appearance to that shown in Fig. 5.1 d. The inaccuracy in
this reconstruction is expected as the underlying attenuation of the mouse atlas is not homo-
geneous and organs in the abdomen surrounding the pancreas have much higher chromophore
concentrations than adipose (Table 5.3). Qualitatively, reconstructions 3 and 4, which used
DOT determined optical properties from clean data using NS and SD methods respectively
appear similar. This is expected due to the similarity seen in the recovered optical prop-
erty distribution (Fig. 5.9) and is confirmed by the similarity in the centre-of-mass error of
these two sources (Fig. 5.12). The source recovered using the ‘DOT-NS-noise 0.5% + angle’
optical properties, is surprisingly qualitatively accurate when considering the inaccuracy of
the recovered optical property distribution (Fig. 5.9). The source appears deep compared
to the true source location, reflected in the centre-of-mass error of the recovered source (Fig.
5.12), but laterally appears in a realistic position. This could be due to the lateral position
of the pancreas avoiding the central high concentration of HbT recovered using the NS DOT
method, therefore enabling the bioluminescent signal to be detected at lateral detectors. Re-
constructions 6 and 7 appear qualitatively very similar, as expected due to the similarity of
the recovered optical properties using the SD method, with initial estimates of homogeneous
adipose and SDR reconstruction respectively.
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Figure 5.11: Target bioluminescent source and sources recovered from a range of optical
properties (indicated in individual cases). The similarity in appearance of all recovered
sources can be seen, there are subtle variations however, and there is varition in the intensity
of each recovered source. Colourbar units: arbitrary intensity units.
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Note the differences in the colourbar scales in all cases in Fig. 5.11, these were scaled
individually to aid visualisation, and highlight the differences in the range of intensities of
the recovered bioluminescent source due to the differing underlying attenuation assumed in
the reconstruction.
Considering the error in centre-of-mass of the recovered sources (Fig. 5.12 a), the lowest
error is from the source recovered using the true heterogeneous optical properties, as expected
as this is the ideal scenario for BLT reconstruction. The source recovered assuming homoge-
neous adipose optical properties has the highest error, which is expected due to the known
inaccuracy of the optical property distribution and the observed inaccuracy of the recovered
source. The similarity in the centre-of-mass errors of sources recovered using the SD method
with clean data, and data with 0.5% random noise and angular noise added (reconstructions
4 and 6 respectively), supports qualitative assessment of the recovered sources and the simi-
larity in the optical property distribution (Fig. 5.9) and demonstrates the ability of the SD
method to account for noise in the data.
The source recovered assuming ‘DOT-SD-noise 0.5% + angle (from region initial)’ optical
properties, the method which will be adopted experimentally (reconstruction 7), has a small
centre-of-mass error which is comparable to that achieved when using the true optical prop-
erties to reconstruct. This suggests that using the SDR method to gain an initial estimate
of optical properties to use in the full DOT reconstruction will be effective when performing
experimental work.
The intensity per unit volume of all recovered bioluminescent sources is shown in Fig. 5.12
b, with the target indicated. Using the true optical properties this value has been calculated
as being 28% too high. This could be due to the reconstruction method used. The CSCG
algorithm assumes a sparse source distribution and tries to reconstruct the most compact
source distribution possible, the compact nature of this recovered source compared to the
target source can be seen. Due to this compactness, the intensity must be higher compared
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to the true value in order to produce equivalent surface measurements.
Figure 5.12: Quantitative analysis of BLT recovered sources for a range of optical properties.
(a) Error in centre-of-mass of recovered source compared to target (mm); (b) Intensity per
unit volume of recovered sources (arbitrary intensity units / mm3).
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As expected, assuming homogeneous adipose optical properties has produced a reconstruction
with a large error in the intensity per unit volume (95.7% low). Considering the sources
recovered assuming DOT optical properties from clean data (reconstructions 3 and 4), the
SD method has achieved an intensity per unit volume comparable to that achieved using the
true optical properties (28.31% high), with the NS method having a larger error of 54.6%.
Interestingly, reconstruction 5 (DOT-NS-noise 0.5% + angle) achieved an intensity per
unit volume close to the target value, the value is only 9.95% higher than the target value,
this is likely to be due to the lateral position of the pancreas avoiding the central high
concentration of HbT recovered using the NS DOT method as described above. However
when visualising the chromophore distribution (Fig. 5.9) it is clear that the distribution is not
anatomically correct. The source recovered using ‘DOT-SD-noise 0.5% + angle’ properties
(reconstruction 6), achieved a bioluminescent source intensity per unit volume just 7.2%
lower than the true value. This is really promising when considering use of the method in
vivo.
However the intensity per unit volume for the source recovered assuming optical properties
recovered using SDR and then SD methods is 39.1% lower than expected. Visually the
recovered source is larger than reconstruction 6 and with a lower intensity (by inspection of
the colourbar), explaining the lower intensity per unit volume calculated comparing the two
SD reconstructions.
These results show that the SD method is able to produce optical property distributions
that, when used as prior knowledge for BLT source recovery, are able to produce source
distributions which are qualitatively and quantitatively comparable to the bioluminescent
source distributions recovered with ground truth optical properties. This suggests that the
method is able to overcome the need for data calibration and free space modelling. However,
there is still some error in the recovered source. The effect of using different optical property
distributions on the recovered bioluminescent source when performing BLT is also shown,
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and combining BLT and DOT improved the quantitative accuracy of the recovered source
compared to that using homogeneous estimates of the optical properties. This suggests that
the two imaging techniques are complementary to each other and can be used together in order
to increase the quantitative accuracy of BLT agreeing with previous findings [37, 43–45,48].
The DOT-BLT data presented in this section used a complex-shaped bioluminescent
source, the pancreas. In order to determine which optical properties enable the most quan-
titatively accurate bioluminescent source recovery in BLT with more confidence, it would be
advisable to repeat this simulation study with a simpler bioluminescent source. For exam-
ple a spherical source could be positioned at multiple different locations within the animal
and the quantitative accuracy of the recovered source determined using a range of optical
properties, such as those used in this section. The shape of the source could then be made
gradually more complex and the quantitative accuracy of the recovered source determined
for each different bioluminescent source. This would enable the ability of the SD method
in gaining prior optical property knowledge for use in BLT source recovery to be evaluated
more thoroughly.
5.4 Conclusions
This chapter demonstrates the importance of using accurate optical properties when per-
forming quantitative BLT. A spectral derivative reconstruction algorithm for DOT using a
non-contact imaging system was developed and presented as a potential alternative to the
spectral reconstruction algorithm (NS) which is traditionally used. The NS method requires
data calibration and free space modelling data processing steps before tomographic recon-
struction, to account for system offsets and obtain initial estimates of the optical property
distribution, and account for angular noise and the passage of light through the free space
between the surface of the imaging subject and the CCD. The SD method was shown to
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produce chromophore distributions which were quantitatively more accurate than those pro-
duced by the NS method and with distributions comparable to the target distributions. The
method was able to account for angular noise comparable to that experienced experimentally,
which is promising for application of the method to experimental data.
Simulations on simple and complex mouse models demonstrated that the SD method was
robust to noise in the measured data, whereas the NS method was affected by the noise,
producing inaccurate chromophore distributions where angular noise was added to the data.
The robustness of the SD method to varying noise levels in the data was demonstrated by
the similar total haemoglobin concentration in all cases, whereas the NS method produced
different chromophore concentrations for all noise levels in the data. Although the spacing
between adjacent measurement wavelengths in this work was much larger than had been
investigated in previous work applying the SD method [200], the efficacy of the method in
accounting for the noise in the simulation data in this Chapter suggests that the assumption
that noise is constant across adjacent measurement wavelengths is an appropriate assumption
to make in this case.
The region-based reconstruction method (SDR), which was used to produce initial homo-
geneous estimates of chromophore concentrations for use in full DOT reconstructions, was
able to produce good initial concentration estimates in replacement of the usual data cali-
bration procedure. At a later date this should be developed so that a further initial guess of
the chromophore concentration is not needed for the SDR method. But for the validation of
the full SD method the SDR method has been effective. These DOT results suggest that it is
possible to perform SD DOT reconstruction without the need for data calibration procedures
or free space modelling prior to reconstruction.
Further demonstration of the importance of using accurate optical properties and the
efficacy of the SD method was done through DOT-BLT simulation using the heterogeneous
Digimouse atlas. When using SD determined optical properties the recovered bioluminescent
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source distribution was qualitatively and quantitatively comparable to the bioluminescent
source distributions recovered with ground truth optical properties. The homogeneous optical
property estimate was found to produce bioluminescent source distributions with a lower
accuracy than true and DOT determined optical properties.
All results presented here demonstrate the potential of the SD method in becoming a
replacement to the currently used NS method for DOT reconstruction. The method would
not require initial data calibration and Free Space modelling prior to reconstruction as is
required when using the NS method. The SD method proved to be robust to noise in the
data and suggests that with further experimental validation the SD method (combined with
the SDR method to gain the initial optical property estimate) can replace the NS method.
In order to evaluate this further, experiments were performed using a murine model, results




Dual Modality Diffuse Optical and
Bioluminescence Tomography of a
Murine Model
Chapter 5 outlined and demonstrated the potential of the Spectral Derivative (SD) method
in reconstructing chromophore distributions in a murine simulation model. The enhanced
quantitative accuracy of BLT when DOT recovered chromophore concentrations were used
was demonstrated. The results suggested that using the SD method in DOT and then
subsequent use of the recovered optical properties as prior knowledge for BLT reconstruction
has the potential to increase the quantitative accuracy of BLT when applied in an in vivo
murine model, as the effect of wavelength independent noise can be eliminated or minimised.
The work in this chapter takes a step towards this eventual aim and applies combined DOT-
BLT in a post mortem murine model, using data acquired using the BLDOT system.
In preparation for data collection, modifications were made to the BLDOT system to
improve the existing DOT component of the system. The following sections detail these
modifications along with characterisation of the updated system. The data collection and
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analysis process for DOT in the BLDOT system will then be outlined before applying this
process to murine data collection. The murine data will build on simulation data presented
in Chapter 5, demonstrating the capability of the SD method and the importance of using
accurate optical properties when performing quantitative BLT. The filter bandwidth model
for BLT source recovery presented in Chapter 4 (the WBW model) is also validated in a
murine model for the first time.
6.1 Updates to the Existing DOT Component of the BLDOT
System
The existing DOT hardware is described in ref.’s [48, 49]. Briefly, the system consisted of
a pocket projector (PK-102; Optoma, UK) positioned underneath the imaging platform as
shown in Fig. 1.5, coupled to an optical fibre (1000 µm diameter, 2 m length, QP1000-2-VIS-
BX; Ocean Optics, UK) which was connected to a tungsten-halogen lamp (HL-2000-FHSA;
Ocean Optics, UK). During DOT data acquisition the projector projected a sequence of 36
Gaussian sources which mimicked a point fibre source of standard deviation 2 mm at the lower
surface of the imaging subject [48]. Multi-spectral images were taken of the light transmitted
through the imaging subject from each source. When performing DOT data acquisition
for a block phantom (solid plastic of dimensions 33⇥26⇥40 mm; Biomimic, INO, Quebec,
Canada; see Appendix A.1 of ref. [48], optical properties characterised in ref. [197]) the total
acquisition time was more than an hour (including surface capture). This long acquisition
time is a disadvantage when performing pre-clinical DOT for use as prior knowledge in BLT
as the time which an animal is anaesthetised for is dramatically increased and throughput
is decreased. A main factor in the long acquisition time was the low intensity of the diffuse
light source due to inefficient fibre-projector coupling. The detected signal from the fibre
coupled to the pocket projector was < 15% of that from the fibre alone (Fig. 6.1) [48].
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Figure 6.1: Measurements of the optical fibre alone illuminating a plain white sheet of paper
(green line, ‘Direct’) and coupled to the projector which was projecting uniformly white
(blue line, ‘Projector’). A tungsten-halogen lamp was used for illumination in both cases.
The decrease in intensity of the signal when the fibre is coupled to the projector compared
to the fibre alone is clear. Reproduced from ref. [48].
In order to decrease the data acquisition time and to increase the intensity of the light
available from the DOT source, the DOT component of the BLDOT imaging system was
updated. This component remains under the imaging platform and replaces the pocket
projector (Fig. 6.2 a). The existing optical fibre was replaced with a more flexible fibre
(1000 µm diameter, 2 m length, FP1000URT; Thorlabs) which was mounted onto a two-
dimensional linear translational stage (X-Y translational stage, Fig. 6.2 b and c; Thorlabs,
MTS50-Z8) with the tip of the fibre positioned as close to the imaging platform as possible
(of the order of ⇠2 mm) to avoid light leakage. Custom LabVIEW software was written
to control the position of the translational stage (and therefore the fibre), which could be
moved to discrete positions in the range 0-50 mm with a resolution of 0.8 µm, in both x and
y dimensions.
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Figure 6.2: Modifications to the existing DOT component of the BLDOT imaging system. (a)
Whole imaging system with the X-Y translational stage which provides the DOT illumination
indicated. (b) The two-dimensional (X-Y) translational stage before incorporation in to the
BLDOT system. (c) Close-up of the X-Y translational stage in situ in the BLDOT system,
underneath the imaging platform, with the optical fibre mounted on top. (d) Image of the
source locations in the imaging platform, a grid of holes are drilled in the platform. The
optical fibre is placed underneath this section of the platform and moved underneath each
hole during DOT imaging to change the source position.
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Initially it was decided that fifteen sources in a 3×5 grid of ⇠4 mm spacing would be
used for data collection (Fig. 6.2 d), however this can be customised by the user. This
covers an area of 8×16 mm which will cover a large proportion of the mouse abdomen.
The existing projected Gaussian DOT illumination sources had a standard deviation of ⇠2
mm [48] and therefore a spacing of approximately 4 mm (see Fig. 6.3), so the new fibre
source distribution has a similar spacing to the old sources but occupies a smaller area (the
area covered by the new DOT sources compared to the existing source distribution is shown
in Fig. 6.3). Optimisation of the source positions (including drilling further holes in the
imaging platform to fully enable customisation) is required but is beyond the scope of this
thesis, the 3×5 grid is used in the work presented in this chapter.
Figure 6.3: Existing distribution of DOT sources showing the standard deviation (black) and
spacing (red). The coverage of the new source distribution is indicated in green.
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6.1.1 Stability of the Light Source Over Time
To ensure the emission of the light source was constant over time, images were taken of
reflected light from a 99% Spectralon reflectance standard (Labsphere, North Sutton, NH,
USA). The optical fibre, connected to the tungsten halogen lamp, was mounted above the
imaging platform. Images of the reflected light were taken at 620 nm (band pass filter with
bandwidth 10 nm, Thorlabs) every minute for 20 mins. To analyse the reflectance images,
the total intensity within an ROI encompassing the centre of the phantom was calculated
(Fig. 6.4). The data is shown in Fig. 6.4 b and shows the intensity to vary negligibly (<
1%) over the timescale of the experiment.
Figure 6.4: (a) Reflectance image of light from the tungsten-halogen lamp in the BLDOT
system with ROI used to calculate total intensity indicated. (b) Variation in intensity of the
light source at 620 nm over 20 minutes.
6.1.2 Instrument Response Function
The intensity detected at the CCD is not the true intensity of the light emitted within the
imaging system, which is subject to attenuation and scatter in free space and is affected by
passage through band pass filters and apertures and lenses within the system. The relative
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intensity between measurement wavelengths used in the BLDOT system was measured (as
detailed below) and the resulting instrument response function (IRF) used to normalise
measured DOT transmission data to remove any dependence of the measured data on the
spectral response of the imaging system.
To measure the IRF for the BLDOT system, images (5 to enable averaging) were taken
of a single DOT source location with a piece of white paper placed on the imaging platform
(assuming that the paper has uniform spectral attenuation at near infrared wavelengths), at
a number of wavelengths (600, 623, 643, 720 and 850 nm; band pass filters with bandwidth
22, 32, 34 nm [Semrock Inc.] and 10, 10 nm [Thorlabs] respectively). The total intensity
within a ROI (20×20 pixels) around the source location for each wavelength was determined
and these values normalised to the maximum value to get the IRF (Fig. 6.5). The error bars
are not included in Fig. 6.5 as they are smaller than the size of the markers. The intensity
was consistent across all five reflectance images taken at each wavelength.
Figure 6.5: Instrument response function for DOT.
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6.1.3 DOT Source Positions
The positions of the DOT sources were determined by finding the maximum intensity of
images taken of each source position illuminated individually (a composite image of all sources
is shown in Fig. 6.6 a). The maximum intensity position was then converted to real-space
coordinates from knowledge of the pixel size from system calibration (detailed in Appendix
6 of ref. [48]) and considering the centre of the image as the origin. The calculated source
positions for 643, 720 and 850 nm are shown in Fig. 6.6 b. This graph shows that there is
negligible difference in the source positions between the three wavelengths, with maximum
standard deviations in position of 0.09 and 0.07 mm for x and y coordinates respectively.
During data analysis these positions in real-space coordinates are mapped directly onto the
lower surface of the subject-specific mesh created from surface capture data for use in DOT
reconstruction.
6.1.4 DOT Source Intensity Variation and Light Leakage
The relative intensity of all sources was calculated to enable the measured transmission data
to be normalised to account for variations in source intensity, which is important as NIRFAST
assumes all sources have equal intensity during DOT reconstruction. Fig. 6.6 c shows the
relative intensity of all 15 sources at 643, 720 and 850 nm. This was calculated from the total
intensity within a 40×40 pixel ROI (corresponding to 6.47×6.47 mm) around each source in
the individual source images. There is up to 10% variation between the intensity of all sources
for 720 and 850 nm and 20% for 643 nm. This is due to the holes drilled in the imaging
platform which determine the source positions. As can be seen in Fig. 6.6 a and b the grid of
sources is not regular, however, the positioning of the optical fibre underneath the imaging
platform assumes a regular grid and so the fibre will not accurately line up with all of the
holes introducing variation in the source intensity. Further work should be done to replace
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Figure 6.6: (a) All 15 DOT sources, with the number of a selection of the sources shown
along with indication of the direction of movement of the source during data collection for
DOT. This image is a composite of individual images taken of each source. Colourbar units:
counts s-1. (b) Source positions calculated from the individual source images at 643, 720 and
850 nm showing negligible variation in position with wavelength. (c) Relative intensity of all
sources at the three wavelengths.
the imaging platform with a larger grid of accurately machined holes. This will reduce the
variation in source intensity and increase the number of sources which are available for use,
enabling source position to be customised by the user.
It was also important to determine that there was no light leakage between source po-
sitions. To do this, ROIs were constructed around all source positions (25×25 pixels corre-
sponding to 4.04×4.04 mm) and the total intensity in all fifteen ROIs was calculated in each
of the individual source images. Plots of the total ROI intensity when source 8 was illumi-
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nated are shown in Fig. 6.7. It can be seen that although there is a high level of background
light in the system (which could indicate that the BLDOT system is not completely light
tight, or that there are sources of light within the system, which should be investigated and
accounted for in the future) there is no bleed-through to the other sources, this is true when
all other sources were illuminated individually. Source 8 is shown here as it is the central
source, if there was any significant light leakage to any of the other sources it would be clear
here. The nearest sources to source 8 are 3, 7, 9 and 13 so these would be expected to
have the next highest intensity if there was any leakage, however the intensity of all source
positions which aren’t illuminated are constant to within 6% for 643 nm and ⇠2% for 720
and 850 nm indicating that there is no light leakage.
Figure 6.7: Intensity at (a) 643 nm and (b) 720 and 850 nm in ROIs encompassing the
location of each DOT source (1-15) with source 8 illuminated. No bleed-through of intensity
to the other source positions is seen. This is the case when all other sources are illuminated.
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6.2 DOT Data Collection and Processing using the BLDOT
System
This section details the method of data collection and processing in preparation for DOT
optical property recovery using the reconstruction algorithms detailed in Section 5.2.1.
1. In preparation for animal data collection the animal is shaved and placed on the imaging
platform covering the source positions. (If imaging a phantom, the phantom is placed
directly on the imaging platform.)
2. Multi-spectral transmission data are collected from each of the fifteen source positions at
643, 720 and 850 nm using band pass filters of bandwidth 34, 10 and 10 nm respectively.
(a) Currently the same exposure time is used for data collection for each source posi-
tion, ranging from ⇠0.1-1.5 s depending on animal size and light source intensity
(different exposure times are used for each wavelength). These are calculated by
moving the DOT illumination to a single position, capturing an image using an
exposure of 0.1 s and calculating the exposure time required to collect a maxi-
mum signal of 60000 counts (the dynamic range of the camera is 65536). This
exposure time calculation method needs to be optimised. Due to the shape of an
animal, which is thicker nearer the centre and thinner at the edges, calculating
an exposure time based on the thinner area of the animal results in low acquired
signal for source positions nearer the centre of the animal. However, calculation
of the exposure time based on a source nearer the centre of the animal will result
in saturation of the signal acquired from the sources nearer the edges. It is there-
fore important to optimise both source positions and exposure time calculation,
possibly with each source having a unique exposure time.
(b) The three wavelengths chosen maximise the use of the filter wheel which has six
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filter locations. 600, 623 and 643 nm are used for bioluminescence imaging, 580
nm is used for surface capture and so two positions in the filter wheel are available
for DOT data collection. 720 and 850 nm have been chosen as they are either side
of the isobestic point of the attenuation spectra of HbO and deoxyHb so enable
the two chromophores to be distinguished.
3. Surface capture data is collected at 580 nm using a fringe projection profilometry
method [83, 97]. This wavelength is always used for data collection as the relationship
between the input pixel intensity (i.e. the intensity of the sinusoidal image input from
the computer to the projector) and the intensity of the light output by the projector is
known and the surface capture images corrected for this. See ref. [48], Appendix A.3,
for more detail.
4. Data processing in preparation for DOT reconstruction:
(a) Images are normalised by exposure time, instrument response function (Fig. 6.5)
and relative source intensity (on a wavelength-by-wavelength basis, Fig. 6.6).
(b) CCD data is mapped directly onto the surface of the mesh, which is created from
surface capture data. Free space modelling is not performed for DOT data when
the SD method is used for reconstruction, due to results presented in Chapter 5
which suggested that the SD method will negate the need for free space modelling
and the initial data calibration step performed in NS DOT. Currently only top-
view data is used, the mirrors which expand the field of view of the system are
not used in DOT imaging. This is due to high intensity signal detected in the
mirror views overwhelming the top view data, and so it was decided that only top
view data would be used while the new DOT component of the BLDOT imaging
system was optimised. Due to the curved shape of animals the top view data
contains some information from the sides of the animal. In further development
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of this analysis workflow the mirror data should be included to provide additional
information.
(c) Source positions (Fig. 6.6 b) are added to the mesh.
(d) Detectors are added to the mesh (using the method described below) and assigned
a CCD measurement.
i. A grid of points with a regular spacing of 4 mm is placed above the mesh,
encompassing an area which is double the width and height of the source
locations.
ii. The z coordinate of the points is decreased until they reach the surface of the
mesh.
iii. The CCD image coordinates are converted to real space coordinates from
knowledge of the pixel size from BLDOT system calibration (detailed in Sec-
tion A.6 of ref. [48]). The detectors are assigned measurements from the pixel
with corresponding real space (x, y) coordinates.
5. DOT reconstruction is performed as detailed in Chapter 5. First SD or NS region
reconstructions (SDR or NSR) are performed to gain an initial homogeneous estimate
of the optical properties, which are then used as an initial estimate for the full DOT
reconstruction using the SD (or NS) method.
6.3 Murine DOT-BLT
This work combines the SD DOT method (presented in Chapter 5) and filter bandwidth
modelling (WBW method presented in Chapter 4), validating both methods in a murine
model for the first time. The following sections describe the methods used for murine data




DOT and BLT imaging was performed on three mouse cadavers in the BLDOT system. The
animals were all culled at the same time but imaged sequentially, with the total imaging
time for each animal ranging from 20 to 45 minutes and total imaging time for all animals
1 hour 25 minutes. Each animal was shaved and an artificial light source (tritium-based,
Trigalight Orange III; mb-microtec, Switzerland) inserted at a depth of approximately 5
mm right laterally to facilitate BLT imaging, using the method detailed in Section 3.2. As
discussed in Section 3.2, the trigalight light source is not truly representative of the behaviour
of bioluminescently labelled cancer cells in vivo, for example the artificial source is a well-
defined volume and does not accurately model tumours in vivo which have diffuse margins
where the tumour is infiltrating surrounding tissue. The intensity of the source will also
be different to bioluminescently labelled cells. Specifically for BLT, which was performed
on these animals, using an artificial light source (or sources) simplifies source recovery as
the number of ‘tumours’ which are to be reconstructed is known. In vivo the number of
sources (tumours) in an animal is unknown, it is possible that the original cluster of cells
injected into the animal has dispersed and multiple tumours have grown, or metastases have
developed at a different location within the animal. However, this is not a problem when
using the BLDOT imaging system and associating algorithms, as the capability of recovering
multiple sources simultaneously has been shown previously [48–50,97]. It would be possible in
future to perform further experiments where multiple trigalight sources are inserted into the
animal to represent situations in vivo where multiple regions of bioluminescence are present
in different regions of the animal.
Following source insertion the animal was placed on the imaging platform such that the 15
DOT light sources were positioned under the abdomen as in the simulation study (Chapter
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5) and transmission data were collected at 643, 720 and 850 nm (band pass filters with
bandwidths 34 nm [Semrock Inc.], 10 nm and 10 nm [Thorlabs] respectively) following the
method detailed in Section 6.2. The right angled mirrors were then placed on either side of
the animal (without moving the animal) in preparation for BLT data collection and surface
capture. The DOT light source was turned off and BLI data collected at 600, 623 and 643
nm (band pass filters with bandwidths 22, 32 and 34 nm respectively, Semrock Inc.). Surface
capture data collection was then performed at 580 nm without moving the mirrors.
6.3.1.2 Data Analysis
In preparation for DOT reconstruction the data was processed as detailed in Section 6.2. To
gain a homogeneous estimate of the optical properties to use in the full DOT reconstruction,
the region-based reconstruction method (both NSR and SDR) was performed on the DOT
data with an initial chromophore concentration of [0.1 mM, 0.1 mM, 50 %] for HbO, deoxyHb
and water respectively. Note that due to data for both BLT and DOT being taken at 643
nm, the BLT image at 643 nm was subtracted from the DOT image at 643 nm to remove any
BL signal from the DOT transmission data. The three dimensional chromophore distribution
was then recovered using both the NS and SD methods.
Prior to tomographic BLT source recovery, free space modelling was performed on the
BLI data. The CSCG method was then used to reconstruct the internal source distribution
using a range of optical properties:
1. Homogeneous - Adipose: homogeneous estimate of adipose (Table 5.3).
2. Homogeneous - SDR: homogeneous estimate from the SDR reconstruction method.
3. DOT opt prop - NS - NBW: chromophore distribution recovered using the NS method,
and using the NBW Jacobian in BLT reconstruction (which doesn’t account for filter
bandwidth, Chapter 4).
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4. DOT opt prop - SD - NBW: chromophore distribution recovered using the SD method,
and using the NBW Jacobian in BLT reconstruction.
5. DOT opt prop - SD - WBW: chromophore distribution recovered using the SD method,
and using the WBW Jacobian in BLT reconstruction (accounting for filter bandwidth).
The aim of this work is to show the dependence of the recovered BLT source distribution
on the underlying attenuation assumed in the reconstruction and to demonstrate the perfor-
mance of the SD method and the WBW reconstruction method applied to a murine model for
the first time. To assess the accuracy of the BLT reconstructions the x, y, z dimensions of the
recovered sources (at FWHM intensity) were compared to the true dimensions of the tritium
light source (1×2.5×1 mm). The depth of the recovered source and the maximum inten-
sity were also calculated. The maximum recovered intensity was compared to the maximum
intensity of the source imaged alone before implantation into the mice, at 600 nm.
6.3.2 Validation of the Spectral Derivative Method in a Murine
Model
Raw transmission data for the three animals for three of the 15 DOT sources is shown
in Fig. 6.8. For visualisation, the data was thresholded at 30% of the maximum. The
change in appearance of the transmitted light due to the change in position of the source is
demonstrated. The intensity of the transmitted light is similar for these three positions due
to them having the same longitudinal (y axis) position underneath the animal, and this area
of the mouse abdomen is a relatively uniform thickness. All data has a dynamic range of at
least 0-1.1 ⇥104 counts s-1. These data (and transmission data at all other source positions)
were mapped onto a three-dimensional mesh of each animal created from three-dimensional
surface capture data.
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Figure 6.8: Transmission images for the three mice at 850 nm for three different source
positions. For visualisation the data was thresholded at 30% of the maximum. Colourbar
units: counts s-1.
In order to gain an initial estimate of chromophore concentrations for use in the full DOT
reconstruction, NSR and SDR methods were used. The results are shown in Table 6.1. The
NSR method was unable to recover biologically relevant (i.e. comparable to the Digimouse
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atlas values, Table 4.1) chromophore concentrations. If, after an iteration, the chromophore
concentrations are negative, the algorithm defaults the concentration value to 0.001 mM,
which is of the order of magnitude of the total haemoglobin concentration of adipose (0.0033
mM), as negative chromophore concentrations are not physically possible. This is why the
recovered concentrations of HbO and deoxyHb for all mice are 0.001 mM when using the
NSR algorithm.
These negative values arise due to a combination of noise in the data (for the SD method
this is minimised) and the ill-posed nature of the DOT reconstruction. To reduce the ill-
posedness it would be possible to introduce some structure into the volume (for NS and SD)
instead of starting with a homogeneous chromophore concentration. This can be done by
registering an atlas, such as the Digimouse atlas, to the mesh created from surface capture
measurements and using the associated chromophore concentrations as initial estimates for
the full DOT reconstruction. All reconstructions (full and region-based) would benefit from
using a larger number of measurement wavelengths than the three used in this work (previ-
ous work used five wavelengths for imaging [48, 49]). This would limit the possible number
of pathways taken by the light from source to detector as the path must satisfy tissue at-
tenuation at all measurement wavelengths. Constraining the possible range of chromophore
concentrations would also limit the possible number of solutions to the problem. Currently
the algorithm limits the concentration of HbO and deoxyHb to non-negative values, but there
is a physical range of concentrations which are present in a mouse. In the Digimouse atlas the
total haemoglobin concentration ranges from 0.0033-0.3 mM [149] and the algorithm could
therefore be constrained to values between 0 and 0.5 mM for example. Similarly the water
content, which is currently limited to a maximum of 100%, could be constrained further,
Digimouse values range from 15-85% [149]. This could also be done by applying a regular-
isation to the reconstruction. However, this may lead to false confidence in the results as
even though the concentration values have been constrained it is not guaranteed that the
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recovered values are correct.
Due to all recovered chromophore concentrations being equal to the default value of the
algorithm, the NSR method was unable to produce meaningful chromophore concentrations.
The recovered water content is 0% which is not biologically relevant (Digimouse soft tissues
range from 50 to 85%, Table 4.1). These inaccuracies are thought to be due to the simplifi-
cation of the analysis process to bypass the usual data calibration step and the inability of
the NSR method to account for noise in the data.
Table 6.1: Chromophore concentrations recovered using the region based reconstruction
method. Initial concentration of HbO, deoxyHb and water: 0.1 mM, 0.1 mM and 50%
respectively.
Mouse Method HbO / mM deoxyHb / mM HbT / mM StO
2
/ % Water / %
1
NSR
0.0010 0.0010 0.0020 50 0
2 0.0010 0.0010 0.0020 50 0
3 0.0010 0.0010 0.0020 50 0
1
SDR
0.0007 0.0010 0.0017 41 100
2 0.0007 0.0010 0.0017 41 81
3 0.0007 0.0010 0.0017 41 100
The SDR method also had some difficulty in recovering haemoglobin content, with de-
oxyHb concentrations given as the default value of 0.001 which indicates that the algorithm
calculated negative values. The HbO concentration values suggest that the algorithm was
able to recover some positive values. These recovered concentration values lead to a HbT
concentration which is low but of the order of magnitude of ‘adipose’ tissue in the Digimouse
atlas. The StO
2
percentage is also low but as the animals are post mortem this is expected.
Considering the concentration values in combination with the recovered water percentages
(> 80 % which is comparable with the values for organs of the abdomen in the Digimouse
model, Table 4.1) the SDR method has been able to recover more accurate concentrations
than the NSR method, although it is difficult to estimate true values as the animals are post
mortem.
147
Although the SDR method was able to recover more meaningful chromophore concen-
trations than the NSR method, the algorithm failed to recover positive concentrations for
deoxyHb. This indicates that although the algorithm performed well in simulation in Chap-
ter 5, it needs further validation and optimisation for experimental data. These optical
properties were then used as an initial estimate for the corresponding (NS or SD) full DOT
reconstruction.
The total haemoglobin distribution of the three animals recovered using both NS and
SD methods are shown in Fig. 6.9. As can be seen from the colourbars, the concentration
recovered using SD is much lower than that using NS for all animals. Considering the total
haemoglobin content of the heterogeneous Digimouse model used in simulations in Chapter 5
(Table 5.3), this ranges from 0.0033 mM to 0.3 mM for organs in the abdomen. The murine
HbT distributions recovered here using the SD method are within the Digimouse range but
the NS properties are approximately 3-7× the maximum HbT in the Digimouse atlas.
It is clear that none of the distributions are anatomically correct. The recovered chro-
mophore distribution for simulated Digimouse data showed the underlying anatomy (see
Fig.’s 5.9 and 5.10), in particular the kidneys, but these can’t be seen in the murine data.
The NS recovered HbT distribution for all animals was localised to the base of the animal, at
the source positions. This, along with the inaccuracy in the recovered concentration values
for HbT, suggests that the NS method is unable to be used without prior implementation
of the data calibration procedure described in ref. [194]. The SD chromophore distribution
for all animals was localised within the animal, with the highest concentration in the centre
of the animal but with diffuse regions of chromophore surrounding this region. This is not
anatomically correct but the position of the HbT localisation is improved and the accuracy
of the concentration values is increased, when compared to the NS recovered values. The SD
method has been able to account for noise in the data, and with further refinement may be a









































































































































































































































































cedure). Remaining error in the recovered source distribution may be due to the assumption
that noise in the data is constant across adjacent measurement wavelengths and that this
noise is multiplicative (Section 5.2.1.1) being incorrect. Work in Chapter 5 demonstrated this
assumption to be appropriate for simulation data, but it is possible that non-multiplicative
noise is present in experimental data. The effect and cause of this non-multiplicative noise
must be considered in future work on the SD method, but these initial results are promising
once the method has been optimised for experimental data.
To test these DOT recovered chromophore distributions further, they were used as prior
knowledge for BLT source recovery for all animals.
6.3.3 Combined DOT-BLT
Raw and corrected (using the free space model) BLI data at 600 nm is shown in Fig. 6.10.
The intensity of the BLI data decreases from mouse 1-3, with the corrected BLI data for
mouse 3 being an order of magnitude less intense than that for mice 1 and 2. This variation
in intensity could be due to differing depths of the artificial sources, or due to the increase in
time since the animals were culled causing differing tissue attenuation. Fig. 5.3 b shows the
variation in transmitted light intensity over time after death for an animal with a light source
under the lower abdomen, in a similar location to the position of the artificial light sources
inserted into these animals, showing that the attenuation increases with time. Mouse 3 was
imaged at the longest time after death of the three animals, and so the tissue attenuation
is thought to be high, which explains the low BLI signal acquired. The corrected BLI data
was then used with a range of different optical properties, as detailed in Section 6.3.1.2, to
recover the internal distribution of the bioluminescent source. Note that due to the low BLI
signal acquired for mouse 3, the BLT source recovery is not expected to perform well.
The recovered bioluminescent source distribution for mice 1-3 at full width half maximum
(FWHM) intensity, along with a table showing the x, y, z dimensions of the source, are shown
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in Fig.’s 6.11, 6.12 and 6.13 respectively. For all animals the differing appearance in recovered
source distribution with the different optical properties can be seen. The homogeneous
estimates (adipose and the SDR reconstruction) recover the largest source distribution, most
prominently for mouse 1. Qualitatively, the source recovered using NS recovered optical
properties, using the NBW Jacobian model (i.e. the bandwidth of filters are ignored; ‘DOT
opt prop - NS - NBW’) for mouse 1 appears disjointed and more diffuse than that recovered
using the SD recovered optical properties (using both NBW and WBW Jacobian models). For
mouse 2 this source appears small, and for mouse 3, appears as two regions of bioluminescence.
Figure 6.10: Raw and corrected BLI of the three mice at 600 nm. Colourbar units: BLI -
counts s-1, corrected BLI - arbitrary intensity units.
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Figure 6.11: Mouse 1 BLT reconstructions (FWHM) using different optical properties. The
table shows the dimensions of the recovered sources, with the target source dimensions in-
dicated. The sources recovered using homogeneous estimates of the optical properties are
much more diffuse than the DOT determined optical properties. Colourbar units: arbitrary
intensity units.
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Figure 6.12: Mouse 2 BLT reconstructions (FWHM) using different optical properties. The
table shows the dimensions of the recovered sources, with the target source dimensions indi-
cated. The sources recovered using homogeneous estimates of the optical properties are more
diffuse than the DOT determined optical properties. Colourbar units: arbitrary intensity
units.
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Figure 6.13: Mouse 3 BLT reconstructions (FWHM) using different optical properties. The
table shows the dimensions of the recovered sources, with the target source dimensions indi-
cated. The sources recovered using homogeneous estimates of the optical properties are more
diffuse than the DOT determined optical properties. Colourbar units: arbitrary intensity
units.
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Table 6.2: Maximum recovered bioluminescence intensity for the five different optical prop-
erties and mice 1-3. The target values are maximum intensity values determined from images
of the sources before insertion into the animals at 600 nm.
Optical Properties Mouse 1 Mouse 2 Mouse 3
1. Homogeneous - Adipose 2.0 ×105 2.4 ×105 4.4 ×104
2. Homogeneous - SD region recon 3.6 ×105 1.2 ×105 2.8×104
3. DOT opt prop - NS - NBW 5.2 ×106 4.6 ×105 1.1 ×106
4. DOT opt prop - SD - NBW 3.3 ×106 1.5 ×106 9.4 ×104
5. DOT opt prop - SD - WBW 2.8 ×104 2.5 ×104 1.8 ×103
Target 6.4 ×104 6.2 ×104 6.2 ×104
This supports the findings in Section 6.3.2, that the NS recovered optical properties are
inaccurate. For all three mice, the sources recovered using SD recovered optical properties
with both NBW and WBW Jacobian methods are visually similar, supported by the similarity
in the dimensions of the recovered source.
Quantitatively, the depth of the recovered source varies depending on the optical proper-
ties used (Fig. 6.14 top row), supporting the data shown in Fig. 5.1 and Table 5.1. For all
animals, the source was inserted at approximately 5 mm. The sources recovered at the clos-
est depth to 5 mm are the sources recovered using SD calculated chromophore distributions,
with the NBW and WBW methods both producing very similar source depths, supporting
previous findings for the filter bandwidth model (see Chapter 4 and ref. [96]). Considering
the maximum intensity of the recovered sources (Fig. 6.14 bottom row), in comparison to the
value measured for each artificial source individually, the source recovered using SD optical
properties and the WBW Jacobian is closest to the true intensity for mice 1 and 2 (Table
6.2). As the true intensity was measured at 600 nm only and three wavelengths were used
in the BLT reconstruction, the maximum intensity of the recovered source is not expected
to be exactly the same intensity but of the same order of magnitude. Mouse 3 recovers a
lower intensity, this is thought to be due to the poor BLI data, showing that even when
subject-specific optical properties determined through DOT measurements are used in BLT
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reconstructions, the quality of the BLI data is important for the quantitative accuracy of
BLT.
All sources recovered using all other optical properties were one or two orders of magni-
tude higher than the target intensity. As can be seen in Fig. 6.14, the bioluminescent source
recovered using the NBW model and either NS or SD determined DOT optical properties
have the highest intensity, which is approximately two orders of magnitude larger than the
measured value. This is most likely due to the use of the NBW Jacobian in the BLT recon-
struction and is consistent with the high intensity recovered sources using the NBW method
in Chapter 4.
This further validates the SD method as a potentially viable method for performing DOT
source recovery without the need for either free space modelling or the data calibration which
is used with the NS method. The WBW method for BLT source recovery is also shown to
be effective in improving the quantitative accuracy of BLT when applied to a murine model.
6.4 Conclusions
This chapter has detailed modifications made to the BLDOT imaging system in preparation
for DOT imaging of a murine model. The updated DOT system was used to image three mice
post mortem and demonstrate the improved efficacy of the SD method over the NS method in
a murine model, although anatomically accurate chromophore distributions were not returned
in either case. Remaining inaccuracy in the recovered SD DOT chromophore distributions
could be due to the bandwidth of the filters used for data collection being ignored in the
reconstruction. Chapter 4 demonstrated the importance of accounting for the bandwidth
of the filters when considering the quantitative accuracy of BLT, so developments should
be made to the DOT reconstruction to account for the filter bandwidth as the quantitative















































































































































the capability of the SD method via simulation using a heterogeneous mouse model but the
data was simulated at a single wavelength, ignoring filter bandwidth. Future work should
determine the effect of filter bandwidth on the recovered chromophore distributions and
account for bandwidth in the reconstruction algorithm. Inaccuracies could also be due to
only three wavelengths being used for data collection, and with a large spacing between
wavelengths. Previous work on the spectral derivative method applied to a contact imaging
system showed the method to be effective when using data at 100 wavelengths with 2 nm
spacing [200]. Using a larger number of wavelengths in analysis may increase the quantitative
accuracy of the SD method when applied to a non-contact imaging system such as the
BLDOT system, but this would increase the total imaging time. Performing measurements
on phantoms with known optical properties to optimise measurement wavelengths and data
analysis procedures for the SD method applied to a non-contact imaging system will prove
useful in further development of this technique.
The results presented here are promising for the potential of the SD model in performing
both DOT and combined DOT-BLT imaging in murine models in vivo, although further
work is required to optimise the efficacy of the SD method before moving into in vivo work.
Combining DOT and BLT has been shown to enhance the quantitative accuracy of BLT, with
the highest quantitative accuracy results obtained when using the SD method combined
with the WBW method for BLT reconstruction. This suggests that, once optimised, the
SD method may provide a large impact on the quantitative accuracy of BLT. Work in this
chapter also demonstrated the importance of using good quality multi-spectral BLI data when
performing DOT-BLT. This work has validated the SD method and WBW model for the first
time in a murine model, demonstrating the efficacy of the two techniques in enhancing the
quantitative accuracy of BLT.
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Chapter 7
Conclusions and Further Work
Bioluminescence imaging is widely used in pre-clinical research, but there remain limita-
tions to the quantitative accuracy achievable by the technique. Bioluminescence tomography
provides three-dimensional tomographic information about the bioluminescent source distri-
bution. However, BLT is rarely used in pre-clinical studies despite the advantages over BLI
in the ability to use orthotopic models, where tumour development can be monitored in the
correct biological location within the animal, for example. There also remain limitations to
the quantitative accuracy of BLT. This work aimed to enhance the quantitative accuracy
of BLI and BLT through hardware and software developments to an existing developmental
imaging system, the BLDOT system.
BLI measurements are highly dependent on the position of the animal, with a small change
in position affecting the measurement. This can lead to incorrect conclusions being drawn
during pre-clinical experiments about the rate of tumour growth or response to treatment,
for example. Previous work has shown a free space model [27] to be effective in accounting for
positional changes of a cylindrical phantom. The work presented here built on previous work
by applying the model to murine BLI data taken from post mortem animals with artificial
sources inserted, and imaged in two different positions in the BLDOT system. The free space
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model was able to improve the quantitative accuracy of the BLI measurements, however this
improvement was limited by changes in the tissue attenuation of the animals over the course
of data collection due to the time after death of the animals increasing. The results were
promising but the model must be validated both in more controlled post mortem experiments
with consistent source depth, rotation angles and time after death, and in vivo before routine
use in pre-clinical research.
Previously the bandwidth of the filters used for multi-spectral data collection for BLT
was ignored (using the NBW model), with all data assumed to be collected at the central
wavelength of the band pass filter. However, when using band pass filters, data collected
encompass the range of wavelengths transmitted through the filter, which is governed by the
bandwidth. Not accounting for the filter bandwidth in the BLT reconstruction ignores the
spectral attenuation of tissue and the spectral source emission, resulting in a model-data
mismatch when performing model-based image recovery. Increasing the bandwidth of the
filters increases this model-data mismatch, resulting in a dependence of the recovered biolu-
minescent source intensity on the bandwidth of the filters. The WBW model was proposed
as a method of accounting for filter bandwidth in the BLT reconstruction. Simulation (using
the heterogeneous Digimouse atlas) and experimental data (using the XPM2 mouse shaped
phantom) showed the WBW model to be effective in removing the dependence of recovered
bioluminescence intensity on filter bandwidth, improving the quantitative accuracy of BLT.
The model was also shown to improve the quantitative accuracy of BLT in a post mortem
murine model. Future work with the WBW model should include optimisation of Jacobian
calculation to minimise the increase in data processing time as compared to NBW recon-
struction, inclusion of filter transmission profile in the WBW model and validation of the
WBW model in vivo.
The BLT data presented in the filter bandwidth modelling study used multi-spectral
bioluminescence data at only three wavelengths (rather than five or six which were used
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previously in the BLDOT system). This, combined with data acquisition using wider band-
width filters (increasing to ⇠20 nm from 10 nm), resulted in a reduction in data acquisition
time by 2
3
when considering the BLDOT system. Simulation data, using a heterogeneous
mouse atlas, and experimental data, using the XPM2 mouse shaped phantom in the BLDOT
system, showed that the decrease in measurement wavelengths did not detrimentally effect
the quantitative accuracy of the recovered source in BLT. This is provided that the WBW
model is used to account for the bandwidth of the filters used for data collection and that
the measurement wavelengths are chosen by consulting the spectral attenuation of tissue and
emission spectrum of the bioluminescent source, with optimum measurement wavelengths
when the source emission is high and tissue attenuation low. Due to this work involving a
variation in both the number of wavelengths used for data collection and the spectral range
of these measurement wavelengths, in the future it is important to determine the effect of
spectral range of measurement wavelengths on the quantitative accuracy of BLT. The work
must also be repeated in order to produce statistically significant results.
These modifications to the data collection and analysis process were shown to improve
the quantitative accuracy of BLT when applied to simulation and phantom experiments, but
must be validated in vivo if they are to be used routinely in pre-clinical research.
The above work involved use of models and phantoms which had well characterised optical
properties. However, in pre-clinical BLT using a murine model the optical properties of
the animal are unknown and in order to perform quantitatively accurate BLT, accurate
knowledge of these properties is vital. A spectral derivative DOT method was presented
as a method of calculating subject-specific optical properties for use in BLT and validated
using the heterogeneous Digimouse atlas via simulation. The SD method was found to be
more robust to noise in the data than the traditionally used NS method, particularly when
considering angular noise in the data which is currently accounted for during free space
analysis. This suggests that the SD method can bypass the need for the free space model in
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analysis of DOT data. When using the DOT-derived optical properties as prior knowledge
for use in BLT reconstructions of the Digimouse model, the recovered bioluminescent source
distribution when using the SD derived optical properties was quantitatively comparable to
the true bioluminescent source distribution.
Validation of the SD method was performed on a post mortem murine model by tak-
ing DOT measurements using the BLDOT system and then using the DOT data as prior
knowledge for BLT source recovery, as with the simulation study. Modifications were made
to the existing DOT component of the BLDOT system to maximise the achievable intensity
of the DOT sources, minimising the exposure times required to collect transmission data
at each source position. Supporting the simulation conclusions, the SD method performed
superiorly to the NS method. However, the quantitative accuracy of the recovered optical
property distribution was limited. The appearance of the distributions was not anatomically
accurate but the results were promising for this first validation of the method experimentally.
When used as prior knowledge for BLT source recovery, the SD optical property distribution
enabled bioluminescent source recovery of a higher degree of quantitative accuracy than that
achievable using NS determined optical properties or a homogeneous estimate. The results
for this first application of the SD method in a murine model suggest that when applied in
vivo the method may enhance the quantitative accuracy of BLT, however, further work is re-
quired to consider the effect of non-multiplicative noise. This experiment included validation
of the WBW Jacobian model, with the bioluminescent source distribution with the highest
quantitative accuracy recovered using a combination of SD determined optical properties
and the WBW Jacobian model. This is an encouraging result, suggesting that the use of
the SD method and WBW models complement each other and will enhance the quantitative
accuracy of BLT in in vivo pre-clinical research.
Due to the remaining inaccuracy in the optical property distribution recovered using the
SD method, imaging of phantoms with known optical property distributions should be done
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in order to optimise the number of wavelengths used for data collection and the position and
number of DOT sources to use (this work used 15 sources in a 3⇥5 grid with 4 mm spacing).
Previous work has shown a SD method, when applied to a contact imaging system, to be ef-
fective experimentally when 100 measurement wavelengths, with 2 nm spectral spacing, were
used. This work used three wavelengths, with a spectral spacing of >75 nm. The SD method
is based on the assumption that noise present in the data is constant at adjacent measure-
ment wavelengths and therefore will cancel out. Further work should be done to ensure that
the assumption that noise contributions remain constant between measurement conducted
under the same experimental conditions is valid, and to optimise the wavelengths which are
used for data collection. Additionally, scatter should be included in the reconstruction. This
work assumed the scatter was known and only reconstructed chromophore concentrations,
which may account for some inaccuracy still present in the murine data presented in Chapter
6.
The DOT reconstructions in this work do not account for the bandwidth of the filters used
for data collection. As shown by the increase in quantitative accuracy for BLT when using
the WBW model, incorporation of filter bandwidth modelling into model-based recovery is
important when using band pass filters for data collection. DOT data collection also uses
band pass filters and so future work on DOT optical property recovery should incorporate
filter bandwidth into the model-based reconstruction algorithm. This will likely improve the
quantitative accuracy of the technique.
A large proportion of the future work required to develop this work further, is to apply
many of the algorithms in vivo. In preparation for in vivo work the BLDOT imaging system
requires some modification to incorporate a heated imaging platform for temperature regula-
tion of the animals during imaging, and addition of an anaesthesia system for induction and
maintenance of anaesthesia.
The work in this thesis has been shown to improve the quantitative accuracy of BLI,
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through validation of the free space model in a murine environment, and BLT through incor-
poration of filter bandwidth modelling into the source reconstruction and use of a SD DOT
reconstruction method to obtain a subject-specific optical property distribution for use in
BLT. Further work is required to optimise the capability of the methods, and validation in
vivo is vital, but the results presented here are encouraging for increasing the future use of
BLT in pre-clinical studies.
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